The popular arithmetic sets a 54% equity claim against 100% of consolidated debt. Correcting that halves the gap, and then a harder problem shows up underneath.

On 2 September, Bloomberg reported that Elliott Investment Management had built a position in Deutsche Telekom and wanted the company to drop a full combination with T-Mobile US in favour of larger buybacks. Reuters matched it the same day with its own source. Within hours the framing had set: more than 70% of Deutsche Telekom’s value is the American stake, Europe’s largest telecom business is therefore nearly free, and an activist has arrived to prise it out.

I spent two days rebuilding that arithmetic from the filings, and I got it wrong twice before I got it right. The popular version is wrong. My first correction was also wrong. What survives is a claim I can defend line by line, and it doesn’t need a peer table or a valuation opinion to stand up.

Deutsche Telekom owns controlling stakes in three other listed telecoms companies. All three trade in public markets every day. And the German business inside Deutsche Telekom is being valued at less than they are.

There is a film of this piece. It works the sum of the parts on screen, the minority-interest add-back, the lease double-count that produces a ratio Deutsche Telekom does not publish, and the thirty-second check that catches it, with the two SEC filings marked at the figures they carry.

Below the paid line: the 4.7x sum of the parts on one basis, the correction line by line with the two joint ventures the residual absorbs, the EUR 8.5bn segment lease split DT never discloses, the ratings notch a merger costs, and what would change my view.

The term the popular arithmetic drops

T-Mobile’s Q2 10-Q puts shares outstanding at 1,072,671,613 as of 17 July, of which Deutsche Telekom holds 582,065,875 directly, per its latest Schedule 13D/A. At the 2 September close of $187.30 that stake is $109.0bn, or €94.2bn at the ECB rate. Against a market capitalisation near €138.0bn, the stake is 68.2% of the parent, not “more than 70%”.

Subtract and you get about €43.8bn for everything outside America. Written that way it looks like the market is giving Germany away.

It isn’t, and the reason is a term the subtraction drops. Deutsche Telekom consolidates 100% of T-Mobile’s borrowings, because consolidation follows control, while its equity reflects only its 54% of T-Mobile’s equity. That comparison is a category error. You have to add back the roughly €79bn of minority interest DT consolidates but doesn’t own, and put net debt on both sides on one basis.

Do that and the non-US business comes out near 4.7x EBITDA after leases. Which is where I stopped, and where I was still wrong.

Two mistakes, because both are instructive

The first was leases. Deutsche Telekom’s H1 2026 report publishes net debt two ways: €138,387m including lease liabilities, €104,352m excluding them. I took the figure that includes leases and divided by EBITDA after leases. EBITDA AL is already struck after lease cost, so that charges for leases twice. I then ran a “second, independent” calculation that agreed to the euro and treated the agreement as confirmation. It was the same equation rearranged. A rearrangement confirms nothing.

The second was the residual, and it’s the one that matters. My €72.5bn of non-US enterprise value is what’s left after a €274bn subtraction, and a residual absorbs everything you failed to model.

Two things sit in it that shouldn’t. Deutsche Telekom’s 49% of GD Towers and 50% of GlasfaserPlus are joint ventures carried at equity. Their value sits inside DT’s market cap, and therefore inside my residual, but their earnings are not in my €15.4bn denominator. DT prints a table of zeros in its annual report to make the point: since February 2023, GD Towers “has no longer been part of the Group.” DT’s own Level 3 fair value marks are €7.5bn and €1.1bn.

Pulling in the other direction, DT consolidates 100% of the EBITDA of three listed European subsidiaries whose minorities are worth about €6.6bn at market, and those minorities belong in enterprise value.

Strip the stakes without the minority added back and the pure operating business is nearer 4.15x.

I want to be clear that I am not confident to two decimal places here, and nobody should be. What I am confident about is the direction: every correction I have been able to make to the naive number has moved it the same way, and the corrections that would move it back are ones I looked for and could not find.

The comparison that needs no opinion

Here’s why I stopped worrying about peer tables. There is no free data source that publishes EV/EBITDAaL for European telecoms, and the same company can span 40% across four providers on one day. Any argument resting on a “European telco average” is averaging across a 2.7x spread.

So use Deutsche Telekom’s own subsidiaries instead. DT is the parent of four listed companies, not one. Alongside T-Mobile US it controls OTE in Greece, Magyar Telekom in Hungary and Hrvatski Telekom in Croatia. All three are quoted daily. All three carry almost no net debt, which removes the leverage argument entirely. And together they are roughly half the Europe segment’s earnings.

When I pulled their market prices I got this: OTE at about 5.6x forward and 6.4x trailing. Magyar at 5.6x and 6.8x. Hrvatski Telekom at 7.0x and 6.9x.

The non-US block blends to roughly 4.6x. Since half of it is marked in the open market between 5.6x and 7.0x, the other half has to be lower. Telekom Deutschland, which produces a 41% EBITDA after leases margin and takes 44% of all German telecom revenue, per the Bundesnetzagentur, is implied at less than its Hungarian and Croatian subsidiaries.

That argument needs no convention, no peer set and no judgement from me about what a fair multiple looks like. It is market prices on both sides of the comparison, which is why I trust it more than the number I spent two days deriving.

I’d still hold it loosely. The stub is a levered residual, so a $10bn move in T-Mobile’s net debt shifts it half a turn. But the direction survives every version I’ve run.

The ten million shares that show how this structure really works

There is a transaction buried in Amendment No. 35 that explains the whole architecture better than any ownership percentage.

SoftBank’s residual holding in T-Mobile is now exactly ten million shares. On 19 March three agreements were executed at once. A novation moved something called the SB-DT 2029 Call Option to a SoftBank entity called Signal Bright. Signal Bright then entered a variable prepaid forward sale contract with an unaffiliated dealer over those shares, pledging them as security. And Deutsche Telekom took a right of first refusal over the pledged stock.

A variable prepaid forward contract lets a holder take cash now against shares delivered later. It is the standard way to monetise a concentrated position without selling outright. So SoftBank gets its money, and I think that is the whole point of the structure.

The votes, though, do not travel with it, and that asymmetry is what I want you to notice. The filing is explicit that Deutsche Telekom “will continue to have the right to direct the vote of the Pledged VPF Shares under the Proxy.” Economics to the dealer, votes to the controller.

One caution against reading too much into it, which I’ll make because I nearly did. The 2029 call option’s strike is the previous day’s closing price. It can never be in the money. It functions as an access and blocking right, and carries no intrinsic value at all. What the arrangement shows is how control gets assembled here: out of contracts instead of purchases, durable enough to survive a counterparty selling out from under it.

Read more

The claim: The number every outlet ran this week, $250,000 into $60 million, a 240x gross return, requires Thirty Five Ventures to hold 0.465% of Hugging Face at closing. No filing, no company statement and no spokesperson has disclosed a percentage. The two documents Hugging Face did file with the SEC, plus its own funding announcements, put Kevin Durant in four financing rounds. The multiple everyone quotes uses two.

The numbers: Hugging Face’s 2018 seed Form D reports $3,315,000 sold against a $4,000,000 offering, to six investors, in debt. The 2019 Series A Form D reports $19,710,523 sold to 30 investors and states on its face that the figure includes conversion of the earlier notes. $60,000,000 divided by $12,900,000,000 is 0.465%.

The catalyst: The acquisition is reported and unconfirmed, and the two outlets that broke it disagree. The Information reports an agreed deal at $12.9bn; Business Insider reports talks that “had not yet produced a signed agreement.” The payout stories ran on the 27th and 28th.

Wrong if: Thirty Five Ventures discloses that its Series B and Series C checks were immaterial, or Durant’s closing stake is confirmed near 0.465% on a $250,000 basis. Either kills this and I withdraw it.

Nvidia has agreed to buy Hugging Face, the repository where open AI models are hosted and downloaded, for $12.9 billion. Inside a day the second story had eaten the first. Kevin Durant put in $250,000. Kevin Durant is getting $60 million. Twenty-four thousand percent.

I went looking for the cap table behind that arithmetic, expecting a disclosed stake and a lazy multiplication on top. The stake isn’t there. So I pulled Hugging Face’s own SEC filings and read the fields one at a time, then checked the investor list of every round it has announced. Both contradict the coverage.

Below the paid line:

• The $60,000,000 sensitivity table line by line: what 240x becomes on a $500,000 basis then a $750,000 basis then $1,250,000 and finally $2,250,000 against the 6.45x ceiling every Series C dollar drags it toward

• Both Form Ds field by field: the isDebtType flag that makes the seed’s ownership unobservable, and the clarification that counts $3,315,000 twice

• The verbatim investor lists from TechCrunch’s March 2021 Series B and Hugging Face’s own Series C post, the two documents that break the denominator

• Why both headline numbers are wrong and move in opposite directions, plus the 0.465% stake the payout silently requires

• Nvidia’s own position in the $235 million Series D, and the $42.3 billion of unnamed private stakes on its balance sheet

• Four confounds I cannot rule out, including the 10% to 20% escrow convention and the unsigned agreement

The $60 million traces to four words, and neither of them is a filing

Provenance first, because everything else depends on it. Bleacher Report attributes the figures to one origin: “Insider Joe Pompliano reported Thursday that Durant and his business partner, Rich Kleiman, invested $100,000 in the seed round and $150,000 in the Series A round.” The payout sentence is quoted from him: “He likely made more than $60 million in this investment alone.”

Two words carry the whole edifice, as I read it. I’m told, for the check sizes. Likely, for the outcome. That’s the entire evidentiary base, and “one guy on X” is not automatically wrong: Pompliano covers this beat and may have a real source.

I chased the attribution and it doesn’t converge. Bleacher Report credits Pompliano. TheNextWeb credits Front Office Sports and says only “early rounds.” Yahoo Sports credits Front Office Sports for the $250,000, then names nobody for the payout, which it reports as “believed to be upwards of $60 million.” Three chains, none terminating in a document, two of them sharing an origin. No SEC filing anywhere, no Hugging Face statement, no Nvidia statement, no comment from Durant or Kleiman.

Then I watched the hedges fall off. Joe Pompliano wrote “I’m told” and “likely made more than $60 million.” Anthony Pompliano, to a much larger audience, posted “Kevin Durant made $60 million from investing $250,000 in Hugging Face. Insane.” No hedge, no conditional. The whole mechanism in two posts.

Hugging Face filed $3,315,000, and it was a note

Hugging Face has filed exactly two documents with the SEC in its life. EDGAR returns “Items 1 - 2” for CIK 0001739138, both Form D. The last is dated 12 December 2019.

I pulled the 2018 filing. An offering of $4,000,000, a total amount sold of $3,315,000, first sale 20 April 2018, investors already invested: six. Signed by Julien Chaumond as Treasurer, out of 81 Prospect Street in Brooklyn. Clément Delangue’s name is misspelled “Delange” in the related persons block, which tells you a founder filled it in.

I keep reading “a $4 million seed round,” and I want to be careful about what the filing does and doesn’t prove. Per the SEC’s Form D FAQ, a later change in “the amount of securities sold in the offering” is among the changes that do not require an amendment. The round may well have closed at the full $4 million with nobody obliged to say so. The press figure is the target. The filed figure is the only dated, sourced number in the story.

Here’s the larger one. Under types of securities offered, the 2018 filing marks isDebtType true and leaves the equity flag unset. The seed money bought a convertible instrument. A note or a SAFE, and no stock.

That one field changes what I can say a $100,000 check means. Equity at a price buys a known percentage the day it clears. A note buys a claim that converts later, on terms set by a valuation cap and a discount, and neither appears in a Form D. Nobody outside the cap table can compute what that $100,000 became. That’s a property of the instrument.

The Series A Form D counts the seed money a second time

The 2019 Form D reports $19,710,523 sold to 30 investors, first sale 27 November 2019, equity this time. TechCrunch reported it as a “$15 million funding round” led by Lux Capital, with “A.Capital, Betaworks, Richard Socher, Greg Brockman, Kevin Durant and others.”

The filing explains its own gap, in a clarification field I doubt many people open:

Offering Amount and Amount Sold includes the conversion of convertible notes and Simple Agreements for Future Equity previously sold by the Company into the Equity issued at this offering.

So the $19.71 million isn’t $19.71 million of new money. It holds the 2018 round arriving a second time. Net the $3,315,000 of converting seed paper against it and you get roughly $16.4 million of fresh equity, close enough to the reported $15 million that the two accounts reconcile. Sum the Form D amounts to get “total raised” and you overstate Hugging Face by $3.3 million.

There’s a subtler consequence. The conversion happened at the Series A, so the note’s cap was applied on 27 November 2019 and the share count folded into that round. Durant’s seed and Series A positions were set in one event, and I can’t find their combined percentage published anywhere.

$60 million back solves to 0.465%, and nobody has disclosed a percentage

Now do the division I could not find anywhere in the coverage.

$60,000,000 divided by $12,900,000,000 equals 0.004651. Call it 0.465% of the company at closing, before any escrow, holdback or consideration mix. I give it three figures because the input has about one: every source hedges it as “likely more than” or “believed to be upwards of,” and a quotient cannot be more precise than what went into it.

That is what the reported payout requires. Requires of whom is the next problem. Bleacher Report attributes the $250,000 to “Durant and his business partner, Rich Kleiman,” others attribute it to Thirty Five Ventures, and all of them attribute the $60 million to Durant alone. The firm was founded by both men and I can find no disclosure of how its position splits from Durant’s own economics. Numerator and denominator may not describe the same holder.

Now ask what public evidence supports it. None does. Hugging Face has filed nothing since 2019, and as a private Delaware corporation it owes no 10-K, no proxy, no beneficial ownership table.

Nvidia’s own disclosure doesn’t help, and I went and read it. Note 6 of its April 2026 10-Q reports every private company stake it owns as one aggregate roll forward and names not one of them. Nvidia’s own Hugging Face stake is invisible in Nvidia’s own filings.

So I read 0.465% as a back solve wearing a measurement’s clothes. Pompliano didn’t measure a stake and multiply. He estimated an outcome, and the percentage is what falls out when you divide. I’m not saying the number is too high. My claim is narrower: nobody outside the cap table can produce it, and the coverage presents it as though somebody counted.

Read more

Zero coupon convertible issuance is being reported as free financing that AI-era stock volatility has made possible. The primary filings show issuers paying real, quantifiable cash for it, and the single deal every tracker cites as proof of the record year carries a 6.25% coupon.

Below the paid line:
- The capped call cost table across Penguin Solutions, Alphabet’s Series B tranche, Tempus, and Bitdeer, with cap prices, premiums, and annualized cost
- The 51-filing EDGAR cross section of 2026 capped call issuers outside AI, and why that sector spread changes the story
- The mechanism proof, line by line, for why a capped call’s price reveals the value of the option the “0% coupon” headline treats as costless
- The convertible arbitrage buy side: delta hedging, gamma capture, and why dedicated arb allocation shrank from roughly 20% of a hedge fund book in 2000 to 1% to 2% today, even as issuance sets records
- The exact falsifier threshold: under 2% of face kills this thesis, and where the four name sample sits against it today

The story every desk is telling: $161.5 billion and a free option

Every desk covering convertibles this year is telling a version of the same story. I do not think it is a dumb one. Rates have stayed high through 2026. Straight high yield debt is expensive. AI-linked equities swing hard enough that the option to convert a bond into stock is worth something real to a buyer. Volatility is the product.

Numerix counted $84.6 billion across 96 global convertible deals in Q2 2026 alone. That is a 67% jump over Q2 2025. A record quarter. Of those 96 deals, 44 priced at a 0% coupon, 46%. ION Analytics puts the year to date global total at $161.5 billion through July 22, already 23.6% above the prior full year pace record set in 2021. Man Group’s own credit desk puts full year 2026 issuance on pace to exceed 2025’s record of $167 billion. The pace is real.

The mechanism analysts cite is standard convertible bond pricing theory, correct as far as it goes. A convertible’s value splits into a straight bond component and an embedded call option on the stock, and that option’s price rises with implied volatility. Push implied vol high enough and a company can sell the option for a 0% coupon while investors still buy the bond at par, paid entirely in optionality instead of cash. Barclays and BofA research, cited across the trade press, frame it as a substitution: companies that would have paid 6% to 8% on high yield debt are instead paying nothing, funded by volatility itself.

The sector concentration behind those totals is worth sitting with, because it is more lopsided than “AI is driving issuance” implies. Computers and electronics accounted for $86.23 billion of the $161.5 billion global year to date total, 53.4% of every dollar raised in the convertible market this year, across 139 deals, per ION Analytics. Healthcare ran a distant second at $12.7 billion, 7.9%. Not close. AI-adjacent supply is not one flavor among several here. It is close to being the whole market for 2026, which is exactly why a mispriced assumption inside that sector’s dominant instrument would matter more this year than in almost any prior one.

My read is that this framing survives exactly as long as nobody opens the prospectus supplement.

Alphabet’s own straight debt told a related story earlier this year: a $20 billion bond offering priced spread compression tight, without any embedded option at all.

Penguin Solutions spent $49.1 million to buy back what it just sold for nothing

I went looking for the cost of that “free” option, because a financial instrument does not cost nothing just because the number on its face is zero. What I found in the filings is that issuers are not treating their own zero coupon deals as free. They are spending real cash, disclosed in dollars, to buy a large chunk of that option straight back.

Penguin Solutions issued $750.0 million of 0.00% Convertible Senior Notes due 2031 on July 17, 2026. The notes carry no regular interest and do not accrete principal, about as close to a literal zero cost instrument as debt gets on paper. Four paragraphs later, in the same 8-K, the company discloses it spent approximately $49.1 million, 6.55% of face value, on capped call transactions to reduce the dilution those same notes create. That is not a rounding error. It is the company underwriting the accuracy of the “free money” pitch with its own cash, and I do not think it fully believes the pitch.

Alphabet’s Series B Mandatory Convertible Preferred Stock, priced the same quarter at a real 6.25% annual dividend, still carried $439.7 million of capped call spending on the base tranche alone, per its own 424B5. Against that tranche’s roughly $8.375 billion in gross proceeds, that is 5.25%. Bitdeer Technologies, the crypto mining company that has spent the past two years converting mining capacity into AI and HPC cloud infrastructure, spent $29.2 million on capped calls against $315.1 million of net proceeds from a February 2026 convertible refinancing. That is 9.27%, the highest ratio of the four names here, on notes that carry a real coupon. Tempus AI, the healthcare data company, priced a true 0.00% coupon note on May 7, 2026 and spent $27.2 million against $384.1 million in net proceeds on the base offering, 7.08%.

Four unrelated issuers. Four separate deals, four different coupon structures. Four capped call costs, all clustered between 5% and 9% of proceeds. That clustering, across issuers who share almost nothing else, is the tell. Four strangers, one number.

The capped call is a receipt: what real dollars reveal about a “free” option

The size of the check an issuer writes for a capped call is the whole argument, so start with what the instrument actually does. Selling a convertible note makes a company short a call option on its own stock: the right the bondholder has to convert debt into equity at the conversion price. If the stock rockets, that option transfers real value from existing shareholders to bondholders, dollar for dollar, on every share issued above the conversion price. A capped call is the company buying that option back from a bank, up to a cap price, recapturing the dilution between the conversion price and the cap.

Penguin Solutions set its conversion price at $116.70 a share and its cap at $175.05, a 125% premium over its July 14 closing price of $77.80. Between $116.70 and $175.05, Penguin is now hedged. Insurance costs money. Every time. Above $175.05, it is exposed again. The price of that hedge was not a fee for paperwork. $49.1 million is the market’s own valuation of the equity optionality Penguin just wrote into its notes, priced by the banks who structured the deal. A dealer’s own margin sits inside that price too, so I read it as a floor on the option’s value rather than a clean clearing price. The floor still runs at real money.

Here is the arithmetic the “0% coupon” headline erases. Amortize Penguin’s $49.1 million over the note’s five year life to maturity in 2031, and you get roughly $9.8 million a year. That is 1.31% of face value annually. Not the highest cost of capital in the market. Also not zero. The company’s own transaction structure proves it.

I make Alphabet’s Series B capped call spend, $439.7 million against roughly $8.375 billion of base tranche gross proceeds, at 5.25%. That sits close to Penguin’s 6.55%, even though Alphabet is investment grade and pays a real coupon that Penguin’s notes carry none of. Two issuers, wildly different credit quality, land within 130 basis points of each other. Credit rating barely moved the price. Vol did.

The reason: a capped call’s cost tracks implied volatility on the underlying stock far more than it tracks the issuer’s credit rating. That’s precisely the variable AI-adjacent equity has pushed to multi year highs, across mega caps and mid caps alike. Bitdeer’s higher ratio, 9.27%, fits the same logic from the other side. A smaller, more volatile name pays more per unit of dilution protection than Alphabet does. Coupon structure doesn’t enter into it. Vol sets the price.

Read more

The claim: Venezuela’s reported 100-year oil lease is being priced by the market as a durable commitment built to outlast any one government. I’d price it as the opposite signal. At any discount rate a Venezuelan sovereign risk deserves, the back eighty years of a 100-year lease are worth almost nothing today.

Consensus: a retirement party, not a departure

The reporting on Venezuela’s possible OPEC exit has converged on one reading, and it is a reasonable one. Bloomberg’s own account, carried by Investing.com, notes the country’s departure “would have limited immediate impact on global oil markets,” given how little it produces today against its own past output. Venezuela has sat outside OPEC’s formal quota compliance since 2016, when collapsing output made its assigned target meaningless. It has produced without reference to a cartel ceiling ever since. A country that already ignores its quota loses nothing by making the exemption official. Nothing lost, nothing new.

The UAE left OPEC+ in May for capacity reasons of its own. It was producing 3.4 million b/d against an estimated 4.2 million of effective capacity, and it wants 5 million by 2027, which the quota it just left would never have allowed. That exit barely moved the strip. Venezuela’s, on this reading, is a smaller version of the same story: paperwork catching up to a relationship that’s already public, one confirmed departure and one live deliberation raising a legitimate but slower moving question about how much pricing power Saudi Arabia and Russia have left. The sell-side version of this same smaller story is narrower and fair on its own terms: Citi’s Scott Gruber told Bloomberg the oilfield services opportunity is real regardless of who owns the lease, a services revenue argument, not a reserve ownership one, and a drilling contractor paid this quarter does not carry the same risk as an equity holder in year 41. A different risk entirely.

There’s a second, stronger version of the consensus, and it deserves a real hearing rather than a dismissal. This time, the argument goes, actually is different. Nicolás Maduro was captured in a US raid on January 3, and Washington has controlled the marketing of Venezuelan crude since, with President Trump saying in late July that sales had already cleared $13 billion. Energy Secretary Chris Wright put the logic plainly at a Goldman Sachs energy conference: the US intends to control Venezuelan oil sales “indefinitely,” saying it needs that leverage to drive change in Venezuela. A reform of the Hydrocarbons Law took effect January 29, letting private companies hold majority upstream positions for the first time since the 2007 mixed company structure. Chevron’s Venezuela output is already up 15% over six months, guided toward 50% growth by the end of 2028. The growth is genuine.

On the strongest telling, a 100-year lease is not bravado. It is the natural conclusion of a government that finally has both the legal framework and the foreign backing to commit for the long run, and the earlier reversals belong to a Venezuela that no longer exists. I take that case seriously. But it is not the discriminating question, in my view. The discriminating question is what happens once US attention moves on, and nothing about a 100-year number answers it.

The variant view: the number is the tell

Here’s what the “no impact” framing misses. Venezuela’s exit changes nothing about barrels this year. That’s true. It is not evidence that nothing about the exit matters. Small does not mean irrelevant.

The 17-field lease being negotiated alongside it is the actual story. Its headline term, a century, isn’t a sign of confidence. It’s a sign the number has stopped doing economic work and started doing political work. No oil company prices cash flow a hundred years out. My read of the reserve math below shows why: at any discount rate that belongs on Venezuelan risk, years 41 through 100 of a lease are worth low single digits of its total value. Almost nothing, by design.

A company that actually expected to collect for a century wouldn’t need to say so. The contract would just run its economically relevant course and get renewed, the way Chevron’s existing Venezuela agreements already do: terms expiring in 2039, 2041, 2047 and 2050, all comfortably inside the window where the arithmetic still matters. A hundred years isn’t a cash flow assumption. It’s a claim about permanence, aimed at persuading investors, lenders, and Venezuela’s own public that this arrangement won’t be reversed the way the last two were. That claim would only need making if the market’s actual prior is that it will be. A tell, not a guarantee.

That judgment already exists, and it’s the sharpest data point in this whole story, though not for the reason it first looks like. Chevron’s own 10-K for fiscal 2024 states it without qualification: “As of December 31, 2024, no proved reserves are recognized for these interests” in Venezuela. This from the one company that never left, that operated straight through Chávez’s 2007 nationalization. It carried roughly 160 million barrels of proved Venezuela reserves on its books right up until 2020, when it took a $2.6 billion full impairment and removed every one of them. Gone, all at once.

Here’s the part I think actually matters: what triggered that impairment wasn’t a Venezuelan expropriation. It was Washington. The US sanctioned PDVSA, Chevron’s own joint venture partner, in January 2019, and months of narrowing licenses later, Chevron’s accountants concluded the loss was no longer temporary. The reserve line has never been restored since, not through five years of licenses granted, revoked and regranted, most recently when the White House pulled Chevron’s operating license outright in February 2025 and then handed back a new one months later, the same relief this piece already credits with Chevron’s current output growth.

That’s the market’s actual, central view of Venezuelan title security, and it isn’t really about Venezuela at all. It is a live demonstration that Chevron’s entire Venezuela exposure runs on a license Washington can revoke on a phone call, which is exactly the discretionary account risk this piece keeps coming back to on the money side too. The reserve line was filed with the SEC under penalty of law in February 2025, months before anyone was discussing a 100-year lease, and it still has not moved. The lease term is a marketing number. I’d treat the reserve line as the real one, for what it actually measures. The filing is the fact.

The mechanism: why 100 years is not worth what it sounds like

Start with the arithmetic, because it is the whole case. A lease’s value is the sum of its future cash flows discounted back to today, and the discount rate does almost all the work in a story this long. Venezuelan sovereign risk, even under the current arrangement, sits in the 8-to-12% range a frontier energy asset typically carries, in my judgment. Nothing exotic about that number.

I ran the standard annuity formula, present value of $1 a year for N years at rate r equals one minus (1+r) to the power of negative N, divided by r, across a full 100-year term against shorter windows. The split is stark. At a 10% discount rate, the first 40 years capture 97.8% of a 100-year lease’s entire value. The last 60 years add just 2.2%. Push the rate to 12%, appropriate for a deal this exposed politically, and years 41 through 100 shrink to 1.1% of total value. Even at a generous 8%, they are only 4.6%. The tail barely moves the total.

I make that the back six decades of “a hundred years” worth somewhere between one and five cents on every dollar the headline implies.

I walk through the full worked example at three discount rates, plus how to apply the same framework to any long-duration sovereign concession, in The Sovereign Concession Discount.

Venezuela’s own base rate is faster than the discount curve

Now replace 40 years with Venezuela’s own measured history, because that is the number that should actually discipline this deal.

The country nationalized its oil industry outright on January 1, 1976, forming PDVSA under President Carlos Andrés Pérez. It reopened to foreign capital through the Apertura Petrolera in the early 1990s, producing the four Orinoco strategic association agreements that became Chevron’s current joint ventures. In 2007, roughly three decades after the original nationalization, Hugo Chávez converted those associations into PDVSA-majority “mixed companies,” and ExxonMobil and ConocoPhillips walked rather than accept the new terms. Chevron, Statoil, BP and Total stayed. Nineteen years after that reversal, the Hydrocarbons Law reform reopened the sector again, this January. The cycle turns again.

Three cycles. One direction each time. The three gaps, 1976 to the early-1990s opening, that opening to 2007, and 2007 to this January, each run somewhere between fourteen and nineteen years. I will use seventeen as the representative gap for the arithmetic below, the middle of that range. Seventeen years, not a hundred.

At a 10% discount rate, the first seventeen years of a 100-year lease already capture 80.2% of its total value. Whatever Venezuela’s own history says about how long an opening actually lasts, I would argue the market has already been paid most of what the full century was ever going to be worth, in present value terms, by the point that pattern would typically turn again.

None of this is unique to Venezuelan crude, as far as I can tell. It is the same math every long duration concession runs into, and the historical record backs the arithmetic instead of complicating it. William Knox D’Arcy’s 1901 concession in Persia ran 60 years on paper; Britain lost it in 1951, at year 50, when Iran nationalized the Anglo-Iranian Oil Company. Kuwait Oil Company, founded in 1934 on a concession commonly put at 75 years, was fully nationalized by the state in 1975, at year 41. Both companies held, on paper, some of the strongest legal protection a foreign concessionaire could get in their era. Both lost control decades before their contractual term ran out: D’Arcy’s grant had ten years left on paper, Kuwait’s had thirty four. Neither one made it.

No concession this long has ever actually run its full course, in either of these two cases, and I found nothing in the historical record that runs the other way. Neither one was actually a hundred years, which makes the pattern more damning for a 100-year claim, not less: even 60 and 75-year grants, shorter and on paper safer, got cut short by decades. Venezuela’s own average across its three cycles, seventeen years, is not an outlier against that record, in my read of it. It is just a faster version of the same pattern, playing out on a shorter clock. A faster clock, same story.

The discriminator: what actually makes this different, and why it cuts the other way

The strongest version of “this time is different” rests on US involvement being categorically new. Bigger, and different in kind. That’s correct as description. Where it breaks down is the assumption that direct US control makes the deal more durable. I think it does the opposite. Legitimacy at home is what actually decided the last two reversals, and legal drafting had almost nothing to do with either one. Politics decided it, not paperwork.

The 1976 and 2007 nationalizations weren’t imposed on a reluctant Venezuela. They were popular. Pérez nationalized in 1976 with broad domestic support during a high oil price boom. Chávez’s 2007 move was a central plank of a presidency that had just won reelection. Both leaders drew domestic legitimacy from taking Venezuelan oil back from foreign companies. Popular moves, both times.

The current arrangement inverts that structure completely. It follows a foreign military operation that captured a sitting head of state, installed an interim government whose own constitutional 90-day mandate lapsed in early April with no confirmed extension vote from the National Assembly, and routes oil sale proceeds through accounts the US Energy Department’s own fact sheet describes as disbursed “at the discretion of the U.S. government.” A State Department official told Congress in April that only about $3 billion of the $13 billion collected has been accounted for, and a congressional watchdog has since opened a formal review. I don’t read any of that as a stronger foundation for a hundred years of commitment than 1976 or 2007 had. I read it as weaker, because it carries no domestic electoral mandate at all. Only a foreign one. And every reversal in this piece’s history came from a government asserting that the deal in front of it wasn’t its own. No local mandate this time.

I should name the strongest counter directly: raw external power has sustained illegitimate arrangements for decades with no local consent at all. The US has held Guantánamo Bay on a lease Cuba has refused to cash the rent checks for since 1959, sixty seven years and counting, on the patron’s staying power alone. But Guantánamo is a fenced enclave needing no functioning courts, no cooperative workforce, no administrative continuity across 28 million people. A national oil sector needs all three, so I think legitimacy matters more here, but I won’t pretend the comparison is airtight. An imperfect parallel, still useful.

What the market’s own burned players think

The clearest evidence the market already agrees sits with the two companies who lived the last reversal directly. ExxonMobil and ConocoPhillips are negotiating a potential return to the 17-field opportunity, and both are visibly reluctant.

ExxonMobil chief executive Darren Woods has said the company has “had our assets seized twice,” and that returning “would require some pretty significant changes from what we’ve seen historically here,” calling Venezuelan oil “uninvestable” without “durable investment protections” and legal change.

I read that as the closest thing available to an expert market view from inside the trade. It’s priced not in a research note but in a chief executive’s own reluctance to commit shareholder capital.

I went into the arbitration record expecting two clean wins for the companies burned last time. It isn’t there. ConocoPhillips is still owed the bulk of an $8.7 billion ICSID award from the 2007 seizure, an amount that has grown past $11 billion with interest after Venezuela lost its annulment appeal. ExxonMobil’s own 2014 ICSID award started at $1.6 billion and went the other way: an annulment committee struck roughly $1.4 billion of it in 2017, leaving the company with closer to $200 million from that proceeding. Binding international arbitration was already the strong legal protection tried once, after the last cycle turned. Where it held up, collecting took the better part of a decade. Where it didn’t, the loss came from the same system that was supposed to be the guarantee. My read: a fresh 100-year lease document doesn’t erase that history. It sits directly on top of it, and the two firms with the most reason to trust a new promise are negotiating hardest against trusting it.

The limits: where the case actually weakens

I won’t pretend the discount I’m describing is total. Chevron’s growth this year is real. 280,000 b/d today, up 15% in six months, against a national total of 1.16 million b/d, means Chevron alone already accounts for close to a quarter of everything Venezuela produces. A real and growing share. Sanctions relief and the new Hydrocarbons Law are functioning changes to the operating environment. I’d count them as more than announcements.

And the degree of direct US financial control here, proceeds settling into US-controlled accounts instead of PDVSA’s own, has no precedent in any of the historical cases I’m comparing it against, whether that’s Iran under the D’Arcy concession, Kuwait under its 1934 grant, or Venezuela’s own two prior openings. If Washington’s involvement persists for years, well beyond one administration’s term, the risk profile could shift in ways my base rate doesn’t capture. A genuine unknown, stated plainly. I have no comparable case of a producing country’s oil sector run this directly by a foreign government for an extended stretch. I can’t rule out that this is a real structural break, not a repeat.

A third limit: Brent and WTI both drifted lower the same week the OPEC-exit report landed, mostly on broader demand worries, and I can’t point to desk commentary pricing a distinct Venezuela premium into the curve. I’m reading that as complacency. A fair critic would read the same silence as a reported number with no signature simply not deserving a reaction yet, and I can’t fully rebut that until a real term sheet exists.

This mispricing has a short shelf life, which I want to say plainly rather than let it read as a standing inefficiency. The moment a term sheet leaks or gets confirmed, whatever gap exists between the headline and the deal’s real economics closes in a single trading session. Fast, once it happens. That is a matter of months, in my estimate, not years, given how actively both governments are negotiating.

The other honest gap: nobody outside the talks has actually seen one. “100 years” comes from Bloomberg’s own unnamed sources alone, per reporting out of Rio Times tracking the same day’s coverage: Reuters and Axios covered the same story without citing any lease length at all, and no government has confirmed a figure. That same Rio Times piece adds the detail that does the most work for my own argument: a hundred years is, by its own account, “a length Venezuelan law does not provide.” If that’s right, the number was never going to be signed as written in the first place. Dead on arrival, maybe. Hydrocarbons minister Paula Henao, appointed in March, has publicly invited American firms to invest, but the specific fields and the specific term she has in mind haven’t been made public. The number could well get replaced by something closer to the 25-to-40-year range Chevron’s existing joint ventures already use. If that happens, the “headline theater” reading I’m making gets confirmed, not refuted. But I should say plainly, here, that I’m reacting to a reported number, not a signed one, and to one outlet’s sourcing at that.

What would change this view

Three things would move me off this read, and all three are dated and checkable, which is the point of writing them down now.

That would be real progress on the first. The second confirms my read directly; no dodging that outcome if it doesn’t hold. That third one is the real test, in my view. Every reversal in this piece’s history came from a government asserting a predecessor’s deal wasn’t its own to honor. The current arrangement hasn’t faced that test yet. It hasn’t had an elected successor yet, by construction. The test has not happened yet.

The close: price the book Chevron actually keeps

If you’re underwriting Venezuela exposure through Chevron, or through any other name that ends up inside the 17-field talks, the instrument to price isn’t the 100-year headline. It’s the paper Chevron already holds.

Joint ventures running to 2039, 2041, 2047 and 2050 sit inside a 13-to-24-year window, almost entirely within the part of the discount curve where the arithmetic still counts. A company with every commercial incentive to book Venezuela at a positive number still won’t put one on its balance sheet, because the license under it can be pulled faster than any Venezuelan government could move. Treat anything past that window as pure optionality, priced the way Chevron itself is already pricing it. At zero. I’d trust that book over this week’s headline.

So which would you rather hold: Chevron’s proven, dated paper through 2050, carried on its own books at zero, or a fresh 100-year lease priced by a negotiating table that has shown no such discipline at all?

I post this same research on YouTube and LinkedIn as it publishes.

The Decision-Grade Version

This piece is complete on its own. The thesis, the arithmetic, and what would change my mind are all above, and nothing was held back to sell you a next step.

The Patreon note is a separate piece of work rather than a deeper cut of this article. It walks the same mechanism as a general framework for pricing any long-duration sovereign concession, with the full three-rate worked example and a section on where the framework breaks that this article doesn’t have room for. Written for people who apply this kind of arithmetic to positions, not just to one headline.

→ Read the sovereign concession discount note

→ Or join the Patreon community for every note

If you strip the country name off this, is a hundred-year contract ever actually worth pricing past year forty, or is a number that long always doing more marketing than arithmetic?

Cover photograph: Dreamyshade, CC BY-SA 4.0, via Wikimedia Commons.

I want to open with the number most of Wednesday’s coverage buried. Moderna fell more than 25% on Thursday, giving back over $18 billion of the new market value it had gained a day earlier, a decline that runs closer to 40% measured against the whole dollar gain instead of the closing price alone. That’s the number that matters. A stock that reprices on durable new information doesn’t usually do that. A stock that got squeezed does, once the forced buying behind the overshoot runs out of sellers left to force.

The consensus, stated at its strongest

The dominant read treats August 19 as a legitimate scientific and commercial reprice, and on the surface it’s a fair one. Merck and Moderna announced that intismeran autogene, an individualized neoantigen therapy, combined with Keytruda met the primary endpoint of recurrence free survival and the key secondary endpoint of distant metastasis free survival in the confirmatory Phase 3 INTerpath-001 trial, a randomized study of 1,137 patients with completely resected, high risk melanoma, the first positive Phase 3 readout ever recorded for an mRNA cancer therapy. Bank of America’s Alec Stranahan called it a watershed moment and raised his price target more than fourfold, to $170 from $40. Brookline modeled potential worldwide sales of $4.67 billion by 2030. None of that is wrong on its face.

Here’s the company’s actual condition heading in. Four years of a collapsing COVID franchise. Cash burn from an unproven pipeline. US vaccine revenue down to roughly $1.2 billion in fiscal 2025. Against that backdrop, Moderna just produced the first hard proof, in a randomized controlled trial, that its core cancer platform works at all. The strongest version of the bull case doesn’t need a squeeze to justify a large move. I take that case seriously. My argument isn’t with the direction. It’s with the size. Full stop.

What Moderna’s own press release didn’t say

Here’s the observation that forces a different read, straight from the company’s own words. Merck and Moderna’s press release did not disclose a hazard ratio for the Phase 3 result, or a percentage risk reduction. It said the trial met its endpoints, full stop, with complete data reserved for an unnamed medical meeting later this year. Every 49% and every 59% figure that ran across financial media on August 19 belongs to KEYNOTE-942, the Phase 2b trial reported back in 2023, cited by the companies themselves, explicitly as historical context, inside the same release that withheld the new numbers. That distinction did not survive contact with most of the day’s coverage. Read the release itself. I think it matters more than almost anything else in this story.

A trial that discloses a bigger effect than before is new information a market has never priced. A trial that says “it worked,” without saying how well, resolves a narrower kind of uncertainty: call it replication risk, the probability that a Phase 2b signal holds up when retested in a larger, harder, randomized Phase 3 population. I’d put oncology near the top of the list of therapeutic areas where that signal most often fails to hold, which is exactly why a positive readout is worth celebrating. Resolving that risk in your favor is worth something real. It isn’t, on its own, obviously worth pricing a $69.6 billion market cap on a company that traded at roughly $25.1 billion the day before (399.24 million shares at Tuesday’s $62.96 close: I make that $25.1 billion, and at Wednesday’s $174.38 close the same share count makes $69.6 billion), off a release that named no magnitude at all. My own read is that the gap between what a bare “it worked” announcement should be worth and what the stock actually did is exactly where the crowding premium lives. Most of that premium, I think, traces to Moderna’s short book. Not all of it, and I correct that in the next section.

How a crowded short book turns a headline into 177 percent

Start with the setup going into Wednesday. Moderna carried 13.5% of its free float sold short, per ORTEX, among the most heavily shorted large caps in the index and several times the S&P 500 median, a position already shrinking through the year as roughly a quarter got covered since January. That is a crowded trade sitting inside a market that had, just weeks earlier, been through its worst systematic long short drawdown since the summer of 2025. Goldman Sachs’ prime brokerage desk had systematic managers giving back roughly a quarter of their year to date gains between late June and early July, down 3.6% and up 10.8% for the year against a 14.4% peak, with Bloomberg separately putting systematic funds down 2.1% in one week on top of a 3.1% five day slide, the weakest two week stretch since December 2023. AI and memory chip momentum sat at the center: SK Hynix fell more than 40% in July alone, its worst month since October 2008, and SK Hynix, Samsung, and Micron together shed roughly $460 billion of market value at once. One dating flag: this drawdown data is six to seven weeks old relative to Moderna’s print, with no fresher figure confirming whether it had deepened, eased, or persisted by August 19. Old data, real setup.

Here is why that backdrop matters for a biotech name most of that coverage never mentioned in the same breath. My own read is that a momentum unwind is never only a long side event, whatever the headlines that week were about. When systematic long short books derisk, they cut both legs at once. The short leg on names like Moderna, deteriorating fundamentals with a heavily crowded bet against it, can get trimmed defensively even absent company news, because VaR limits and gross exposure targets force the trim regardless of what any single manager thinks about a trial. Jordi Visser at 22V Research put the broader mood bluntly in early July, roughly six weeks before Moderna’s print: momentum volatility, running hotter than the dot com era by his own read, was flushing out “hedge funds with VAR limits and retail traders chasing breakouts.” I take that as evidence of the mood. Nothing sharper than that. It isn’t proof the short book was still primed to shrink six weeks later, on the specific day Moderna reported. A real gap I don’t fully close: the funds in that evidence read as systematic, momentum driven books, while Moderna’s own short base reads as fundamentally motivated biotech bears betting against a shrinking COVID franchise. I can’t show those are the same funds. Same direction, unconfirmed identity. What I can show is that both were leaning short and derisking in the same broad window, and a catalyst this size gives any crowded position a reason to move all at once, whichever funds were actually holding it.

A second mechanical amplifier the short book alone doesn’t explain

MSCI’s own factor research on the comparable summer 2025 episode is the closest thing to a peer reviewed account of the mechanism. Stocks that combine high short interest with high residual volatility “systematically exceeded the prediction of a linear model” during a crowding unwind. The amplification is non linear. I would call that the documented mechanism here, on a different set of names, in a comparable episode roughly a year earlier. A linear model says a stock should move in rough proportion to the surprise in its fundamentals, and it undershoots exactly these setups, because the second order effect, forced buying from funds that are short and derisking on the same clock, was never something an information only model was built to capture. The math misses the crowd.

The per share arithmetic makes it concrete. Peter Hillerberg at ORTEX put it plainly: each shorted share down almost $100, exactly the kind of pressure that can trigger a squeeze. ORTEX marked the single day loss for shorts at $4.8 billion; S3 Partners put it closer to $5.5 billion, bringing year to date losses to roughly $7.7 billion. Neither figure rounds to zero against a $69.6 billion repricing. Real money. Real pain. Real leverage. A short book that size, forced to cover into a thin, gapping tape, does not add a proportional amount to the move. It adds a multiple.

I owe this section one correction on my own initial read. I went looking for what could break it, expecting the short book to be the whole story. It wasn’t. The short book was not the only mechanical amplifier running that day. The Aug 21 $120 call was the single most traded options contract in the name, more than 510,000 contracts, a record, moving from a penny to $54.20. Deep out of the money calls that cheap don’t just reflect a squeeze. They cause a second one: market makers who sold those calls must buy the underlying stock to stay delta neutral as the price runs, its own source of mechanical, non fundamental buying. I can’t cleanly separate how much of the 177% came from shorts covering versus dealers hedging their own book, and I doubt anyone outside the market makers can. Genuine uncertainty, stated plainly. Both are crowding. Neither is the trial data.

Read more

Big Tech’s off balance sheet AI obligations are not one undifferentiated $3 trillion risk. Credit markets are already pricing them on a single variable the aggregate number hides, and Oracle’s July 2026 downgrade is the receipt.

Photo: Håkan Dahlström · CC BY 2.0, resized · via Wikimedia Commons

I’ve spent several days inside five sets of SEC filings, plus a full adversarial pass trying to break my own read. My read is that most of the coverage of this week’s Wall Street Journal analysis missed the actionable part. The $3 trillion figure is real. It dwarfs the roughly $248 billion in leases and $356 billion in debt these firms report on their balance sheets today. Strip out Oracle’s own $260 billion, already downgraded slice, and roughly $2.7 trillion of this is still sitting in footnotes, being treated by the market as one undifferentiated pile. But treating it as one number, one risk, one story, is exactly the mistake a sophisticated credit desk isn’t making. They’re already discriminating inside it, on a narrower variable than “AI lab concentration” alone. The discriminator sits in a footnote most equity analysts skip past on the way to the capex guidance.

The consensus treats these as footnotes

The prevailing view, stated in a form its own believers would sign, goes like this. Purchase commitments and leases that haven’t commenced are executory contracts, not liabilities. Under ASC 842, a lease doesn’t hit the balance sheet until the space is delivered and the term begins. Alphabet, Microsoft, Meta and Amazon are, by every conventional metric, among the strongest balance sheets on the planet. Microsoft carries an AAA adjacent rating. Alphabet and Meta are barely levered against their operating income. The balance sheets are real.

These four companies generated more free cash flow last year than most G20 sovereigns raise in annual tax revenue. Analysts already model AI capex through the capex line and the depreciation schedule that follows it, both of which sit in every DCF on the Street already. The footnote disclosure exists precisely so nobody has to guess: it’s all there, filed quarterly, audited annually. A commitment isn’t a debt until you draw it.

Comparing $3 trillion in largely conditional, multi year forward obligations to $356 billion in funded debt, as several of this week’s viral posts did, is comparing a ten year grocery list to a mortgage. Moody’s own July report put the sharpest number on this: $1.2 trillion in total lease commitments across six companies, more than $820 billion of it from leases not yet commenced. And Moody’s still concluded that Microsoft, Alphabet, Amazon and Meta retain among the strongest corporate balance sheets in the world. Their investment grade ratings, in Moody’s own view, are unlikely to be under imminent threat. Moody's isn't worried. If the rating agency that ran the numbers isn’t worried about the big four, why should anyone else be?

The variant view: the market already split the $3 trillion in two

Here’s what that consensus reading misses. S&P already acted on it. On July 9, 2026, S&P Global Ratings cut Oracle’s long term issuer rating from BBB to BBB-, one notch above junk. It cited almost the identical mechanism the WSJ just described in aggregate: leases that haven’t commenced, running years into the future, invisible to a standard leverage ratio. S&P was watching anyway.

Oracle’s $260 billion in uncommenced data center leases is smaller in absolute terms than Microsoft’s $329.1 billion or Meta’s $278.99 billion (Microsoft 10-K; Meta 10-Q). Same accounting treatment. Same asset class. Same AI buildout. Only one company got downgraded.

That’s the fact the aggregate $3 trillion number cannot explain. It’s also the fact that makes this actionable instead of merely alarming. Moody’s report, the source of the $1.2 trillion figure, drew the same line I’m drawing here: it grouped Oracle with CoreWeave as the two names it did not extend its safety reassurance to, while naming Microsoft, Alphabet, Amazon and Meta specifically as the four that were fine. That’s not commentary. A rating agency, in the same document that produced the scary aggregate number, told you exactly which pieces of it it’s actually worried about. My read is that the $3 trillion headline does the opposite of what good research should do. It flattens a real, discriminating credit signal into one terrifying total, and that makes for a better hook on a feed than a basis for a position.

The demand side is just as concentrated as the supply side

Before the mechanism, it’s worth pausing on why a counterparty concentration story is even plausible here. The demand side of this buildout is exactly as narrow as the risk I’m describing on the supply side. Ramp’s own AI Index, as reported, puts the top 1% of AI spending US businesses at a median $7,400 per employee per month as of July 2026. The top 10% spend $650. The median firm spends $11.95. A steep drop-off. I read that as a whales first market, concentrated at the very top of the distribution.

The hyperscalers know it: a handful of frontier labs and enterprise whales account for a disproportionate share of the incremental demand supposed to fill $3 trillion of new capacity.

Nvidia’s own financing choices show it treats that concentration as a real risk to manage. Nvidia is reportedly finalizing roughly $100 billion in credit support for OpenAI’s planned 10 gigawatt Ohio data center campus, a figure still moving as I write this and sourced to a paywalled report, same limitation as the WSJ piece this article responds to. That guarantee was under discussion at up to $250 billion before being scaled back, and other reporting this week puts the settled number closer to $120 billion. Still nine figures. The company selling the chips is choosing to underwrite OpenAI’s credit directly, instead of letting OpenAI raise that debt on its own standalone signature. If Nvidia doesn’t think OpenAI’s own name is enough to raise nine figures cheaply, that’s a market priced signal about counterparty risk. It’s the same risk sitting inside both Oracle’s downgrade and Microsoft’s much larger, so far unpenalized, RPO. I found the same gap one layer down the stack when I compared how Google and its own lessees price the identical AI data center guarantee: the counterparty writing the contract and the counterparty relying on it can value the same piece of paper wildly differently, and that gap is where the real risk hides.

The mechanism: tenor mismatch is what gets priced

This section is the analytical core, and I am going to walk through it in full, because size is not the variable, and this is where almost every hot take on this topic goes wrong.

Start with the accounting. A lease that has not commenced sits outside the balance sheet under ASC 842 because the right of use asset and the corresponding liability are not recognized until the lessor actually delivers the space and the lease term begins. I checked this against all five companies’ own filings, and the treatment is identical every time. It is the standard, applied uniformly, not a loophole one lessor found and the others missed. Alphabet discloses $85.2 billion in uncommenced leases. Meta discloses $278.99 billion, plus another $68 billion signed in July, per its 10-Q’s subsequent events disclosure. Microsoft discloses $329.1 billion. Amazon discloses $137.2 billion in its own commitments table. Oracle discloses $260 billion, tagged explicitly in its own XBRL data as LesseeOperatingLeaseLeaseNotYetCommencedLeaseCommitments. All five sit in the identical accounting no man’s land. Same rules, every time. If accounting treatment were the discriminator, all five would carry the same incremental risk premium per dollar. They do not.

What S&P actually named was a mix of factors, and I want to be precise about the weighting rather than overstate one piece of it. The primary, quantified trigger is leverage. S&P’s own downgrade trigger is adjusted debt to EBITDA sustained above 4.5x, against a base case that peaks near 4.4x. The capex guide behind this downgrade jumped from roughly $60 billion to $90-95 billion inside one review cycle. Layered on top of that leverage story, on the record, is the structural piece I am arguing matters more than the headlines gave it credit for. Andrew Chang, the S&P credit analyst who led the Oracle downgrade, called the mismatch between 15 to 19 year data center leases and up to five year customer contracts an “absolutely key risk.” Oracle has to assume, in his words, that AI demand holds or improves “multiple years out.” Only then does the ecosystem underwriting those lease payments stay viable. A real, dated risk.

Then layer on the third piece. Reported estimates put Oracle’s OpenAI exposure at almost half of its $638 billion revenue backlog, a single, currently loss making counterparty. Oracle has not published a customer level RPO breakdown, so treat that as a closely sourced estimate, not an audited disclosure. If OpenAI’s revenue trajectory falls short of what its five year Oracle contract commits it to, Oracle remains obligated to a data center lease running three to four times longer than the contract paying for it. That gap is the risk.

Read more

The last vendor to run this playbook wrote the tell into its own filing. Lucent, in 1999, justified calling its customer receivables collectible “based on various factors among which is the ability of Lucent to sell these loans and commitments”. Collectability rested on the existence of a buyer for the paper. On 10 August, Nvidia went looking for six.

The consensus is a weight argument, and it’s a good one

The figure moving around desks this month: Nvidia contributed more than 10 percentage points to the S&P 500’s roughly 84% five year total return, about 12% of the entire gain, against Apple at 5 and Microsoft, Broadcom and Alphabet at 3, 3 and 2. Five names, 30% of the rise.

I want to be careful with that number, because I cannot reproduce it and I could not trace it to a source I can open. No index provider publishes it, the attribution method is nowhere stated, and a chained contribution calculation on a stock whose weight rose this far over the window is extremely sensitive to whether you use beginning weights, ending weights or daily chaining. So I’m not resting anything on it.

What I can verify is the weight. In the SPDR S&P 500 ETF Trust’s daily holdings file dated 13 August 2026, Nvidia is 8.13% of the index, Apple 6.68%, Microsoft 5.50%, Amazon 3.87%, Alphabet 5.45% across both classes, Broadcom 2.95%, Meta 1.95%. Those are one fund’s weights on one date standing in for the index’s own, so I checked them against Vanguard’s at 31 July: Nvidia 7.55%, the fortnight between the reads being a rally rather than a disagreement.

The consensus built on those numbers deserves its strongest form before I depart from it. Passive vehicles hold the index as given, and American retirement savings sit disproportionately in them: $9.9tn in 401(k) plans alone at 31 March 2026, 58% of it in mutual funds, per the Investment Company Institute. A saver who chose an index fund to avoid single stock risk holds an 8% position in one semiconductor company, sized by a rule nobody debated. If AI capex slows, the index falls inside accounts whose owners never made the bet.

I think every part of that is true. It describes price risk, which is the part the market already prices.

What the filing shows that the weight doesn’t

Here is what I did not expect to find when I opened the 10-Q.

Nvidia now runs a credit book against its own customers, and it’s large. At 26 April 2026, on unaudited quarterly statements covering $81.6bn of revenue, the balance sheet shows $43.4bn of non-marketable securities, up from $22.3bn three months earlier. The equity component, stakes in privately held companies, went from $3.24bn to $42.34bn in twelve months. That’s a 13.1x increase. $17.9bn of it landed in one quarter.

These are what they sound like: positions in companies with no public market, carried at cost less impairment and marked only when a transaction forces it. No daily price. No bid.

Three items underneath it matter more. Investment commitments were $27bn, contracted capital Nvidia expects to fund through the rest of fiscal 2027. Equity method investments in infrastructure funds were $1.0bn, with maximum loss exposure including commitments of $2.3bn. Then the one that changed how I read the filing. During fiscal 2026 Nvidia entered agreements to guarantee partners’ facility lease obligations on default, in exchange for warrants. Maximum gross exposure is $3.5bn, declining as partners pay lessors over terms of five to seven years, with $712m placed in escrow against it. The filing classifies these as credit derivatives, with fair value changes running through other income.

Read that again. Nvidia is selling default protection on data centre leases and taking equity upside as the premium. That’s a bank’s trade. A bank writing it would report it as a credit exposure with an allowance against it; Nvidia reports it in four sentences of a note, at a fair value the filing calls not material.

$74.5bn, gross and before recovery. A notional, not an expected loss, and I come back to what it’s worth in the limits. Against $13.2bn of cash plus $37.1bn of marketable debt securities, the book is 1.48 times liquid reserves, 38% of shareholders’ equity and 91% of a quarter’s revenue. None of it appears in an index fund factsheet, which reports a weight.

A quarter of pre-tax income now comes from below the operating line

For anyone reading the private book as a rounding error, this is the part I’d put in front of them.

In the quarter to 26 April 2026, Nvidia reported operating income of $53,536m and income before tax of $69,903m. The gap is $16,367m of non-operating income, of which $15,929m sits in the single line “Other income (expense), net”. A year earlier that same line was negative $180m, and total non-operating income was $272m against $21,910m of pre-tax income.

The share of pre-tax income arriving from below the operating line went from 1.2% to 23.4%. In twelve months.

The filing says what feeds it. Unrealized gains on non-marketable equity securities run through Other income (expense), net, and were $2,603m in the quarter. Marketable equity securities, which include positions that graduated out of the private book when their issuers listed, rose from $12,886m to $30,237m over the same three months, marked through the same line. Net income was $58,321m against $18,775m, and a meaningful slice of the increase is Nvidia marking up its holdings in companies that buy its chips.

One more number frames how untested those marks are. Cumulative gross unrealized gains on the non-marketable equity book stood at $5.3bn, against cumulative gross unrealized losses and impairments of $199m. That is a 27-to-1 ratio of markups to markdowns on a portfolio of illiquid private positions built almost entirely within one year. Every venture book I’ve seen looks like that early. None stays like it.

The receivables point at the same corner of the market as the equity stakes

Concentration in the revenue line moved hard. In the first quarter of fiscal 2027, three direct customers represented 21%, 17% and 16% of total revenue. A year earlier, two direct customers represented 16% and 14%. Thirty percent across two names became 54% across three. In a year.

The receivables say the same thing one step further along. Three direct customers accounted for 30%, 18% and 16% of the accounts receivable balance, a combined 64%, against 25%, 18% and 13% at the January quarter end. Accounts receivable net stood at $40.7bn.

Nvidia doesn’t identify its direct customers and doesn’t itemise the private equity book, so I can’t prove the two lists are the same names. What the filing establishes is that both narrowed sharply and simultaneously while the private stakes grew 13x. Where they overlap the exposure compounds rather than adds: funding the buyer, booking the revenue, holding the receivable against a name whose ability to pay depends partly on capital Nvidia supplied, then marking the stake in that name up through the income statement.

For the public half I don’t have to infer, because Nvidia files it. Its 13F for the quarter ended 30 June, filed 14 August, lists eight positions worth $63.4bn, two of them its own AI cloud customers: CoreWeave at $4.70bn and Nebius at $0.33bn. A 13F is long only, US equities, quarter end and lagged, so it says nothing about the private book or the guarantees. Within its limits it names counterparties, which is more than the 10-Q manages.

And the 10-Q describes the wider loop in its own words, in a passage that gets far less attention than the customer-concentration line: “We estimate that one AI research and deployment company contributed to a meaningful amount of our revenue by purchasing cloud services from our customers in the first quarter of fiscal year 2027.” Nvidia’s telling you a company it doesn’t sell to is driving a meaningful share of what it books, through companies it does sell to. And in some cases funds.

What 10 August actually changed

The press release is short and worth reading in its own words. Six strategic partnerships, “the first compute financing platforms of their kind at global scale,” designed to create “dedicated pools of capital at significant scale at attractive rates for NVIDIA customers.” Over $500bn of third party capital, mobilised over time, and the whole arrangement “subject to execution of the final agreements.”

The framing everywhere is that this cuts circular financing, because the money is third party. On direction of travel that’s right. It also does something nobody has priced, and it follows from where the disclosure lives.

Today every dollar of it shows up where an index fund holder can open it. The $42.3bn, the $27bn of commitments, the $3.5bn of guarantees, the $712m escrow, the $2.6bn of marks: a handful of paragraphs in a public 10-Q. The exposure is ugly. It is also visible.

Move the next $500bn into six privately managed platforms and that changes. Be exact about how, because the loose version of the claim is wrong: some private credit sits in BDCs, which are SEC reporting companies filing schedules of investments that name each borrower at fair value. Nothing stops getting filed. It’s that nothing aggregates. No filing will tell an S&P 500 holder the total leverage written against Nvidia hardware across six platforms, at what advance rates, on what collateral schedules. Today that is one line in one 10-Q. Afterwards it is a quantity nobody computes, and the platforms’ legal form is still unannounced.

There is a size problem underneath the disclosure one. In its May 2026 Financial Stability Report the Fed puts the entire US private credit market at about $1.4 trillion, roughly 10% of US nonfinancial corporate debt, so a $500bn target is 36% of the whole asset class being asked to fund it. Treat that as an order of magnitude rather than an estimate: the $1.4tn is data from the second half of 2025 so the denominator has grown, and $500bn is cumulative with no stated horizon. It’s still an unusual amount of one asset class to point at one manufacturer’s hardware.

The obvious reply is that I have this backwards, and it deserves full strength. If the $500bn genuinely comes from third parties with no Nvidia recourse, Nvidia’s exposure falls and an index holder’s falls with it, because that exposure runs through NVDA’s equity. On that reading the platforms are the de-risking they were announced as, and I’m mistaking a vanishing disclosure for an appearing risk.

My answer: the risk changes address inside the index rather than leaving it. The lender isn’t outside the portfolio, five of the six sponsors are constituents, and the fastest growing private credit vehicles are sold to individuals through funds those same households hold. What leaves is Nvidia’s balance sheet, where the exposure was consolidated, dated and readable on one line. Where it lands it is none of those. For a diversified holder that’s a transfer into worse instrumentation.

Checking each against the SPDR holdings file, five of the six sponsors are S&P 500 constituents: Goldman Sachs 0.458%, BlackRock 0.254%, Blackstone 0.165%, KKR 0.119%, Apollo 0.099%, combined 1.10%. Only Brookfield sits outside. That’s small, under a seventh of Nvidia alone, and I won’t inflate it. What matters is that the index holds the supplier, the buyers and the lenders, so one portfolio absorbs the loss on whichever leg breaks first.

Run the whole complex: Nvidia 8.13%, Microsoft 5.50%, Amazon 3.87%, Alphabet 5.45%, Meta 1.95%. That’s 24.9% of the S&P 500 in companies sitting on both sides of one transaction, before the lenders. Read it precisely: that’s the weight of the firms on both sides, not the share of index earnings riding on AI capex, which is far smaller because those four earn most of their money elsewhere. Every broad index owns suppliers and their customers. What isn’t ordinary is the speed and concentration, one capex cycle running through a handful of names in about three years.

The collateral is a chip, and the seller sets its useful life

Two sentences from the announcement do more work than the $500bn headline.

David Solomon, for Goldman Sachs: “...we’re excited for the new opportunity to create a market for credit backed by NVIDIA compute.”

Jensen Huang, in the same release: NVIDIA compute “is broadly adopted, flexible across models and workloads, fungible and transferable across customers and operators, and continuously improved through CUDA software [...] extending its useful life and improving its economics over time.”

The structure’s explicit. No ambiguity in it. The collateral behind this credit market is GPUs, and the claim that it holds value comes from the party selling it. Put the terms against each other: Nvidia’s own lease guarantees run five to seven years, and a GPU generation has been turning over in roughly two. A lender’s being asked to hold collateral across two to three product cycles on a residual value the manufacturer supplies. I don’t think Huang is wrong about CUDA, and the fungibility argument is stronger for Nvidia hardware than for most capital equipment. A lender underwriting a term loan against depreciating semiconductors is still taking a residual value view, and the residual value view on offer here is the vendor’s.

That’s what I’d want independently modelled before underwriting a dollar of it. I have no number that contradicts Huang. I want to be clear about that. My concern is structural: a market where the manufacturer supplies the collateral, the demand forecast and the useful life assumption has exactly one input nobody at the table is short.

What separates this from Intel Capital and GV

The obvious rebuttal, and the one I’d raise first: every cash-rich technology company runs strategic investments. Alphabet has GV, Intel ran Intel Capital for decades, and a $42bn private book at a company earning $58.3bn a quarter is unusual in size and ordinary in kind.

Two specifics separate it, both disclosed facts before they are interpretations. A venture arm doesn’t write credit derivatives on its portfolio companies’ lease obligations; Nvidia does, for warrants, on five to seven year terms. And a venture arm’s investments aren’t a precondition for its parent’s revenue line: hyperscale revenue was $37.9bn of $75.2bn total data centre revenue, so roughly half of data centre sales go to buyers outside the four biggest hyperscalers, and that cohort is the one needing financing to buy.

Nvidia’s own answer is stronger than either of those, and it is on the record. In a seven page memo sent to analysts in late November 2025 and obtained by Yahoo Finance, the company wrote that it “does not resemble historical accounting frauds because NVIDIA’s underlying business is economically sound, our reporting is complete and transparent”, and noted that its customers pay within 53 days rather than over years. The receivables in the filing agree with the company: $40.7bn against $81.6bn of quarterly revenue implies about 45 days, faster than it claims.

I think that rebuttal is sound and I think it answers a different claim than mine. Vendor financing, in the sense Nvidia denies, means lending a customer the cash to buy your product and waiting years to be repaid. Nothing here alleges that. What the filing discloses is equity in customers, $27bn committed to more of it, and credit derivatives written on customers’ leases. None of those is a loan to buy a chip. All of them are Nvidia’s own words.

The counter I can’t dismiss is that this is simply what supplying a capital intensive buildout looks like, and that vendor financing in semiconductors, telecom equipment and aircraft has always worked this way. That’s fair, and it’s why the last vendor to run this playbook at scale is worth reading in its own words.

Lucent said the same thing in 1999, and the sentence to read is about selling the loans

The closest documented precedent is in a filing. Lucent’s Form 10-Q for the quarter ended 31 December 1999 opens its management discussion this way: “Network operators worldwide are requiring their suppliers to arrange or provide long-term financing for them as a condition of obtaining or bidding on infrastructure projects.” It then discloses commitments to extend credit to customers of about $8.4bn, of which $1.1bn had actually been advanced, plus guarantees of customer debt of about $1.4bn.

Two sentences are why I’m using it. First: “As market conditions permit, Lucent’s intention is to lay off these long-term financing arrangements... to financial institutions and other investors. This enables Lucent to reduce the amount of its commitments and free up additional financing capacity.” That’s the 10 August announcement, written by a different vendor twenty six years earlier.

The second is the one I’d frame: “Lucent has determined that the receivables under these contracts are reasonably assured of collection based on various factors among which is the ability of Lucent to sell these loans and commitments.” Collectability rested on the existence of a buyer. The buyers left. Both halves went at once.

Scale it, because the raw sizes mislead. Lucent booked $9,905m that quarter, so its $9.8bn of commitments and guarantees was 24.7% of annualised revenue. Nvidia’s $74.5bn against $326bn annualised is 22.8%. Within two points, which surprised me and is the honest version of this comparison. One difference runs against Nvidia: Lucent had advanced $1.1bn of $8.4bn, 13% funded, while Nvidia has deployed $43.4bn of $74.5bn, 58% funded. That book was promises. This one is money.

Nvidia has answered this comparison by name. In the same November 2025 memo: “[U]nlike Lucent, NVIDIA does not rely on vendor financing arrangements to grow revenue.” True, and not my claim. The parallel is the EXIT ROUTE, not the reliance. Lucent’s filing says it intends to sell the paper to institutions to free up capacity; eight and a half months after telling analysts it was nothing like Lucent, Nvidia announced six platforms to do that at a $500bn scale. Both can be true. I think they are.

The difference that genuinely weakens the comparison is one Nvidia did not make, so I’ll make it. Lucent lent to capital starved CLECs with little revenue and no investment grade access. Nvidia’s disclosed base is led by four of the most creditworthy companies on earth, funding capex from operating cash flow. Matching the books on a revenue ratio while ignoring who owes the money is the sloppiness this piece is complaining about. So the comparison holds for the half of data centre revenue coming from buyers outside those four, which is the half being financed, and not for the hyperscalers.

To be precise about what I’m not claiming: the SEC charged Lucent in May 2004 over revenue recognition in fiscal 2000, and Lucent settled without admitting or denying. I draw no inference of that kind. The analogy is structural: same industry position, same disclosed instrument, same stated exit route.

Three things I cannot rule out

The exposures may not fully overlap. I infer compounding from two separately disclosed concentrations, and the 13F only names the public half. If the funded companies and the top three customers are largely disjoint, the risk is additive and my framing overstates it.

The guarantees may be small. Nvidia states the credit derivatives’ fair value “was not material.” I quote maximum gross exposure of $3.5bn because that’s the number a stress case uses. Treat my $74.5bn as a gross notional. Expected loss is a smaller and unknowable number.

The $27bn is contingent. The filing says investment commitments are “subject to certain contingencies.” Some portion may never fund. I’ve counted it at full value because it’s contracted, and a reader can reasonably disagree.

And the $500bn is a mobilisation target attached to partnerships that are not yet definitive. Nothing has closed yet.

What would change this view

Nvidia reports its second fiscal quarter in late August, on a period that ended before the platform announcement. That filing settles three things, and here is what each would mean, written before I see it.

If non-marketable securities keep compounding near $17.9bn a quarter while commitments stay near $27bn, the book is growing faster than the platforms can absorb, and the announcement is an addition rather than a replacement. If commitments fall sharply without a matching rise in the non-marketable balance, they were contingencies that lapsed, which is the cleanest kill of this thesis and checkable in one table. If three customer revenue concentration falls back toward 30%, the buyer base is broadening and the argument weakens on its own terms.

A fourth marker resolves more slowly, and I’ve had to sharpen it. Watch whether anything ends up publishing an AGGREGATE: total committed capital across the six platforms, advance rates against GPU cost, collateral schedules. A single BDC filing its schedule of investments would not settle it, because position rows in six vehicles are not a number. If an aggregate does get published, whether by the sponsors, a regulator or an index provider, the second half of this argument is wrong and I’d retract it.

What I’d actually do with this

I wouldn’t trade the index weight. That’s the crowded expression, and 8.13% is a number every allocator already has. The re-underwriting worth doing is on the disclosure surface: your largest single position runs a credit book you can read today and probably cannot read next year, and Notes 6 and 8 of the last 10-Q take ten minutes. For anyone underwriting the platform paper when it comes to market, I’d put the residual value question ahead of the coupon. Ask who set the useful life assumption in the collateral schedule, and whether that party is selling the collateral.

Then watch the vehicles that grew fastest, because they close the loop back to the household. The Fed’s report puts perpetual-life BDCs at $161bn of net assets and interval funds at $80bn, and notes most perpetual BDCs cap redemptions at 5% of NAV per quarter, some already exercising those limits amid “concerns about the quality of underlying assets.” The Fed’s own spring survey of market contacts most frequently cited geopolitical risks, an oil shock, artificial intelligence, private credit and persistent inflation. This structure sits on two of those five at once, which is where the saver ends up holding Nvidia through the index and the paper financing Nvidia’s customers through a semi-liquid fund, with a redemption gate on one and none on the other.

So here’s the question I’d put to anyone who has underwritten equipment backed paper before: at what advance rate against GPU cost would you lend on a five year term, given that the useful life assumption is the manufacturer’s? I’d start around 50%, and I suspect that’s too generous.

Two related pieces, if the disclosure angle is the part you want more of: Alphabet’s $20bn bond offering and the AI-vendor financing it guarantees, where the guarantor discloses quarterly what everyone else calls opaque, and SpaceX’s $1,146m AI profit and the share-release schedule underneath it.

The Patreon note is a separate piece of work rather than a deeper cut of this article. It takes the one thing a desk would actually use, the four-note aggregation itself, and writes it the way you would carry it: every line with its filing location, the Lucent book normalised for size, the three limitations I will not argue past, and the single line in the Q2 10-Q that settles it.

→ Read the vendor-credit note
→ Or join the Patreon community for every note

More of this work: YouTube · LinkedIn

Cover photograph: Rhododendrites, CC BY-SA 4.0, via Wikimedia Commons.

Berkshire Hathaway’s cash and Treasury bills fell to $359.2 billion at the end of June, from $373.5 billion three months earlier. That is the first decline since 2022 and the largest since the first quarter of that year. It is also the third decline in eighteen quarters, so the interesting question is what it took.

It took about $24 billion. Net purchases of equities ran $19.8 billion in the quarter, after the book handed $8.1 billion back to the pile in the three months before. The buyback went from $235 million to roughly $4.2 billion. Both of those are Abel’s, and both are new.

I had put the break-even at $14.5 billion a quarter, from Berkshire’s own inflows. This quarter cleared it by about nine billion, and the pile moved almost exactly as that arithmetic said it would. What I want you to keep is not the fall. It is the measure the fall has to be read on, because the widely quoted series and the company’s own series disagree about direction in two of the last six quarters, and one of them will be wrong about this one too.

I also made this as a film. It does the one thing text can’t: the adjustment is worked on screen, line by line, so you watch the published figure become the real one instead of taking my word for it.

Eighteen quarters, three declines, and the third one is his

Here’s Berkshire’s own figure, the one it prints in Management’s Discussion and Analysis, net of payables for unsettled purchases. I pulled it from every quarterly and annual report back to 2021.

Intermediate quarters are omitted for space and every one of them is positive. Three declines in eighteen quarters, and the two before this one were both in 2022.

That matters for how much weight the June quarter carries. A single fall in a series that only falls when something large happens is not noise, and it does not need a significance test to be interesting. Abel’s first quarter, at +$4.5 billion, sat 0.72 standard deviations below the trailing twelve on my own calculation, which is nothing. This one is a different kind of event.

What he actually spent: $24 billion in thirteen weeks

The June 10-Q reports six months, so the quarter has to be backed out of it. Half-year operating cash flow was $21,653 million against $10,438 million in the first quarter, so the June quarter produced about $11.2 billion. Half-year equity purchases were $39,405 million and sales $27,780 million.

Take the first quarter off both. Purchases of $23.5 billion against sales of $3.7 billion, so the equity book absorbed $19.8 billion of cash in three months. Three months earlier that same book returned $8.1 billion. That is a swing of roughly $28 billion in one quarter, and it is the largest single change in this company’s behaviour that I can find in the Abel era.

Berkshire’s own stock moved the same way. Berkshire “acquired $4.8 billion of treasury stock in the first six months of 2026, most of which was in the second quarter,” and the cash flow statement carries $4,444 million for the half against $235 million in the first quarter. So the June quarter bought back something close to $4.2 billion of its own stock, against $235 million in the quarter before it. Eighteen times.

Add the two and I make discretionary deployment about $24 billion. Against a break-even near $14.5 billion, that is roughly $9.5 billion of genuine drawdown, and the pile fell $14.3 billion. The gap between those two figures is capex, debt and the accretion I set out below, and it is close enough that the arithmetic holds.

What a real spend down costs: $51.1 billion in three months

I keep going back to 2022, because it is the only larger decline Berkshire has produced in the era of a giant bill book.

In the first quarter of 2022 it bought $51,119 million of equity securities and sold $9,724 million. That’s $41.4 billion of net buying in thirteen weeks, into Occidental, Chevron and the Alleghany agreement. Net cash fell $41.2 billion over the same quarter. Almost exactly a dollar off the pile for each dollar of stock bought.

June 2026 is the same shape at about a third of the size. $19.8 billion of net buying, $14.3 billion off the pile. The ratio is looser because the buyback and a bigger operating inflow both sit inside it, but the mechanism is identical: this balance sheet moves when the equity book moves, and it moves by roughly what the equity book absorbs.

What 2022 says about willingness is unchanged. The pile stood at $143.9 billion then and Berkshire moved 29% of it in thirteen weeks, which tells me the machinery works and the constraint has never been operational. What it also showed was a trigger: an energy complex on mid cycle multiples, an insurer available whole, and a market falling. I could not see any of those three in March. I still can’t, which makes the June quarter harder to explain by conditions and easier to explain by the person.

The $17.2 billion line that moves the published number

Two series are in circulation and only one of them is Berkshire’s.

Add the two balance sheet lines for the insurance and other businesses at 30 June and you get $360.0 billion: cash of $35,096 million and Treasury bills of $324,905 million. Berkshire’s own figure for the same date is $359.2 billion. The difference is a payable of $771 million: bills bought before quarter end that hadn’t settled, sitting in short term investments with a matching liability. Nothing moved economically. Yet only one of the two figures reaches the reader.

Every row I checked subtracts to within rounding. And the left column falls in June 2025 and December 2025, by $2.6 billion and $8.4 billion, in two quarters when the right column rose by $11.8 billion and $14.7 billion. Wrong sign, twice, on the most watched number at the company. Anyone can verify it in two minutes.

At the March quarter the same arithmetic ran $21.6 billion gross against $4.5 billion net: $390.7bn less a $17.2bn payable, against $369.2bn less $167m. So seventy-nine per cent of the headline move was the payable and nothing else.

This quarter the two agree, because the payable happens to be small. Which is exactly why I subtract it every quarter, not only when it looks necessary: the gap is not stable, so you cannot know whether it matters until you already have. Run June unadjusted and you get a $30.7 billion fall instead of $14.3 billion, because you are comparing a quarter carrying a $17.2 billion payable against one carrying $771 million.

Why so unstable? My first guess was the auction calendar, and it was wrong, which turned out more useful than being right. Using the Treasury’s own auction records I measured the pool of bills auctioned before each quarter end that settled after it: $240.2bn, $363.9bn, $393.8bn, $306.7bn, $481.8bn and $254.7bn. That pool is never empty. Berkshire’s payable works out at 5.33%, 3.95%, 0.00%, 7.57%, 0.03% and 6.76% of it. In the quarter with the biggest pool of all, December 2025 at $481.8 billion, its payable was $167 million.

So it isn’t the calendar. Berkshire either bought at those auctions or sat them out, and when it participated it took four to eight per cent. That’s roll management on a bill book that turned over half its value in a quarter. It carries no capital allocation information at all, and it has been as much as four times the size of the change it obscures. One caveat on my own measurement: secondary purchases settle T+1 and never appear in auction data, so my pool is a floor.

What I find odd is that this survives at all, because Berkshire hands you the correction, in the financial condition paragraph of every filing since September 2024. My guess at why the wrong number still wins is boring and probably right: the balance sheet is where anyone looks first, the two lines are adjacent and easy to add, and the sentence correcting them sits forty pages later, in a section most readers skip. The error isn’t hidden. It’s just further away than the mistake.

If you want the procedure rather than the finding, I wrote the method up separately: how to spot this payable in any filing, the three checks for which issuers carry one, and the worked example end to end including the step where my own first attempt used the wrong perimeter. It’s here: Berkshire’s Cash Line Grossed Up $23.2bn on One Treasury Settlement Date.

Second time in a month a headline number turned on an accounting adjustment, after SpaceX’s AI profit and its depreciation add back. Same shape, different line.

Read more

The market sold an $18bn capex number. The filings show the quarter’s headline milestone is an accounting identity, and the only price-contingent clause in the capital structure had already expired.

▶ Watch the film: the reconciliation, worked line by line from the filing · 7:56

It puts SpaceX’s own earnings exhibit on screen and walks the four add-backs in the order the company prints them, so the document is visible as the arithmetic runs.

The trade this changes, and what the tape got wrong

SpaceX reported its first quarter as a public company after the close on 4 August 2026. Revenue was $7,814m, up 92% on the $4,071m of Q2 2025. The net loss narrowed to $541m from $1,010m. Adjusted EBITDA came in at $3,538m, up 191%. Every one of those figures is in the company’s own earnings release, filed as an exhibit to the 8-K.

The stock closed $125.33 on the day of the release and $108.27 the day after, a fall of 13.6%, against a $135 IPO price and the $225.64 peak set on 16 June.

The explanation ran everywhere within the hour, and it was capital expenditure: capex went from $10,107m in Q1 to $18,369m in Q2, of which $15,828m was AI infrastructure. That account is accurate, and it is what a terminal gives you in ten minutes. It also misses the two things in the filings that change how this equity should be sized, both of which required reading the 10-Q and the prospectus instead of the release.

The first is that the quarter’s proudest number is an accounting identity. The second is that the supply clause the entire market spent July watching had already resolved, permanently, in a direction almost every outlet described backwards.

The bear case at its strongest, before I argue with it

The people who sold this on 5 August were not being stupid, and their case deserves stating properly.

A company spending 2.35 times quarterly revenue on capital assets is making a concentrated, non-reversible bet on one technology cycle. AI infrastructure depreciates over a few years where launch hardware depreciates over decades, so the cost lands on a short clock regardless of whether the revenue shows up. Free cash flow for the half is negative $25.0bn. Group debt and finance leases went from $22.9bn to $39.4bn in six months. No return metric was disclosed against the $15,828m, so nobody outside the company can check what it earns. And asked directly about the spending, Musk moved a $1tn revenue target a year closer instead of answering, which tells you something about what was available to disclose.

Hold all of that and “sell” is a coherent conclusion. Several good funds reached it and were paid inside a day, and nothing below argues they were wrong. What I argue is narrower: the reason the tape gave was not the constraint that binds, and the two things that changed this quarter sat in documents nobody read that day.

The AI segment’s profit is its own depreciation, to the dollar

The release leads on it: the AI segment reached positive Adjusted EBITDA of $1,146m, against negative $276m a year earlier. That was the quarter’s evidence that the compute build is starting to pay.

Read the reconciliation directly underneath it. The AI segment’s GAAP loss from operations was $1,257m. The distance between the loss and the profit is entirely add-backs:

The arithmetic closes exactly. The segment’s entire adjusted profit comes from adding back $1,885m of depreciation on the assets that the $15,828m of quarterly capex is buying, plus half a billion of stock compensation. Strip the depreciation alone and the segment is $739m under water on the measure the release celebrates.

This is not an accusation of anything improper. Adjusted EBITDA is disclosed, reconciled and labelled non-GAAP, and the company says plainly that it “should not be considered in isolation.”

The obvious objection deserves answering first, because it’s what a sceptical reader says immediately: adding back depreciation is what EBITDA is. That’s correct, every capital-intensive business shows that gap, and pointing at one is not analysis.

Three things make this one worth the ink anyway. The magnitude: the add-back is 1.6 times the profit it produces, so the metric is composed of depreciation rather than merely adjusted by it. The direction: AI D&A grew 132% year over year while the segment crossed zero, so the add-back is outrunning the thing it should be a footnote to. The timing: the $15,828m spent this quarter is largely not yet in service, so its depreciation is not in the $1,885m at all.

So the issue isn’t that EBITDA excludes depreciation. It’s that this segment was declared profitable for the first time on a measure structurally unable to reflect the spending that defines it, in the quarter that spending grew twenty-one-fold.

The trajectory is the argument. AI segment D&A ran $811m, then $1,493m, then $1,885m across the last three quarters. AI capex over the same three ran $749m, $7,723m, $15,828m. Depreciation is chasing capex up with a lag, and the lag is the whole question.

Group PP&E went from $42,602m to $65,736m in six months, per the 10-Q, and group D&A ran $5,290m against $2,970m a year earlier. On the assets bought this quarter, the depreciation has not started.

I work the reconciliation quarter by quarter, against the disclosed compute build, in the companion note: SpaceX’s First AI Profit Is $1,146m. Its Own Depreciation Add-Back Is $1,885m.

The balance sheet closes the affordability question

The coverage framed the spend as unaffordable. The 10-Q says otherwise, and this part is not close.

SpaceX ended the quarter with $93,522m of cash and cash equivalents plus $6,487m of marketable securities, which is the $100bn the CFO cited. Against Q2 capex of $18,369m:

A company with 5.4 quarters of capex in cash, a narrowing loss and 92% revenue growth has no funding problem at this horizon. Whatever was repriced on 5 August, it was not the ability to pay.

The cash did not come from operations, going from $24,747m at year-end because the June IPO raised $85,675m net on 638.9m shares at $135, and because a $25bn inaugural bond issue closed on 26 June across five tranches at a weighted average 5.855%. The company raised the money before spending it, the opposite of what the “burning cash” framing implies.

The genuine cash figure the coverage should have led on is further down the same statement. Operating cash flow for the six months was $3,466m; purchases of property, plant and equipment were $28,476m. Free cash flow for the half was therefore negative $25,010m. That is the real number, it is far larger than anything the wires quoted, and it is entirely prefunded. Both halves of that sentence are true and they point in opposite directions, which is exactly why the affordability framing was the wrong argument to have.

The price condition did not fail narrowly. It failed 0-for-10

SpaceX’s post-IPO lockup is staggered. The final prospectus sets out the schedule for the shares under the 180-day lockup, and every tranche in it is a percentage of one base. Up to 911.5 million shares represent 20%; 455.8 million represent 10%; 319.0 million represent 7%. All three imply the same base of roughly 4,557m shares.

One tranche in that schedule, and only one, releases on a price rather than a date. In the prospectus’s own words:

“if the reported closing price of our Class A common stock on Nasdaq is at least 30% greater than the public offering price set forth on the cover page of this prospectus for at least five of the ten consecutive trading days ending on, and including, the First Earnings Release Date”

Thirty percent above $135 is $175.50. The First Earnings Release Date was 4 August. So the test window was the ten trading days ending on 4 August, and here is every close in it, from the price history:

Not one session cleared $175.50. The best close in the window was $125.33, 28.6% below the trigger. The Motley Fool reported simply that “that didn’t happen.” Put the filing against the tape and you can say how badly: it was never in contention, and the stock hadn’t closed above $175.50 at any point in the month before the window even opened.

The window looks backward, and it has closed. This is the detail that inverts most of the commentary, and I’ll be direct that it inverted the first draft of this piece too. I had it as a live trigger. It isn’t one. The condition was never a standing option that re-arms on a rally; it was a one-time test against a fixed ten-day window ending on a fixed date. That date has passed and the test failed, so no future price path can satisfy it. If you’re still watching $175.50 as a supply level, you’re watching a clause that no longer exists.

Read more

BP’s Archaea impairment is being read as a verdict on renewable natural gas. Read BP’s own filings and it is mostly a verdict on BP’s capital budget: the company impaired an asset it had decided to stop funding, and is now selling it.

The consensus is that Elliott won and the green bet died

I want to state this at its strongest, because the strong version is largely true. Elliott Management built a stake near 5% in BP through early 2025, worth roughly £3.8bn, about $4.75bn, and pushed for a return to hydrocarbons (Financial Times, via BOE Report, February 2025). The February 2025 reset cut transition spending and raised oil and gas investment. Murray Auchincloss stepped down as CEO in December 2025. Meg O’Neill took over in April 2026, after an interim stretch under EVP Carol Howle. Chairman Albert Manifold, in the seat only since October 2025, was ousted in May 2026 over “governance standards, oversight and conduct” concerns (Al Jazeera, May 2026). That was a conduct scandal, not another domino in the strategy story, though the board has now turned over almost completely regardless. Since the reset, BP has sold the Gelsenkirchen refinery, agreed to sell Austrian retail, announced its exit from the UK North Sea, and now Archaea.

On that reading, Archaea is the tombstone. BP paid $4.1bn at the top of the transition trade in October 2022, promising around a five fold increase in Archaea’s own RNG production by 2030 and total bp biogas supply near 70,000 boe/d (bp, October 2022). Nearly four years later it is selling into a repriced category. A $4bn round trip, and a shareholder base that got what it asked for.

My read is that this story is right about the politics and wrong about the asset. It does not survive contact with BP’s own sensitivity disclosures.

BP bought contracts, and 77.5% of the price was the contracts

The most useful line in BP’s accounts is one I have not seen quoted anywhere. When BP finalized its purchase price allocation for Archaea in 2023, it recognized $3,178m of intangible assets, down from a provisional $3,475m. The filing describes these as “primarily the biogas rights agreements Archaea Energy has with landfill owners” (20-F 2023, Note 4).

That is 77.5% of the $4.1bn enterprise value, and I make it the single most important number in the whole file. More than three quarters of what BP actually booked was the contractual right to landfill gas, not the plants that turn it into pipeline methane. Archaea was an option strip: long agreements with landfill owners, each giving BP the right to take the gas, each worth nothing until a plant gets built on top of it.

For anyone who hasn’t underwritten one of these, a landfill gas rights agreement sits closer to an undrilled acreage position than a producing well. You pay today for the option to spend capital later. It’s worth what you expect to spend, and it collapses when you stop spending.

By 31 December 2025 the intangible was carried at a cost of $2,983m and a net book value of $1,714m. Two measures matter here. The clean, single year, impairment only figure: $710m of impairment against this line in 2025, less an $84m reversal, net $626m, or 25.7% of the $2,433m the rights were carried at going into the year. The blunter since acquisition figure runs from the finalized $3,178m acquisition value to today’s $1,714m, a 46% decline, but that blends impairment with three years of ordinary amortization and the 2023 remeasurement, so it overstates the write down. The itemizable pure impairment total is $344m in 2024 plus $710m in 2025 less $84m reversed, net $970m, roughly 31% of the acquisition value, taken almost entirely since the reset began.

The same annual report says Archaea grew

This is the part I keep coming back to. In the year BP impaired its transition businesses by $3,537m, BP’s own strategic report says: “Our biogas business, Archaea Energy, continued its growth, starting up eight new renewable natural gas (RNG) landfill plants in 2025.” Two came online in the fourth quarter, Middle Point and NW Tennessee, for “a total capacity of more than 6 million mmBtu.” Since 2023 Archaea has added 19 landfill plants and 18 million mmBtu per year of capacity. In December it signed a biomethane offtake with Osaka Gas Trading and Export.

Deloitte brought in its own “Landfill Production Specialists” to test the long run production rates, which I’d read as a risk flag rather than a health signal. More useful is a different line in the same audit passage: Deloitte tested BP’s plan for “consistency with bp’s capital frame” (20-F 2025, auditor’s report), real corroboration of the capital reading, sitting in the same paragraph as the plant count.

Set that against the national picture. The American Biogas Council counts 20 new landfill gas projects online across the United States in 2025, and says all of them produce RNG (ABC, July 2026). Archaea built eight of them, two in five by project count. On a capacity basis it’s smaller still: the Council’s 20 projects added 39.9 Bcf nationally in 2025, against roughly 6 Bcf from Archaea’s eight plants, call it 15% of the country’s new landfill biogas capacity. That’s a meaningful minority, not the “close to three quarters” I derived in an earlier pass. I’d mispaired a different sentence in the same release, about a separate, larger 2020-2025 count, onto the 20 projects of 2025 alone.

I still don’t read any of this as the audit trail of a business falling over. A company that added nineteen plants in three years, signed international offtake, and grew capacity every year, while its owner impaired $626m of the core intangible in that same year: those facts only reconcile through the discount rate and the capital plan.

The build rate is where I can see the capital decision

BP’s 2022 plan was about 70,000 boe/d of biogas supply by 2030. Archaea’s disclosed additions since 2023 come to 18 million mmBtu per year. I can convert that against BP’s own factor from the Q2 glossary: 5.8 billion cubic feet equals 1 million barrels.

At roughly 1,000 Btu per cubic foot for pipeline quality methane, 18 million mmBtu is 18 bcf a year. Divide by 5.8 and I get 3.10 million barrels a year, roughly 8,500 boe/d of capacity added across three years. I’m rounding deliberately; the Btu/cf factor is itself an approximation.

Two caveats. The 70,000 boe/d target covered BP’s total biogas supply including bought and traded volumes. And 8,500 boe/d is capacity added since 2023 alone. So this indexes the build rate and nothing finer. Even so, a run rate near 2,800 boe/d a year never reaches 70,000 boe/d this decade, and that gap in gas is the same gap that shows up in dollars: BP’s own sensitivity prices a 10% Archaea revenue shortfall at $0.5bn, and a build rate running roughly half of what 2030 requires implies a revenue shortfall well past that threshold. The capital decision and the impairment are the same number, read two ways.

What the credit price can and cannot explain

The obvious objection is that RNG revenue collapsed and any owner would have taken the same charge. I tested that first, and the numbers don’t carry it, though the test is less clean than I first made it.

RNG monetises D3 RINs, a separate market from the D4 and D6 credits most energy readers track. OPAL Fuels reported a realised D3 price of $2.41 in Q1 2026, down $0.30, a fall of 11.1%, sized at roughly $4m of EBITDA. Real, and nowhere near a collapse. Montauk Renewables produced 1.4 million mmBtu in Q1 2026, flat year over year, and lifted adjusted EBITDA 22.8% (Montauk, Q1 2026). One operator growing EBITDA 23% while another gives back $4m is a sector with dispersion in it. It is not a sector being liquidated. BP’s own sensitivity prices an 11% revenue move at roughly $0.5bn, against a $3,537m charge.

I priced only one leg of RNG revenue, though. RNG also earns a California LCFS credit, and that one moved much harder. LCFS fell from a peak above $200 a tonne to a $57.77 average in mid-2025, spot as low as $40.25 on 10 June 2025 (Sylvera), inside the year of the $710m rights impairment. That complicates my price argument. It doesn’t reverse it, but it’s a real second input I should have priced.

There’s also a regulatory mechanism specific to unbuilt rights. California’s Air Resources Board amended the LCFS in November 2024, effective 1 July 2025: pathways certified before that date claim three ten year avoided methane crediting periods, pathways certified through 2029 claim two, and projects breaking ground after 2029 see avoided methane credits stop by 2040, whatever capacity they build (Advanced BioFuels USA, on the adopted CARB amendment). That’s a dated, non capital reason unbuilt rights specifically are worth less this year than last, on any owner’s discount rate. I can no longer treat RNG pricing and policy as settled.

The discount rate explains none of the remainder. BP’s post tax impairment rate “was 8% (2024 8%)”, unchanged, confirmed again at the half year. Price and policy moved. The rate didn’t. The capital decision is what’s left to explain the gap.

The third variable is the one BP controls

BP names all three inputs itself: “Management considers discount rate, renewable natural gas prices, and the level of capital expenditure and its consequential impact on production volumes to be the key sources of estimation uncertainty” (20-F 2025, Note 1). Its impairment note gives the fuller version, worth quoting in full: the charges “arose as a result of revised assumptions including capital and operating expenditure and the impact of market conditions on project development“ (20-F 2025, Note 4). Operating expenditure is a cost cause I can’t rule out from outside. What I can say: across three separate notes, capital sits first every time it’s named, and RNG prices are never named as a cause at all.

Capital expenditure is a decision, and BP took it in February 2025. Investment across every transition business in 2025, EV charging, bioenergy, Archaea, Lightsource and the rest, came to $2.3bn including $0.8bn of inorganic spend. Call it $1.5bn of organic capital for the whole portfolio, against a single asset BP had paid $4.1bn for a little over two years earlier.

Value in use runs off the approved business plan. Cut the capital, and you cut the plants. Cut the plants, and you cut production. Cut production, and the rights are worth less. For Archaea, BP discounts a plan running “up to 2050”, a twenty five year forecast, against ten years for Lightsource bp. A lower build rate compounds against you over that much longer a stream.

My working read at this point: BP impaired Archaea largely by deciding not to fund it. The next two disclosures are what actually earn that reading, rather than just restating it.

First, why the next revision hit immediately. BP publishes goodwill headroom by test, and the transition businesses carry none, a dash against $2,917m for upstream gas. I don’t read that as a hidden signal. It’s the mechanical result of having just impaired to recoverable amount. But it does mean no buffer was left going into 2026.

Read more

Two companies that took Google’s guarantee on AI data-centre leases valued what they paid for it, in their own audited books, at between 16% and 39% of the amount guaranteed, while Alphabet’s own balance sheet marks the liability for guaranteeing its entire book of these contracts, at the same date, at four-tenths of one percent.

The consensus I’m departing from, stated the way its believers would state it

The prevailing reading of Google’s roughly $200bn of interlocking commitments around Anthropic is that it’s vendor financing, and that the danger lies in what can’t be seen. Google sells the tensor processing units, funds the buyer, and guarantees the landlord who houses the machines. Revenue arrives on one side of the ledger while the obligation that produced it sits in a footnote on the other. The structure runs through Broadcom, Apollo, Blackstone, Morgan Stanley and a set of former bitcoin miners, and the sceptical conclusion is that the exposure sits in vehicles nobody consolidates, so no outsider can size it.

That’s a serious argument. Circular financing did inflate the 1999 telecom build, and the mechanism was identical in shape. But the people making it are missing something better than “opaque.” This exposure isn’t unsized. It’s priced twice, by four different parties, and the two prices disagree by a factor of nearly sixty.

I’ve covered the public-market side of this same financing complex before, Alphabet’s own $20 billion bond issuance and the $400 billion AI bond wave it sits inside. Neither piece touched the contingent side: guarantees, priced by an accounting entry instead of a coupon, which is what this one is about.

What I actually found, and why the piece changed under me

I started this thinking Alphabet’s rising guarantee mark, 41 to 186 basis points of notional over six months, was evidence AI vendor credit is deteriorating. I checked that against Alphabet’s own disclosures and it doesn’t hold up cleanly. The Q1 10-Q had already flagged $15.3bn of new backstops signed in April 2026. Q2’s notional grew $15,349m over the same quarter. A 100.3% match. Almost the entire six-month rise in the book is new paper. Existing risk barely moved. Alphabet even disaggregates the earnings effect: the credit-derivative P&L line ran -$147m in Q1, then +$70m in Q2: a gain, in the exact quarter the ratio kept climbing. A book that was mostly zero eighteen months earlier, growing mostly from new contracts, isn’t a clean deterioration series. I’m saying so directly rather than shipping the weaker version of this piece.

What replaced it doesn’t depend on reading a trend. It’s two audited numbers, already public, that nobody has put next to each other.

TeraWulf’s 10-K: “The Company recorded an asset of $515.5 million based on the fair value of the Google Warrants at issuance.” That’s against a combined $3.2bn of Google backstop: the original $1.8bn from August 14, 2025, plus a $1.4bn expansion four days later for a new lease at the same campus. Cipher’s 10-K does the same in a table: “Fair value of warrants as of issuance date 544,450” (in thousands), against its own $1.4bn backstop. Both used Black-Scholes. Cipher says it engaged a third-party valuation firm to run it.

Divide it out. TeraWulf’s price for the guarantee was 1,611 basis points. Cipher’s was 3,889. Alphabet’s own mark for the liability side of its entire book of these guarantees, at the same 31 December 2025 date both 10-Ks report from, was 41 basis points.

The mechanism: two firms pricing one transaction from opposite sides

Here’s why this isn’t an apples-to-oranges trick.

A backstop is one transaction with two sides. Google promises to cover a lessee’s payments on default; in exchange, Google receives warrants. TeraWulf and Cipher record what they gave up, the warrants, as an asset, at fair value, because GAAP requires it: it’s the cost of the benefit they received. Alphabet records what it’s on the hook for, the guarantee, as a liability, also at fair value, under ASC 815 as a credit derivative. Same transaction. Same date. Two audited fair-value measurements, from the two parties who negotiated the price, of the two halves of one contract.

They should track each other. I’d expect that going in. A guarantee worth $515.5m to the party paying for it is, roughly, a guarantee that costs something in that neighbourhood to write. Instead Alphabet’s own mark for guaranteeing its whole $16.94bn book, which contains both of these deals, is $69m. Pro-rate that down to just the $4.6bn these two deals represent (27.2% of the book) and the implied share is $18.7m. The two counterparties’ own books say Google took $1.06 billion. That’s 56.6 times the pro-rata share of what Alphabet’s own model says the liability is worth.

I checked whether Alphabet’s credit-derivative assets line absorbs any of this. It doesn’t. Zero. Nothing. It reads $0 in every period reported. The warrant consideration isn’t netted against the liability anywhere in Note 3. It sits somewhere else entirely, most likely folded into non-marketable securities, disconnected from the number a reader would take as “what Google thinks this guarantee costs.”

I wrote this exact comparison up separately too, as a standalone trade note with the worked arithmetic and the position-level detail carried further than a Substack piece should: Google’s AI Guarantee Book: A 39x-96x Gap Between the Disclosed Mark and the Disclosed Price.

Two readings of the gap, and I can’t fully separate them

A sophisticated reader’s first objection: warrants aren’t a clean insurance premium. That deserves its own section. Not a caveat.

Reading one: the liability mark is too low. If $1.06bn is close to a fair price for $4.6bn of guarantee exposure, Alphabet’s Level 3 model is understating the expected cost of the guarantees it writes, possibly across the whole book, and the reported $69m-to-$815m series understates what should be on the balance sheet.

Reading two: the warrant price isn’t pure insurance premium. Google wasn’t only selling protection. It was helping two bitcoin miners re-rate into AI infrastructure operators, a transformation their own stock prices show real value in beyond the lease guarantee itself. I think some share of that $1.06bn plausibly compensates for things a pure credit spread wouldn’t: standing up project financing for young, single-purpose entities; an equity-like reward for enabling a risky pivot; maybe favourable terms elsewhere in the TPU relationship that never surface as their own line item.

I can’t cleanly apportion the $1.06bn between the two from public filings, and I won’t pretend I can. But even a generous, deliberately favourable allocation to reading two still leaves a large number sitting in reading one. If only a third of the warrant value is priced credit protection in any real sense, that’s still roughly 19 times the pro-rata liability share Alphabet carries. Shrink the “partnership” share as far as the facts allow, and the gap doesn’t close. It just gets less enormous.

I’d also flag what reading two is actually buying, since I think it’s easy to wave at “partnership value” without pricing it. TeraWulf and Cipher were bitcoin miners before these deals, companies whose core business was proof-of-work hashing. Leasing power-hungry campuses to AI labs came later. A backstop from Google doesn’t just de-risk a lease. It’s the signal that let both companies raise project debt at all: TeraWulf’s own 10-K ties the warrant pledge directly to its $3.2 billion of 2030 Senior Secured Notes, and the backstop is named as collateral support for that financing. If part of what TeraWulf paid for was access to a bond market it couldn’t otherwise reach, that’s real value, and it’s not obviously smaller than the credit protection itself. I raise this because it’s the honest version of reading two, not vague hand-waving about “partnership” but a specific, named, verifiable channel through which some of that $515.5m bought something other than insurance.

Read more

For a decade, the clearest method of generating alpha from SpaceX was not owning SpaceX. It was owning the access-constrained proxies that held it by necessity, at premiums that reflected the structural gap between demand and supply. S3 Partners confirmed the mechanism in the week following the June 12 IPO: “SpaceX’s record IPO removes the central constraint of the space trade — for years it meant buying public proxies because the category leader wasn’t listed.” With Phase 1 fully captured and Phase 2 decaying on a disclosed calendar through December 9, 2026, the one alpha channel still open requires correctly disaggregating why space stocks sold off on IPO day, but that disaggregation only holds if you understand what the ASTS bear case actually rests on, which is not the satellite count.*

🎬 Prefer to watch rather than read? A NotebookLM-generated video overview of this article is available here: Watch the video overview → Full analysis, citations, and data remain in the article below.

Phase 1: The Proxy Access Alpha (2008–2026, Captured)

SpaceX’s private status imposed an access constraint that most institutional capital could not cross. Investors who needed exposure held it through vehicles that could reach the secondary market or had carried the position for years, while those vehicles traded at premiums reflecting the optionality of owning the category leader before it listed. The figures below are drawn from the best available primary sources: state regulatory filings, fund investor communications, and contemporaneous press releases, but none are audited returns, and that limitation applies to the entire section.

Google’s approximately $900 million investment in SpaceX’s January 2015 round, an amount consistently estimated across secondary sources including Bloomberg and Fortune but not disclosed in Alphabet’s SEC filings, produced a stake that a 2026 Alaska state filing reported by Bloomberg placed at 6.11% of SpaceX at end-2025, since diluted to approximately 5% following the February 2026 xAI merger. At the $1.75 trillion IPO price, that range represents a paper gain of approximately 97x to 120x on the estimated cost basis, with the cost basis itself unverifiable from any Alphabet filing.

Founders Fund invested approximately $20.4 million in SpaceX’s Series C in August 2008, confirmed in a contemporaneous SpaceNews press release. The firm last appeared in Alaska’s state shareholder disclosure at a 5.76% stake as of December 2023, per Bloomberg. The stake has since fallen below the 5% reporting threshold, meaning Founders Fund has sold down some portion and its current holdings are unverifiable from public records. Founders Fund partner Scott Nolan told Axios in May 2026 the remaining stake “could be worth more than $60 billion.”

Scottish Mortgage, Baillie Gifford’s flagship UK investment trust, invested GBP £151m (approximately $200m at time of purchase) in SpaceX between December 2018 and August 2021. Per its pre-IPO briefing note of May 2026 (an investor communication, not an audited filing) the stake carried a fair value of GBP £2.98bn as of March 31, 2026, a stated 19.7x return on invested capital. The same document describes SpaceX as “our biggest contributor to returns over 1, 3 and 5 years.”

For funds without direct secondary market access, DXYZ (Destiny Tech100) offered a publicly listed vehicle with SpaceX as its largest holding at 16.2% of portfolio. DXYZ reported a net asset value of $19.97 per share as of December 31, 2025, per its Business Wire press release, while trading at a substantial premium to that figure in the months preceding the IPO, reflecting the pure optionality value attached to pre-IPO SpaceX exposure.

Decay: Complete as of June 12, 2026. Forge Global states it no longer tracks SpaceX. Any fund still holding proxy vehicles at a premium to NAV for SpaceX exposure is paying the access premium for a structural constraint that no longer exists.

Capacity: Limited pre-IPO to the secondary market’s effective throughput, with individual institutional tender-offer participation capped by SpaceX’s own structure. The edge was access-constrained rather than market-impact-constrained.

Phase 2: The Float Mechanics Trade (June 12 to December 9, 2026, Decaying)

SpaceX listed with an initial float of approximately 555.6 million shares, expanded to approximately 638.9 million after underwriters exercised the full greenshoe on June 15, producing a public float of approximately 4.9% of 13.08 billion total shares. This float met an estimated $35 to $50 billion in forced MSCI passive buying concentrated into roughly $70 billion in tradeable shares. SPCX ran from the $135 IPO price to an intraday peak of $225.64 on June 16, a 67% move driven by supply-demand mechanics, not by any new information about the businesses. It now trades at approximately $154.

The staggered lock-up schedule is disclosed in the 424B4 prospectus: a first tranche releasing approximately 20% of the 180-day lock-up block on the second full trading day after August 6 earnings; staggered 7% tranches at days 70, 90, 105, 120, and 135 post-IPO; a Q3 earnings-triggered 28% release; full 180-day expiry on December 9, 2026. Musk’s approximately 6.4 billion Class B shares unlock June 12, 2027.

Decay: Mechanical and calendar-driven. S&P 500 exclusion is structural: the index requires GAAP profitability in both the most recent quarter and cumulatively over four quarters. SpaceX posted a $4.94 billion GAAP net loss in 2025 and approximately $4.3 billion in Q1 2026, a range reported as $4.27B to $4.30B across credible sources reading the same prospectus. The GAAP losses are driven by xAI’s $6.355 billion operating loss on $3.20 billion in 2025 revenue. The vast S&P 500-linked passive capital base, excluded from buying SPCX on inclusion criteria, remains a structural buyer waiting until SpaceX posts four consecutive GAAP-profitable quarters, not realistic on current trajectory before late 2027.

Capacity: Approximately $2B AUM before position sizing creates material price impact against the current float. Inaccessible to larger funds without moving the market.

Phase 3: The Post-Proxy Disaggregation Trade

S3 Partners identified a clean divergence in how capital moved through the space sector around the IPO. Short interest in Rocket Lab declined 22% year-to-date, while short interest in AST SpaceMobile built 41% year-to-date to approximately 54 million shares. S3 estimates only 22% of ASTS short interest is convertible-bond arbitrage, meaning approximately 78% is directional. The firm’s characterization: “Rocket Lab and Viasat, the cash-generating operators, ran the other way: shorts covered both over the past month and YTD. At the genuinely directional shorts, AST SpaceMobile’s +41% build and Virgin Galactic’s +86%, the short side outran the long.”

The IPO-day rotation sold all space stocks simultaneously. Rocket Lab fell approximately 10.8%. Analysts called it capital rotation. That characterization is correct for RKLB and structurally incomplete for ASTS, where the rotation and a genuine fundamental repricing arrived simultaneously, priced as a single event when they are not the same trade.

Why the two names have different exposures to SpaceX

Rocket Lab is a launch services and space systems provider. Its Q1 2026 SEC 8-K filed May 7, 2026, reports record quarterly revenue of $200.3M (+63.5% year-over-year), record backlog of $2.22B (+108% year-over-year), and Q2 2026 guidance of $225M to $240M against a consensus of $207.5M. Its backlog includes an $816M Space Development Agency Tracking Layer Tranche 3 contract for missile warning and defense satellites and a $515M SDA Transport Layer-Beta Tranche 2 program, totaling more than $1.3 billion in contracted SDA work awarded competitively from a field that did not include SpaceX on TRKT3 specifically. SpaceX competed in the same SDA ecosystem via the $2.29 billion SDN Backbone award and a $4.16 billion Air Moving Target Indicator contract in May 2026, both representing a separate and larger program enclosure. The medium-term risk is real: as SatNews reported, the week of those SpaceX awards was “the seven days in which American military space lost its remaining alternatives,” and RKLB’s SDA pipeline beyond its current contracted work faces a genuine consolidation risk. What is not at risk from SpaceX competition today is the existing contracted backlog of $1.3B in SDA work already awarded. RKLB joined the Nasdaq-100 on June 22, 2026, creating structural passive buying demand. Neutron, targeting a Q4 2026 debut at $50 to $55M per mission versus Electron’s approximately $8M, represents a step-change in unit economics if it delivers.

The pair trade is not a bet that RKLB is immune to SpaceX competition in government space. It is a bet that the existing contracted backlog, Nasdaq-100 inclusion demand, and Neutron optionality constitute a fundamentally different risk profile from ASTS, and that the IPO-day rotation priced them identically.

The ASTS Bear Case: What It Actually Rests On

The satellite count argument (9 operational BlueBirds today versus Starlink’s 650-plus DTC satellites) is true but insufficient as a thesis anchor on its own, because ASTS is assembling satellites at 6 per month and announced BB11–13 launching in the first half of August from Cape Canaveral, per a BusinessWire release on June 23. At the August 6 catalyst date, ASTS will likely have 12 operational BlueBirds, a ratio of roughly 54:1 against Starlink, better than the current 72:1, but directionally the same. By year-end 2026 at the targeted 45 satellites, the ratio is approximately 14:1. A directional short seller reading the satellite count will immediately ask whether ASTS’s trajectory invalidates the thesis. It doesn’t, but the reason why is not the satellite count.

The correct anchor is ASTS’s 10-K revenue recognition policy, which states verbatim: “Revenue for SpaceMobile Service will be recognized over the life of the contract, beginning when AST provides MNOs access to its satellite network. To date, the Company has not recognized any revenues from its SpaceMobile Service.” The $1.2 billion in contracted MNO revenue commitments does not recognize on satellite deployment milestones. It does not recognize on carrier infrastructure investment by partners. It recognizes when ASTS provides network access, meaning commercial service launch, which the company targets for H1 2027 and requires reaching a minimum constellation density of 25-plus satellites for limited non-continuous service. The 45-satellite year-end target is necessary for that commercial launch, not sufficient in itself for revenue recognition.

This means the Q1 2026 revenue miss requires a more precise interpretation than its surface appearance suggests. The $14.7 million in Q1 came from gateway equipment deliveries and government contract milestone achievements, not from SpaceMobile Service. ASTS’s own Q1 press release described the result as “consistent with plans for quarterly revenue ramp.” The miss was against Wall Street consensus, not ASTS’s internal plan. Q2 will test something more specific: whether gateway deliveries and government milestones can accelerate enough to reach the $40 to $50 million quarterly run-rate implied by the $150 to $200 million full-year guidance, with the additional variable of whether initial commercial service activations in targeted markets generate any SpaceMobile Service revenue recognition in H2 2026.

The structural bear case: even at 45 satellites and commercial service launch in H1 2027, Starlink DTC will have 18 months of commercial data with T-Mobile, multiple carrier partnerships, and a proved product. The moment ASTS’s $1.2B in contracted MNO revenue starts recognizing, those same MNOs face a choice between a committed supplier and a proven incumbent. The satellite trajectory accelerating through year-end is a necessary operational milestone, not a revenue event. These are different things, and conflating them is how the bull case overstates the near-term.

As of December 31, 2025, ASTS carried $227 million in deferred contract liabilities (cash received from partners including a $175 million prepayment from stc Group), sitting on the balance sheet because the performance obligation (network access) has not yet been satisfied. That $227M represents commercial demand. It also represents revenue that won’t hit the income statement until ASTS crosses the commercial service threshold in 2027.

ASTS Q1 Earnings in Context

ASTS’s Q1 2026 results showed revenue of $14.7M against estimates of $37.5M to $39M, with net loss of $191M against an expected $86.8M loss, EPS of -$0.66 against a -$0.21 to -$0.24 estimate, and total operating expenses of $164.1M. The 60%-plus miss against consensus was driven by the inherently lumpy nature of gateway delivery timing and government milestone achievements, not by SpaceMobile Service revenue failing to materialize; that revenue doesn’t start until commercial launch. The company targets full-year 2026 revenue of $150 to $200 million, implying a significant ramp in Q2 through Q4 from gateway sales and milestones. That ramp is the August 6 test, not whether the 12-satellite constellation has commercialized.

The three-scenario expected-value model, position sizing at 10% ADV participation, stop-loss triggers, borrow mechanics, and the specific falsification condition that forces an immediate exit before August 6 are in the full institutional note on Patreon.

The Morningstar Reference: What the $62 Includes

Morningstar’s $62 fair value estimate for SPCX was published in the context of the Cursor acquisition analysis, revised down from $63 at IPO to $62 after the $60 billion all-stock deal. The estimate accounts for Cursor dilution. The market price of approximately $154 also reflects post-Cursor trading. Both figures are post-Cursor, making the 2.5x premium ratio consistent on the same basis. Morningstar’s methodology yields $40 per share for core space and connectivity operations, $16.50 probability-weighted for the AI segment, and $5.51 net cash less debt, totaling $62.51 before rounding. The ratio of approximately 2.5x at current prices reflects the gap between that sum-of-parts math and the market’s implied valuation of the Starship and orbital computing optionality.

The Strongest Objection

The investor community Juxtaposed on TipRanks published the opposite position as of June 21: bullish on ASTS, hold on RKLB. The ASTS bull case: $3.5 billion in cash, cash equivalents, and restricted cash as of Q1 2026, per the ASTS 10-Q, against $2.97 billion in long-term debt, plus $1.2 billion in contracted revenue commitments from AT&T, Verizon, Vodafone, Rakuten, and others, and BB11–13 launching in early August with production already through BB37. If carriers treat ASTS and Starlink DTC as complementary, and if ASTS reaches commercial launch in H1 2027 as planned, the contracted revenue begins recognizing and the deferred $227M starts flowing.

There is also a material valuation concern on the long side. RKLB trades at approximately 45x forward price-to-sales against SpaceX at roughly 30x, despite RKLB’s substantially lower revenue base, per Seeking Alpha’s post-IPO analysis. On this metric, RKLB is priced more expensively than the category leader. RKLB’s SVP and General Counsel disposed of $9.5M in shares on June 18, 2026, per SEC Form 4 disclosures. And RKLB’s $3.0B at-the-market equity offering creates ongoing dilution. Separately, SpaceX’s growing role in SDA military space, specifically the SDN Backbone and AMTI wins in May 2026, represents a medium-term encroachment on RKLB’s government revenue pipeline beyond the current contracted backlog.

The pair trade survives this objection only if RKLB’s Nasdaq-100 inclusion and government contract backlog provide structural support against its valuation premium and dilution headwind, while ASTS misses its Q2 gateway and milestone run-rate target by enough to cast doubt on full-year guidance. If ASTS demonstrates a clean Q2 acceleration to $40M-plus in revenue driven by gateway deliveries, the timing-miss narrative is validated and the directional short fails.

Decay and Capacity

Long RKLB: Decays if Neutron’s Q4 2026 debut fails or is delayed; if Q2 earnings miss the backlog-implied revenue trajectory; or if RKLB’s SDA pipeline beyond current contracts erodes as SpaceX consolidates military space. The June 18 insider disposal is a monitoring signal. Approximate capacity: at standard 10% participation over five trading days against RKLB’s approximate 20-day average daily volume of $350M to $450M, a position of roughly $175M to $225M stays below standard single-name impact thresholds. These are estimates based on stated participation assumptions, not hard figures; actual market impact depends on execution strategy and prevailing liquidity.

Short ASTS: Decays if ASTS Q2 2026 revenue accelerates materially toward the full-year guidance run-rate, demonstrating the Q1 miss was execution timing rather than structural failure. Per S3 Partners via Yahoo Finance, approximately 30M shares are available to borrow with borrow costs below the squeeze threshold at last report. At the same 10% participation rate against ASTS’s approximate 20-day ADV of $100M to $150M, a position of roughly $50M to $75M is the practical impact threshold; above that level, the short begins moving the price. Total combined capacity for the pair at these participation assumptions: approximately $225M to $300M. Larger positions require longer execution windows and higher cost.

Why the edge persists: The IPO-day rotation was mechanical. Capital exited all space stocks without fundamental differentiation. The RKLB/ASTS fundamental divergence (a $2.22B defense-anchored backlog against a 60%-plus consensus revenue miss, with ASTS revenue recognition structurally deferred to 2027) has been visible in public filings since May 2026. The market priced both names identically on June 12. The S3 short interest data shows that informed directional positioning had already diverged before the IPO. The question is whether August confirms or invalidates that divergence.

What Would Change This View

Three conditions flip the thesis. ASTS Q2 2026 revenue materially beats the $40M to $50M quarterly run-rate implied by full-year guidance, demonstrating that gateway deliveries and government milestones can accelerate beyond Q1’s rate. Starlink DTC adoption stalls from spectrum interference challenges or carrier resistance to the T-Mobile exclusivity structure. Neutron’s Q4 2026 debut fails or is delayed, removing the primary RKLB re-rating catalyst.

A fourth condition that would change the broader three-phase framework: evidence that ASTS’s MNO revenue recognition begins earlier than H1 2027 because network access is provided to carriers for limited commercial use before the full 45-satellite constellation is reached. The 10-K language (”beginning when AST provides MNOs access to its satellite network”) is not satellite-count specific; it triggers on network access provision. If ASTS activates limited commercial service in one or two markets in late 2026 with fewer than 45 satellites, some portion of the $1.2B in contracted revenue begins recognizing sooner than the H1 2027 base case.

The Actionable Implication

Phase 1 alpha is fully captured. It is not replicable. Phase 2 decays mechanically through December 9, 2026, accessible only to funds below approximately $2B AUM. Neither has residual alpha available to a reader who was not already positioned.

Phase 3 is the only channel that does not require timing the float mechanics or taking direct SPCX exposure at a 2.5x fundamental premium to Morningstar’s $62 sum-of-parts estimate. Its combined capacity of approximately $225M to $300M at standard participation rates keeps it from being fully arbitraged by platforms that would otherwise close it immediately, and that ceiling is the structural reason the divergence persists.

The August catalyst is specific: RKLB and ASTS both report earnings within days of the first SPCX lock-up tranche release. Three information streams become simultaneously observable: RKLB Q2 versus its $225M to $240M guidance, ASTS Q2 versus its $40M to $50M implied quarterly run-rate, and the initial insider selling decision from SPCX insiders who for the first time can reveal their private price discovery. Each is analytically distinct. Together, they constitute the most information-dense calendar event between now and December 9.

The pair trade is long a launch company with a record $2.22B contracted government backlog, Nasdaq-100 inclusion demand, and a Q4 Neutron launch option, against short a direct-to-device satellite operator whose $1.2B in contracted MNO revenue is structurally deferred to 2027, whose Q1 revenue was consistent with its own plan but 60%-plus below Wall Street consensus, and whose 12 operational satellites at the August window face a 54:1 disadvantage against Starlink DTC. It is not a bet on valuation convergence. It is a bet on fundamental divergence that IPO-day rotation priced as the same position.

📊 Want Deeper Quantitative Analysis?

This research took a very long time of data collection, verification, and analysis. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon.

By joining, you’ll be supporting my work and motivating me to publish more content like this.

→ Join the Patreon community here

Full institutional note — three-scenario EV model, stop-loss triggers, borrow mechanics, capacity ceiling, and all primary SEC sources: Patreon.

Primary sources: Rocket Lab Q1 2026 SEC 8-K (May 7, 2026); AST SpaceMobile 10-K FY2025 (revenue recognition policy); ASTS Q1 2026 press release via SEC (March 31, 2026 quarter); ASTS BB11-13 launch announcement, BusinessWire (June 23, 2026); ASTS Q1 2026 earnings, Yahoo Finance; S3 Partners post-IPO space sector analysis, Yahoo Finance; SpaceX prospectus xAI financials, Yahoo Finance; Rocket Lab SDA Tranche 3 contract, SEC press release (December 19, 2025); SpaceX SDN Backbone $2.29B contract, SpaceNews (May 2026); SatNews military space consolidation analysis (June 2026); Morningstar $62 SPCX fair value, post-Cursor (June 14, 2026); Scottish Mortgage pre-IPO briefing note, Baillie Gifford; Alaska state filing on Alphabet stake, Bloomberg; Founders Fund 2008 investment, SpaceNews; Scott Nolan interview, Axios; S&P 500 exclusion, Yahoo Finance; SpotGamma index flow analysis. Investor letters and fund communications are marketing materials, not audited statements, and are attributed accordingly. This article does not constitute investment advice. The author holds no position in any securities mentioned.

Follow the research: YouTube — The Mathematical Trader · LinkedIn · Patreon

Cover photograph: SpaceX, CC0, via Wikimedia Commons.

🎬 Prefer to watch rather than read? A NotebookLM-generated video overview of this article is available here: Watch the video overview → Full analysis, citations, and data remain in the article below.

The Consensus and Its Missing Variable

The dominant published view on PE in European football is accurate as far as it goes: clubs are globally recognized brands trading at 3–6x revenue against peer entertainment assets at 10–12x, implying a structural discount. According to PitchBook’s Big Five football dashboard, more than 36% of Big Five clubs have financial backing specifically from PE, VC, or private debt firms at the start of 2025-26; multi-club ownership networks (MCOs) — a broader category that includes strategic investors and family offices alongside PE — cover 48% of Big Five clubs, up from 41.7% in 2024. Source limitation: PitchBook’s figures reflect publicly disclosed deal information; undisclosed private stakes are not captured and the true penetration rate is likely higher.

European football dealmaking grew from approximately €66.7 million in 2018 to a peak of approximately €4.9 billion ($5.4 billion) in 2022, the year the Chelsea and AC Milan transactions settled, per the PitchBook Q3 2023 Analyst Note. Deal activity has remained elevated since but has not exceeded the 2022 peak, according to PitchBook’s Part III update from August 2025.

What the consensus omits is the distribution within the sector. A club with €600M in revenue priced at 5x EV/Revenue and a club with €80M in revenue priced at 1.3x are not the same trade. Treating them as one asset class generates the illusion that the opportunity is either uniformly attractive or uniformly crowded. It is neither.

The IRR Math: Why Trophy and Mid-Tier Are Different Trades

All documented inputs are cited to primary sources; exit multiples are scenario assumptions explicitly labeled as such.

Documented inputs:

• Revenue CAGR: 6.2%, for Europe’s top 32 clubs since Football Benchmark’s inaugural 2016 edition through 2025. Limitation: Football Benchmark is a commercial analytics firm; its figures derive from club-reported financials with variable auditing standards across leagues.

• Five-year hold (standard PE football horizon).

Scenario A — Mid-Tier Entry at 1.5x Revenue:

Exit multiple: 3.5x — an assumption reflecting FSR-forced EBITDA normalization and unlocked UCL access. There are no documented PE football exits yet to anchor this figure; it is a scenario input, not an empirical estimate. The first exits from the 2018-2021 cohort will validate or substantially revise it. If only FSR normalizes and UCL access is not achieved, a 2.5x exit yields approximately 17.6% gross IRR. The model is sensitive to this assumption in both directions.

Scenario B — Trophy Entry at 5x Revenue:

Exit multiple: 6x — an assumption of modest expansion from current levels. This is below Manchester United’s documented 6.5x in Football Benchmark 2024 and therefore conservative for the trophy tier, though the 6x exit is itself undocumented for any completed PE football transaction.

Net IRR to LPs after fees: approximately 6–7%. This does not clear the institutional PE hurdle rate for a $5B+ fund. The 6x exit assumption is generous given Accuracy Group’s analysis of Chelsea (2022) and Manchester United INEOS (2024) shows actual transaction prices ran approximately 20–30% above Football Benchmark’s theoretical valuation — buyers at trophy level paid a control premium before the hold period began.

Scenario C — Mid-Tier Entry → Relegation:

Serie A domestic rights for 2024-2029 total €900M/year across 20 clubs, per Reuters’ reporting of the official October 2023 club vote, giving a mid-table club approximately €40–55M annually. Serie B’s total broadcast rights for the 2021-2024 cycle stood at €48.5M for the entire league, per Sportcal’s direct reporting of the Sky + DAZN deal. Limitation: this figure covers the 2021-24 cycle; the current cycle may differ. A primary source for current per-club Serie B distributions was not obtainable. The structural argument — that any individual Serie A club’s annual broadcast share substantially exceeds a pro-rata share of a ~€50M total pool — holds regardless of the exact current figure.

Post-relegation revenue falls toward approximately €60M (broadcast line collapses; other revenues partially hold). Distressed exit at 1x revenue implies approximately €60M EV.

Equal capital split between Scenario A and Scenario C produces a blended MOIC of approximately 1.78x (€532.9M returned against €300M invested) — a materially positive outcome, not the netting-to-zero that a naive average of the two gross IRRs (25.8% and -26.3%) might suggest. That naive average is the wrong calculation: it treats percentage returns as additive across mismatched hold periods (5 years versus 3) and ignores capital weighting. The portfolio implication is the opposite of intuitive — the trade survives even a 50% Scenario C hit rate. What it does not survive is Scenario C clustering non-randomly across a portfolio rather than landing independently, which is the more realistic underwriting concern, and the subject of the next section.

A Case Consistent With the Thesis: Hellas Verona

In January 2025, Presidio Investors acquired Hellas Verona, as confirmed by the joint statement published by the club and Presidio. Financial terms were not officially disclosed. Private Equity Wire, citing a source familiar with the deal, estimated the enterprise value at €120M–130M including existing debt. TheScore.com citing AFP reported Italian media estimated approximately €130M total. According to the managing partner in an interview with ION Analytics/Mergermarket — a practitioner’s statement, not independently verified — no new debt was raised; Presidio bought out the existing equity with existing debt remaining in place.

Hellas Verona was officially relegated from Serie A during the 2025-26 season, per Football Italia’s final standings report, confirmed independently by Yahoo Sports. The club finished 19th — within 17 months of acquisition. The managing partner stated, per the ION Analytics interview, that the firm reviewed approximately “70 to 80 different clubs” before selecting Verona.

This is a single case (n=1). It is consistent with the thesis that relegation risk is systematically underweighted in PE underwriting of mid-tier football clubs. It is also consistent with Presidio simply being unlucky, or with them being poor at evaluating squad quality for survival. One observation cannot establish a pattern. What it does demonstrate is that the tail event is accessible even to investors who conduct thorough deal selection; the number of clubs reviewed is not the relevant variable. The academic evidence below argues the mechanism is structural, not random — but that argument rests on limited evidence and should be weighted accordingly.

Why the Mid-Tier Discount Exists and Why It Is Changing

Three structural factors price mid-tier clubs below their asset value: illiquidity (no exchange-traded market), relegation risk (can destroy 40–60% of EV within a season), and governance weakness (family/founder ownership with no institutional cost discipline). These are real and explain the discount.

Two catalysts are changing the underlying economics in ways backward-looking multiples do not capture.

The FSR Inflection: UEFA’s regulations cap squad costs at 90% in 2023/24, 80% in 2024/25, and establish a permanent 70% ceiling from 2025/26. Football Benchmark 2025 documents the average squad cost-to-revenue ratio declining from 95% in 2023 to 82% in 2025. A club with €100M revenue and squad costs structurally capped at €70M posts a visible forward EBITDA margin for the first time. Standard DCF frameworks will update when 12–18 months of constrained financial statements are published.

The UCL Media Rights Cycle — What the Actual Bids Show: The 2027–2033 tender, managed by Relevent Sports under a mandate announced in March 2025, has produced disclosed results for the big five markets. Bloomberg reported in November 2025 that UEFA will receive approximately €2.5 billion per year from the five major European markets in the next cycle — up from approximately €2 billion in the current cycle, a 25% increase. The total revenue target across all competitions, all territories, and all revenue streams (broadcast, sponsorship, and licensing) exceeds €5 billion per season, per the UC3 joint venture’s stated goal — roughly 14% above current total men’s club competition revenue of €4.4 billion, per UEFA’s own 2024-25 financial results.

The 25% increase in big five media rights is meaningful and confirmed. At a constant 4.9x EV/Revenue multiple, a €20M annual UCL distribution increment for a mid-tier club that achieves qualification translates to approximately €100M in EV — significant option value for a club purchased at 1.5x revenue, even without the secondary catalysts.

The Mechanism That Makes Scenario C Non-Random

The most analytically interesting feature of the Hellas Verona case is not the outcome but the path: Presidio’s value creation strategy would have required rotating to younger, cheaper players to achieve FSR 70% compliance, which simultaneously disrupts the player coordination structures that determine on-field performance. If this observation is general — if the FSR compliance mechanism that drives the financial upside also degrades the squad quality that prevents relegation — then Scenario C is not an independent tail event. It is endogenous to the strategy.

This is a hypothesis, not a demonstrated mechanism. The evidence supporting it is preliminary: a 2024 SSRN working paper by Kristina Lalova-Yuhasz (Michigan State University) studies 96 European clubs (28 PE-backed, 68 non-PE) across the five major leagues in a staggered difference-in-differences design and finds PE investments increase commercial and matchday revenue but decrease player network centrality metrics and on-field match performance. Disclosure: the SSRN submission lists Lalova-Yuhasz as sole contact author; ResearchGate’s indexing of the paper lists Brennan Cimpeanu as co-author alongside Lalova — the same attribution Cimpeanu makes on his LinkedIn profile. The conflict between SSRN (sole author) and ResearchGate (two authors) is not resolvable from public information. ECGI’s publication of the author’s summary captures the tension: PE is “highly effective in enhancing financial outcomes” while this “comes at the expense of on-field performance.” Note: this is Lalova-Yuhasz’s own ECGI blog post, not an independent editorial assessment.

The limitations are significant: pre-peer-review, single season (2023-24), 28 PE-backed clubs, mechanism not externally replicated. The endogeneity claim does not require the Lalova-Yuhasz paper to be correct — it is a structural observation about the strategy’s internal logic. The paper provides preliminary empirical support, not proof. If the finding survives peer review and replication across multiple seasons, the probability that Scenario C is endogenous rather than random increases substantially. If it does not survive, the mechanism reverts to a structural hypothesis with one consistent anecdote.

The practical implication is the same either way: a PE investor who deploys the standard “optimize costs, rotate squad, improve commercial” playbook without modeling the joint probability distribution of FSR compliance and relegation avoidance is misspecifying the return distribution.

The Crowding Signal: Where Alpha Has Already Decayed

The trophy-asset tier is clearly crowded. Accuracy Group’s analysis of Chelsea (2022) and Manchester United INEOS (2024) shows actual transaction prices approximately 20–30% above Football Benchmark’s theoretical valuation. Paying a control premium on an EBITDA-negative asset at 5x revenue is the signature of more capital than deals.

The crowding is accelerating. Named vehicles with documented European football investments or public commitments now include: Apollo Global Management ($5B Apollo Sports Capital, September 2025), Ares Management (sports fund launched 2022, reportedly building a second), CVC Capital Partners (refinancing a sports portfolio valued at £9 billion as of July 2025 per Bloomberg and Sportcal — a PitchBook article from November 2025 cited “$14 billion” for the same vehicle; the discrepancy may reflect portfolio revaluation or different asset inclusions and is not resolvable from public information), RedBird Capital Partners, Clearlake Capital, Oaktree Capital Management, Sixth Street Partners, Arctos Partners, MSP Sports Capital, TPG, Presidio Investors, and Elliott Management. This is approximately 12 vehicles based on publicly confirmed transactions and announcements, and is a lower bound — undisclosed vehicles are not captured. The August 2024 NFL PE approval additionally admitted Blackstone, Carlyle, Dynasty Equity, and Ludis to American sports, expanding the pool of institutional capital with sports-sector exposure.

The Regulatory Barriers That Permanently Reduce the Investable Universe

Germany — 50+1 Rule: In July 2025, the German Federal Cartel Office issued preliminary findings that the Bundesliga’s 50+1 ownership rule is broadly compatible with competition law, while requiring the DFL to enforce open club membership more strictly. The FCO’s guidance is preliminary, not a final ruling, but the practical effect is unchanged: PE cannot hold control positions in Bundesliga clubs, removing approximately 18 Bundesliga 1 teams from the mid-tier PE control thesis.

England — Football Governance Act 2025: The Act, receiving Royal Assent in July 2025, established the Independent Football Regulator with powers to approve ownership suitability, impose licensing conditions on financial planning and fan engagement, and intervene in revenue distribution. Licensing implementation phases throughout 2026, extending deal timelines and constraining operational autonomy for Premier League clubs.

France — Ligue 1 Structural Revenue Crisis: Deloitte’s Football Money League 2026 confirms the DAZN termination “will negatively impact French clubs’ broadcast revenues in the short-to-medium term.”

Capacity Bound: A Transparent Construction

A precise count of qualifying mid-tier clubs is not publicly available. What follows is a transparent derivation from documented inputs, not a database count, and should be read as an order-of-magnitude estimate.

Starting universe: Five Big Five leagues, approximately 96 clubs total.

Filter 1 — Regulatory inaccessibility: Germany’s 50+1 rule removes approximately 18 Bundesliga 1 clubs from PE control consideration. France’s broadcast crisis excludes Ligue 1’s 18 clubs from the near-term accessible universe — not a permanent barrier like Germany’s, but treated the same way for this construction. The accessible universe for control-position mid-tier investments concentrates in England, Italy, and Spain — approximately 60 clubs (96 total, minus 18 Bundesliga and 18 Ligue 1).

Filter 2 — Already PE-backed: PitchBook’s dashboard reports 36% of Big Five clubs have PE/VC/private debt backing. Scaling that penetration rate to the 60-club accessible universe (acknowledging this is an approximation, since the German penetration rate is near zero and distorts the Big Five average) suggests approximately 20–25 accessible clubs are already PE-backed, leaving approximately 35–40 uninvested clubs in accessible leagues.

Filter 3 — Trophy-tier pricing: The top 6–8 Premier League clubs trade at 4x+ revenue (trophy tier, Scenario B territory). Removing these leaves approximately 28–34 mid-tier clubs in accessible leagues currently available for entry at 1–2x.

This construction produces an estimate of approximately 30 qualifying clubs with a range of roughly 25–35. That range is wide enough that the capacity claim cannot be stated precisely. What can be stated: the universe is not large, and with approximately 12 named vehicles actively pursuing it, the deal-to-buyer ratio is thin.

Fund-size implication: A dedicated sports vehicle with $500M–$2B AUM can make 5–10 investments at €150M average check without being forced into trophy assets. At $5B+ AUM, a fund cannot deploy at scale into mid-tier clubs without concentration risk and is functionally pushed into Scenario B. The alpha at mid-tier is structurally inaccessible to large-cap generalist PE — not because of any analytical advantage the smaller funds have, but because they can match their fund size to the available deal flow.

→ A condensed, single-document version of this analysis — the same sourced figures and IRR math, formatted as an institutional reference note — is available on Patreon.

What Would Change This View

UCL big-five media rights disappointing further. The €2.5B/year from big five markets is confirmed for 2027-2031. If subsequent tender waves (Eastern Europe, Americas, Asia-Pacific) yield materially below expectations, total revenue fails to reach the >€5B target and the incremental club revenue uplift is smaller than the 25% already achieved in big-five media rights.

UEFA FSR enforcement asymmetric. The 70% permanent cap must produce documented sporting sanctions — not just fines — against non-compliant clubs in 2025-26 for the EBITDA normalization to materialize.

The endogeneity hypothesis failing to replicate. If peer-reviewed replication of the Lalova-Yuhasz finding shows no systematic on-field decline under PE, or if it shows the effect is fully absorbed by clubs without relegation consequences, Scenario C reverts to a random tail event, the IRR distribution improves, and the mid-tier trade becomes more attractive than Scenario A suggests.

The 2018-2021 exit cohort disappointing. The first realized IRRs from PE football exits will either validate Scenario A assumptions or indicate the exit multiple assumed is too high. If realized exits cluster below 2.5x MOIC, the mid-tier thesis is under-earning and will not attract subsequent institutional capital on the necessary terms.

Actionable Implication

The mid-tier European football club trade has a closing window, the length of which is genuinely uncertain. The capacity construction above suggests 25–35 qualifying clubs remain uninvested; against approximately 12 named vehicles, the supply-demand balance is thin but not exhausted. The trade is accessible to vehicles of $500M–$2B with football operational expertise. The two observable signals worth tracking: (1) UEFA FSR enforcement producing documented sporting sanctions against clubs exceeding the 70% squad cost cap — fines without sanctions mean the cap is not binding; (2) the outcome of post-relegation revenue recovery for Hellas Verona under Presidio’s ownership, which will be the clearest near-term single-club test of whether the operational thesis can survive a Scenario C event.

Deloitte’s Sports Investment Outlook identifies 2025 as the year of first significant PE exits. Those realized returns, as they become public through LP reporting, will be the first empirical test of whether the trade delivered what buyers claimed.

📊 Want Deeper Quantitative Analysis?

This research took considerable time to collect, verify, and analyze. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon.

By joining, you’ll be supporting my work and motivating me to publish more content like this.

→ Join the Patreon community here

Navnoor Bawa writes at navnoorbawa.substack.com · YouTube · LinkedIn.

Cover photograph: Marco Assini, CC BY-SA 2.0, via Wikimedia Commons.

SoftBank Is Not One Trade. It Is Five Recurring Structural Edges.

Most financial writing about SoftBank asks the same question: was Masayoshi Son a genius or a reckless gambler? That framing misses the more interesting analysis entirely. For sophisticated hedge funds, SoftBank was never a single binary bet. It was a layered set of structural mispricings — some favoring a long position in the stock itself, some rewarding those who shorted its overvalued portfolio companies, some extracted from the mechanics of its derivatives flow — that repeated with enough regularity to be traded systematically.

The five trades documented here span 2018 to 2024. Some are long SoftBank. Some are short SoftBank’s portfolio companies. One rides the dealer hedging mechanics created by SoftBank’s own internal trading unit. All are supported by primary evidence: earnings call transcripts, SoftBank IR press releases, SEC filings, and contemporaneous reporting. None required privileged access to information Son had not already disclosed publicly.

🎬 Prefer to watch instead of read?

I made a full video breakdown of all five trades — same depth, same primary sources, structured as a research briefing.

→ Watch on YouTube

📊 Want deeper quantitative analysis like this?

This research took significant time in data collection, primary-source verification, and structural analysis. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon. By joining, you will be supporting independent research and motivating more content at this level.

→ Read the full institutional trade note here

Or join the community: The Mathematical Trader Patreon

Follow along on: YouTube — @TheMathematicalTrader | LinkedIn — Navnoor Bawa

Trade 1 — The NAV Discount Long: Elliott Management and Tiger Global

The Setup: A $100+ Billion Gap, Visible to Anyone Who Could Read a Filing

SoftBank Group’s market capitalization has chronically traded below the aggregate value of its listed holdings — a standard conglomerate discount amplified by three structural factors: Masayoshi Son’s unilateral governance style, the group’s leverage, and persistent market skepticism about unverifiable private marks inside the Vision Fund.

By March 23, 2020, SoftBank’s own press release announced a ¥4.5 trillion ($41 billion) emergency monetization program on the same day its shares were trading at a record 73% discount to aggregate net asset value — meaning the market was pricing $1 of SoftBank’s Alibaba, Arm, Sprint, and Japanese telecom assets at 27 cents through the stock. The 7gc.co analysis confirmed the 73% discount, attributing it to “markets mistrust of Masa’s long-term strategy, FMV reporting disparities, and high net debt levels, currently at a 4.5x Net Debt/EBITDA multiple”.

Son himself confirmed the spread on his Q1 FY2021 earnings call (August 2020): “The equity value, well, the ¥24.4 trillion is the current shareholder value. And the SoftBank market cap is ¥13 trillion or so” — a gap of roughly $105 billion, disclosed live, in public, with no delay.

The trade structure was straightforward: buy SFTBY at the discount, apply activist pressure to force buybacks or asset monetization that mechanically compresses the spread, exit once the gap narrows. Every element — the NAV calculation, the gap, the catalyst mechanism — was derived from publicly available filings.

Elliott Management: Running the Same Campaign Twice

2020 campaign: Elliott, a $40 billion hedge fund run by activist investor Paul Singer, built a stake close to $3 billion in SoftBank by February 2020, led by Gordon Singer. Elliott’s public statement was precise: “Elliott’s substantial investment in SoftBank Group reflects its strong conviction that the market significantly undervalues SoftBank’s portfolio of assets.” Its demands: a $10–$20 billion buyback to “help close a yawning gap between the company’s market value and the value of stakes in companies in which it has invested,” plus governance improvements. It engaged privately, stating it was “working constructively on solutions to help SoftBank materially and sustainably reduce its discount to intrinsic value.”

SoftBank shares jumped as much as 8.2% on the day the Bloomberg report broke — alpha from the disclosure itself, before any capital was returned. Son responded within weeks: the ¥4.5 trillion monetization announcement sent the stock up close to 19% in a single session. The Bocconi Students Investment Club documented Elliott’s thesis: the company’s valuation was “circa $150bn short of its true valuation”. Elliott sold almost all its shares by August 2022, having reportedly “lost conviction in Masayoshi Son’s ability to lead a turnaround” — a clean entry-to-exit cycle across 2.5 years.

2024 campaign: Elliott rebuilt a $2 billion+ stake in June 2024 and pushed for a $15 billion buyback, with Reuters confirming Elliott had engaged SoftBank senior management for two to three months before the disclosure. The engagement was led by Nabeel Bhanji — the same partner who led the 2020 campaign. SoftBank shares jumped more than 5% on the disclosure, hitting ¥9,420 — the highest in three years. The logic was structurally identical: NAV gap, undervalued listed assets, pressure for capital return.

Tiger Global’s Earlier Read

Tiger Global’s Chase Coleman disclosed a $1 billion+ stake in July 2018, explicitly telling investors in a client letter the stock was trading at too steep a discount to NAV and failing to reflect Alibaba’s appreciation. SoftBank’s shares rose 5.5% on the day — the same announcement-day mechanism Elliott would use twice in the years following.

The key insight across all three of these positions: this is not a trade against SoftBank. It is a long trade on SoftBank, made possible by Son’s own repeated public acknowledgment that the stock was undervalued. The activists did not discover information Son was hiding. They acted on information Son was broadcasting.

Trade 2 — The Vision Fund LP Structure: Why the Coupon Forced Bad Bets

A Capital Structure That Made Overvaluation Inevitable

This is the least-discussed structural edge and the most mechanically precise. Vision Fund 1 closed with $98.6 billion in total committed capital: SoftBank contributed $28 billion, PIF (Saudi Arabia) $45 billion, Mubadala (Abu Dhabi) $15 billion, and other investors including Apple, Qualcomm, Foxconn, and Sharp contributed approximately $5–8 billion more — approximately $70 billion total from outside LPs.

The structural defect: approximately 40% of each outside LP’s commitment was structured as preferred equity carrying a 7% annual coupon on invested capital, regardless of fund performance or liquidity. The maximum annual coupon obligation when the fund was fully deployed was $2.8 billion per year. Over the fund’s lifetime, the Vision Fund needed to generate more than $11 billion in returns just to cover coupon payments before a single dollar of profit could flow to LP equity holders.

Axios confirmed the capital carousel: of $1.6 billion in coupon payments through mid-2019, only $400 million came from actual portfolio distributions. The rest came from additional capital calls — limited partners were literally paying themselves in a circular cash loop.

The Mechanical Consequence: Deploy Fast, IPO Fast, or Bleed Cash

Wharton asked the central question: could this coupon structure have caused SoftBank to deploy 80% of the fund’s capital in 2.5 years — twice as fast as planned? The 7gc.co analysis was direct: the LP structure “backfired and ultimately made the underlying portfolio riskier by incentivizing GPs to make quicker, riskier investment decisions,” and the Vision Fund had to invest an average of $55 million per day to meet its five-year deployment schedule.

Any fund that modeled this constraint could trace a direct causal chain. The coupon pressure explained: (a) why SoftBank offered inflated valuations — it had to deploy $55M/day to match schedule, making competitive discipline secondary to deal velocity; (b) why IPOs were mandatory rather than optional — they were the only mechanism generating real cash distributions; © why when IPOs failed or underperformed, SoftBank was compelled to sell its most liquid listed assets — Alibaba, T-Mobile, Uber — to plug the gap.

The American Prospect confirmed the logic: “given the fund’s massive debt obligations; its hefty, performance-irrelevant annual payouts to investors; and its need to yield billions in profits steadily, it’s no surprise that it placed huge pressure on these tech investments to bear fruit quickly.” In August 2019, when IPO distributions dried up, the Vision Fund borrowed up to $4 billion against its Uber and Guardant Health shares to return cash to investors — an arrangement the Wall Street Journal called “unusual.” That borrowing was a publicly observable, filing-documented signal that forced selling of listed assets was imminent.

Understanding the LP structure is not simply background — it is the causal root of Trade 3.

Trade 3 — The IPO Short: Reading the Valuation Gap Before the Market Did

Why Vision Fund Portfolio Companies Were Systematically Overpriced at IPO

The coupon-driven deployment pressure from Trade 2 created a predictable output: every late-stage pre-IPO funding round was written at an inflated valuation, both to win the deal under competitive pressure and to generate the paper mark-up that allowed the fund to show interim gains while real distributions were scarce. The 7gc.co analysis documented that WeWork’s “peak fair market value” in SoftBank’s own portfolio marks was $18.8 billion above SoftBank’s invested capital — unrealized gains that were never realized. When these companies hit public markets, investors without a SoftBank relationship repriced them on public GAAP metrics. The gap between private mark and public clearing price was the short.

Uber: SoftBank invested $7.65 billion in early 2018 — $6.6 billion buying secondary shares at $32.87 per share at a $48 billion valuation (down from a prior $70 billion private mark), and $1.05 billion in new shares at $48.77 per share. CNN confirmed SoftBank acquired most of its stake “at a $48 billion valuation — down from the $70 billion it had most recently been valued at on the private market” — a forced secondary that itself signaled the widening gap between VC marks and clearing prices.

In Q1 FY2020 (the quarter ending June 30, 2019 — Uber’s first full quarter as a listed company), SoftBank recorded Vision Fund unrealized losses of approximately $1.84 billion across Uber and other portfolio investments. By September 3, 2019, SoftBank was more than $600 million underwater on its Uber position based on total entry price versus market price alone. In Q2 FY2020 (July–September 2019), Uber’s shares fell 34%. The S-1 unit economics — negative margin on every ride, contested California AB5 reclassification risk, no moat — were public before the IPO. The short thesis required no private information, only a willingness to read the filing.

WeWork: SoftBank’s January 2019 funding round valued WeWork at $47 billion. The S-1 filed in August 2019 disclosed $900 million in net losses on $1.5 billion in revenue in H1 2019, $17.9 billion in long-term lease obligations, and a metric called “community-adjusted EBITDA” that removed the core rental cost entirely. Any short seller had six weeks of S-1 data before the IPO was pulled. The valuation collapsed 83% to the SoftBank rescue price of $7.8 billion, then further to $2.9 billion by March 2020 — a 94% destruction of peak private value in under 14 months. SoftBank’s cumulative losses in WeWork totaled $14.2 billion through September 2023 before WeWork filed for bankruptcy in November 2023.

Son’s own words confirmed the thesis on the May 2020 earnings call: “We made a failure on investing in WeWork and I’ve been admitting that several times. I was foolish. I made a wrong decision.” He also disclosed: “Out of 88 companies, 15 could go bankrupt. That’s my assumption at this moment.” That is a CEO publicly quantifying distress across a $100 billion portfolio, live, with no lag.

The Q3 FY2020 earnings call (February 2020) added further confirmation: WeWork and Uber failures had “caused concern amongst potential investors in Vision Fund 2” — a public signal that future IPO-driven distributions were collapsing, making Alibaba and T-Mobile stake sales the only remaining cash source. Any fund monitoring the coupon coverage ratio now had a CEO-sourced verification that the forced-selling clock was running.

Trade 4 — The Nasdaq Whale Gamma Loop: Profiting From SoftBank’s Own Flow

SoftBank Became the Market

In summer 2020, a distinct and unusual opportunity emerged: SoftBank’s internal trading unit became a large enough options buyer to mechanically lift the underlying equity prices of the stocks it was trading. The trade was not against SoftBank. It was alongside — or more precisely, downstream of — SoftBank’s dealer-hedging mechanics.

SoftBank’s SB Northstar unit — run by former Deutsche Bank trader Akshay Naheta under a three-member investment committee of Masayoshi Son, Naheta, and SoftBank vice-chairman Ron Fisher — spent approximately $4 billion in options premiums on call options tied to roughly $50 billion in notional exposure across Apple, Amazon, Tesla, Facebook, Alphabet, and Microsoft. Son acknowledged the activity on his Q1 FY2021 earnings call (August 2020): “we purchase these issues…in addition to that, in order to minimize the risk, we use derivative transactions as well.”

Northstar’s peak underlying equity holdings included $6.3 billion in Amazon, $2.2 billion in Facebook, $1.8 billion in Zoom, and $1.4 billion in Alphabet.

The Gamma Feedback Mechanism

The mechanical chain runs as follows. When a large buyer purchases call options at scale, dealers who sold the calls must delta-hedge by purchasing the underlying shares — the hedge proportional to each option’s delta. As spot prices rise, delta increases on out-of-the-money calls moving toward at-the-money, requiring dealers to buy more shares to rebalance. More buying lifts prices further, which again increases delta, which forces more buying. The Irish Times described this precisely as “a classic ‘tail wags the dog’ feedback loop.”

The signal was detectable from observable market data. Single-stock call volumes in large-cap tech on short-dated maturities were extraordinary — the Financial Times reported trading volumes in single stocks had surged beyond the average daily volumes of calls on broader stock market indices. One derivatives-focused hedge fund manager told the FT: “These are some of the biggest trades I’ve seen in 20 years of doing this. The flow is huge.” Rising spot prices alongside rising implied volatility — the inverse of the normal relationship — was a mechanical fingerprint of concentrated directional buying. Any fund long the same underlying names during this period extracted yield from SoftBank’s dealer-forced buying.

The Outcome

SB Northstar reported $3.7 billion in losses by November 2020. The strategy’s total loss reached $5.6 billion. Son personally lost $1.3 billion (¥150 billion), which he disclosed directly on a quarterly earnings call. SB Management’s US-listed equity portfolio collapsed from over $17 billion to just over $1 billion within a year. The unit was shut in April 2022. Naheta, who had also executed the Wirecard derivatives bet funded by Mubadala and individual SoftBank executives rather than SoftBank’s own balance sheet, departed the firm.

The trade logic for hedge funds positioned in these names was straightforward: SoftBank was creating a mechanical buyer in dealer desks across Wall Street. Any fund that identified that buyer from options market data could ride the flow rather than stand against it.

Trade 5 — The Alibaba Prepaid Forward Collar: The Dealer-Side Position Nobody Published

A Structure That Was Fully Disclosed and Widely Ignored

From 2016, SoftBank monetized its Alibaba stake not through open-market sales but through a series of variable prepaid forward contracts — fully disclosed in SoftBank’s own press releases and in SEC EDGAR filings, but rarely modeled by market participants at the portfolio level.

The mechanism: a SoftBank subsidiary pledged Alibaba shares to financial institution counterparties, received a cash prepayment of roughly 70–80% of market value at signing, and agreed to deliver a variable number of shares at a future settlement date. The 2016 transaction via West Raptor Holdings embedded collar derivatives — a cap and a floor on the exact number of shares to be delivered at settlement, tied to Alibaba’s final price. In June 2019, West Raptor Holdings delivered 73 million Alibaba ADSs to settle that 2016 contract, having received $5.4 billion at signing.

The April 2020 transaction — via SoftBank subsidiary Skybridge — involved 512.3 million Alibaba shares, settled in tranches between October 2021 and January 2024. The 2022 settlement batch was the largest single event: 242 million ADSs, cutting SoftBank’s Alibaba stake from 23.7% to 14.6% and realizing approximately $34 billion in proceeds.

The Critical Dealer Mechanics

SoftBank’s own August 2022 press release stated explicitly: “Alibaba shares subject to these prepaid forward contracts were hedged in the market at the time of the original monetization transactions by each financial institution counterparty.” The counterparty banks confirmed by contemporaneous reporting were Goldman Sachs, Mizuho, and UBS.

This sentence is the core of the trade logic. From the day each contract was signed — in some cases years before physical settlement — Goldman, Mizuho, and UBS were structurally short Alibaba in the open market as a delta-hedge. Their short position persisted until physical share delivery extinguished it. The settlement schedule was publicly disclosed in SoftBank’s filings, and the settlement dates were known in advance.

For funds reading those filings, the information set was complete: a known counterparty short position in Alibaba, a known settlement schedule, and a known structural overhang — with no private information required. An 86Research analyst confirmed the mechanics after the 2022 settlement: “The positions were already hedged when forward contracts were signed, so there is no more impact on public market” — which is precisely why the overhang was a factor during the contract period, not after.

The CEO Signal Layer: Masayoshi Son’s Earnings Calls as a Trading Calendar

Across all five trades, there is a consistent meta-source of edge that deserves standalone treatment: Masayoshi Son’s public earnings calls. Son is among the most candid CEOs of any large asset holder, and his quarterly presentations generated a stream of actionable signals that required no interpretation — only a willingness to model their cash-flow consequences.

May 2020 — direct portfolio stress admission: “Out of 88 companies, 15 could go bankrupt. That’s my assumption at this moment.” On the same call: “I was foolish. I made a wrong decision,” on WeWork — a CEO publicly quantifying distress across a $100 billion portfolio.

November 2021 — buyback at documented peak discount: Son announced a ¥1 trillion ($9 billion) buyback, simultaneously disclosing the NAV discount had reached 52%. He stated directly: “With a discount this wide, I thought, what would make shareholders happy? A buyback.” Reuters confirmed the stock jumped 10.5% on the following trading day. Any fund monitoring SoftBank’s quarterly LTV and NAV publications — both posted on the SoftBank IR site — could anticipate this announcement category before the press release.

Q2 FY2022 (November 2021) — pre-emptive China write-down signal: Son described the environment as “in the middle of a blizzard” as Chinese portfolio NAV declined — preceding significant further write-downs in subsequent quarters.

March 2020 — “defensive mode” as forced-selling pre-announcement: Son confirmed on the earnings call that “we need to be defensive and protect from any attack,” then announced the ¥4.5 trillion monetization. The stock rose 19% that day.

Beyond the calls: Fortune’s May 2024 reporting revealed SoftBank had assembled an internal equity capital markets team drawn from Goldman Sachs specifically to manage Vision Fund stake exits through block trades, timing them to minimize market disruption — with those block trades visible in EDGAR 13F filings before final settlement. Since end-2021, the Vision Fund’s US-listed portfolio shrank by approximately $29 billion through Coupang, DoorDash, and Grab stake sales — each block trade visible in regulatory filings before settlement.

The Unified Framework: Five Structural Edges, Five Different Mechanisms

The five trades documented here are not random alpha. They form a coherent system, each arising from a different layer of SoftBank’s architecture.

What links all five is a single underlying condition: SoftBank’s disclosures were exceptional in their completeness, and Son’s behavior was consistent in its predictability. The NAV gap was disclosed quarterly. The LP coupon terms were in fund documents. The IPO S-1s were public. The options flow was legible from market data. The forward contract settlement schedules were in press releases.

The alpha did not require privileged access. It required the discipline to read what Son had already published — and the rigor to model the mechanical consequences before the price moved.

📊 Want the Institutional-Grade Trade Note?

This article is the public version. The full trade note — published exclusively for paid subscribers on The Mathematical Trader Patreon — goes further:

• Trade structure with explicit entry thesis, exit signal, and risk management parameters

• Five falsifiable risks to the thesis, each written as a specific, testable claim

• Catalyst calendar — five events to monitor with precise instructions on what each means for the position

• 10-row verification table mapping every number and quote to its named primary source

• Format: institutional. Bottom line first. Written for portfolio managers and quant researchers.

If you are serious about hedge fund strategy at this depth, this is where the work lives.

→ Read the full trade note on Patreon

Join The Mathematical Trader Patreon

Follow along on: YouTube — @TheMathematicalTrader | LinkedIn — Navnoor Bawa

Primary sources: Bloomberg — Elliott $3B stake Feb 2020 | SoftBank IR — March 2020 asset-sale announcement | CNBC — 73% discount, $41B buyback | CNBC — Elliott Feb 2020 statement | Fortune — Elliott $10–20B buyback demand | CNBC — Elliott 2024 stake rebuild | Reuters — Elliott $15B buyback 2024 | Yahoo Finance — Elliott 2024 detail | Elliott Wikipedia | Governance Intelligence — Elliott private engagement | Bloomberg — Tiger Global $1B stake | Bocconi BSIC — Elliott Japan analysis | Wharton — Vision Fund LP structure | 7gc.co — Vision Fund deep dive | Axios — Vision Fund coupon | American Prospect — forced IPO pressure | Pitchbook — Vision Fund LP breakdown | Wikipedia — Vision Fund structure | eMorningCoffee — Uber entry price analysis | CNN — SoftBank Uber IPO | CNBC — $1.84B Q1 FY2020 loss, $600M underwater | CNN — Uber –34% Q2 FY2020 | CNBC — Son “foolish,” WeWork $2.9B | Seeking Alpha — Son Q4 FY2020 call | Business Insider India — Son quotes May 2020 | Yahoo Finance — WeWork $14.2B cumulative loss | Seeking Alpha — Q3 FY2020 earnings call | NZ Herald — SB Northstar losses and committee | Fortune — Nasdaq whale unmasked | Irish Times — gamma loop | CNBC — SoftBank options buying | Grokipedia — Naheta total losses | Yahoo Finance — Son personal loss | Nation and State — SB Northstar shutdown | InvestorsNewsBlog — Naheta Wirecard | SoftBank IR — August 2022 Alibaba settlement | SoftBank IR — 2016 collar, June 2019 settlement | SCMP — Alibaba final settlement | Asia Financial — $34B gain | Yahoo Finance — Goldman Sachs, Mizuho, UBS counterparties | US News — 86Research dealer mechanic confirmation | Time — $9B buyback, 52% discount | Reuters — 10.5% jump Nov 2021 buyback | Seeking Alpha — Son Q2 FY2022 “blizzard” | Seeking Alpha — Son Q1 FY2021 call | Fortune Asia — Goldman ECM team, block trades

Cover photograph: Wikiuser0805, CC BY 4.0, via Wikimedia Commons.

An industry that obsesses over single basis points is ignoring a recovery pool exceeding $15 billion annually that sits untouched, year after year, inside its own trading history. According to Hedgeweek research surveying more than 100 hedge fund managers, just 7% of hedge funds systematically participate in securities class action settlement recoveries. Another 14% participate case-by-case. The remaining four out of five funds leave their entitlement on the table entirely.

The structural consequence is not neutral. Settlement funds are distributed on a pro-rata basis among eligible investors who actually file. When you don’t file, your share goes directly to your competitors who did. The non-filer is not merely forgoing income. They are subsidizing everyone else.

This article covers the full mechanics of that transfer — the zero-sum pro-rata structure that turns non-filing into competitor income, the recognized loss calculation that determines your exact payout, the Lead Plaintiff lever that enlarges settlements, the opt-out strategy with documented recovery multiples of 10–90x the class rate, the parallel $8 billion antitrust pool, and the international jurisdictions offering recovery rates two to four times the U.S. average. Who captures it, how they do it, and exactly how much is being left behind.

🎥 Prefer to watch instead of read?

I’ve created a full video breakdown of this research. Same analysis, same data — for those who’d rather listen than read.

→ Watch the full breakdown on YouTube

📊 Want Deeper Quantitative Analysis?

This research took extensive time in data collection, verification, and analysis. If you found value in this deep-dive, I’ve already published the exclusive companion piece for Patreon subscribers: “Settlement Recovery: The Five Systematic Trades” — every recovery lever in this article broken down as a structured trade log with entry triggers, execution mechanics, payoff ranges, and documented failure modes.

→ Read the companion trade breakdown on Patreon · → Join the community

The Annual Pool: What Is Actually Available

The accessible recovery pool is substantially larger than the U.S. securities class action settlement figure alone.

In 2024, U.S. securities class action settlements totaled $3.7 billion across 88 settled cases, with a median settlement of $14 million, according to Cornerstone Research. Per Hedgeweek and SS&C Battea’s own reporting, investors recouped $5.2 billion in U.S. settlements in 2024, a figure that includes SEC Fair Fund distributions — regulatory disgorgement pools that follow the same pro-rata claims process. International recoveries reached $483 million in 2024 — part of a multi-year surge that has grown more than four times from 2022 levels.

The full accessible pool is broader still. SS&C Battea’s platform currently confirms investor eligibility against a potential annual pool of $15 billion, spanning U.S. securities settlements, antitrust cases, and international group actions — sourced from research across nearly 8,000 global cases in their database. SimCorp, a Battea integration partner, has separately confirmed that more than $15.7 billion in settlement funds are available to eligible institutional investors when you include ongoing U.S. securities, international collective actions, antitrust, and LIBOR-linked litigations.

Most of this goes unclaimed. Financial Recovery Technologies (FRT) reports that 65% of available settlement funds — totaling billions of dollars — go unclaimed every year due to missed opportunities. At the 2024 U.S.-only settlement figure of $5.2 billion, that implies roughly $3.4 billion flowing annually to a minority of eligible investors who chose to file.

Why the Money Exists: The Fraud-to-Fund Mechanism

When a public company makes materially false statements that cause its stock to trade at an artificially inflated price, and then the fraud is exposed, investors who bought during the “class period” — the window when inflation existed — suffer real losses when the price corrects. Federal securities law under Rule 10b-5 of the Securities Exchange Act of 1934 provides those investors with the right to sue collectively.

Almost all cases settle rather than go to trial. The defendant pays a lump sum into a court-supervised common fund. A Plan of Allocation — approved by the court — specifies the formula for calculating each eligible investor’s “recognized loss.” After legal fees are deducted (typically 22–28% of gross settlement), the net fund is distributed to those who submitted valid claims, pro-rata by recognized loss.

In 2024, the largest settlements included Apple at $490 million, Alibaba at $433 million, and Alphabet at $350 million. Each created a fund. Each fund had eligible institutional claimants. The majority did not file.

The claims process requires no courtroom testimony, no legal exposure, and no ongoing litigation involvement. As McCreesh explained in a Convergence podcast in October 2024, Battea covered case studies of alpha generated for clients specifically from this process — none of it involved directional risk.

Recognized Loss: The Calculation That Determines Your Payout

“Recognized loss” is not your accounting loss. It is a court-constructed formula applied specifically to each case. Getting it wrong means receiving a fraction of your entitlement — or having your claim dismissed entirely.

FRT documents that one-third of claims manually filed by institutional investors are dismissed before settlement due to errors and omissions. The most common failure modes:

Inflation tables by date. Each Plan of Allocation specifies the alleged per-share inflation embedded in the stock price on each trading day of the class period. Purchases at higher inflation dates carry greater recognized loss; purchases at lower inflation dates carry less. These tables are case-specific and require matching against the fund’s exact transaction records — not quarterly positions, but individual trade-level data.

The PSLRA 90-day lookback cap. Under the Private Securities Litigation Reform Act of 1995, recoverable losses are capped by the mean trading price of the security during the 90 days following the corrective disclosure. If a stock corrects sharply on disclosure day but then partially recovers over the following quarter, the lookback mean reduces your recognized loss — sometimes to zero for positions sold early in the recovery period.

FIFO vs. LIFO trade matching. Whether purchases are matched against sales using first-in/first-out or last-in/first-out methodology can flip a substantial recognized loss into zero. Cornerstone Research has documented that FIFO vs. LIFO elections are specified case-by-case in each Plan of Allocation, and choosing the wrong method results in claim rejection.

Account-level aggregation decisions. For multi-fund or multi-account managers, how transactions are organized across sub-accounts affects whether recognized losses are aggregated (potentially netting gains and losses) or calculated separately per entity. The structurally optimal approach depends on the specific case, and the difference is not trivial.

FRT has documented cases where hedge fund clients who had been filing claims independently were missing recognition of entire eligibility windows because their prior provider was collecting quarterly position data rather than case-specific transaction records. The audit revealed missed recoveries and incorrectly filed claims worth millions of dollars.

The Pro-Rata Mechanism: Your Inaction Is Your Competitor’s Income

The most important structural fact about the settlement recovery opportunity is that it is not a fixed entitlement. It is a share of a common pool distributed only among those who file.

If the Apple $490 million settlement produces $370 million after fees, and eligible investors representing 35% of aggregate recognized loss do not file, the $370 million is distributed among the 65% of recognized loss that did file. The payout rate per dollar of recognized loss increases by roughly 54% above the theoretical ratable share — paid permanently, without recourse, to every competitor who acted.

FRT’s platform documentation confirms this explicitly: the 65% of funds that go unclaimed annually are not pooled into escrow or returned to defendants. They flow to filers. The pro-rata model transforms non-filing from a passive choice into an active wealth transfer.

When Hedgeweek researchers disclosed this mechanism to survey respondents, only 7% said they would immediately assess their unclaimed amounts. Nearly one in three cited “other priorities regardless of potential amounts.”

McCreesh put it directly in the Hedgeweek interview: “Hedge funds must realise that should they not file, the money owed to them will just go to others. If you are not filing, then your competitor is likely receiving your share.”

The Lead Plaintiff Lever: From Passive Claimant to Active Principal

Beyond passive claim filing, the PSLRA creates a higher-value strategic role: Lead Plaintiff.

Under the PSLRA, after a securities class action is filed, any potential class member has exactly 60 days to apply for Lead Plaintiff appointment. The court appoints the investor with the largest claimed financial interest. The 60-day deadline is strictly enforced — missing it permanently forecloses Lead Plaintiff status for that case, though passive class membership and claim filing rights remain.

The Lead Plaintiff role is not ceremonial. The Lead Plaintiff selects the law firm, shapes litigation strategy, decides when and at what amount to settle, and exercises active oversight over the case. Cornerstone Research’s multi-decade data shows that institutional investors serving as lead or co-lead plaintiff are consistently associated with larger settlements: in 2022, for cases involving an institutional investor as lead plaintiff, median simplified tiered damages and median total assets were five times and eight times higher respectively than for cases without an institutional lead.

Despite this, in 2024, institutional investors served as lead plaintiff in only 39% of settled cases — the lowest rate in the past two decades.

The lead plaintiff decision is a free option. Monitoring new class action filings is handled automatically by every major recovery provider. The only required decision is whether the fund’s loss in a specific case clears the threshold where Lead Plaintiff involvement is economically justified.

The Opt-Out Strategy: Non-Linear Upside for Large Positions

For funds with large positions in a fraudulent security, the class action settlement is a floor, not a ceiling.

The structural reason: class settlements are constrained by aggregate defendant liability. A defendant facing a $10 billion class faces insolvency risk at settlement amounts well below that ceiling, which depresses the per-investor recovery rate. Cornerstone Research documented that the overall median settlement in 2024 was just 7.3% of plaintiff-style damages — that is, the typical investor recovers roughly 7 cents per dollar of their estimated losses via the class mechanism. In large-damage cases, that rate is even lower.

Opt-out litigation bypasses the constraint. An opt-out plaintiff files a separate direct action against the defendant, unbound by the class settlement ceiling. According to the Cornerstone Research and Latham & Watkins study of opt-out cases from 1996–2011, the documented cases of outsized recovery are striking:

AOL Time Warner ($2.4 billion class settlement, 2006): Over 100 plaintiffs pursued roughly 40 opt-out cases. Total opt-out settlements: $764 million — with recoveries reaching up to 90 cents per dollar of actual investor losses, compared to a fraction of that in the class. The state of Alaska filed under Alaska state law and reportedly recovered 50 times what it would have received remaining in the class. CalPERS received $117.7 million by opting out.

Qwest Communications ($445 million class settlement, 2006): Total opt-out settlements of $411 million — equal to 92.4% of the final class settlement amount, paid to a small group of investors who chose not to stay in the class. Colorado PERA’s opt-out settlement was reportedly 38 times what it would have received within the class, and its attorney’s fees were 5% of the recovery versus 15% for class members.

WorldCom ($6.2 billion class settlement, 2005): One law firm represented 65 opt-out investors with documented settlements totaling $336 million — on top of, not instead of, the class recovery received by remaining class members.

The prevalence of opt-out cases scales with case size. The same Cornerstone study found that 53% of class actions with settlements above $500 million had at least one opt-out case, compared to just 3% of all cases. The pattern is not coincidental: the larger the case, the greater the gap between the constrained class recovery rate and the unconstrained opt-out recovery rate.

The opt-out option requires retaining independent securities litigation counsel — invariably on contingency — and producing transaction and decision documentation. Most cases settle without trial. Legal fees for opt-out plaintiffs can run lower than the 22–25% class attorney fee rate, as the Colorado PERA example demonstrates.

The International Expansion: Higher Rates, Lower Competition

While U.S. recovery rates typically fall in the 2–15 cents-on-the-dollar range, McCreesh has stated that international jurisdictions — particularly the Netherlands — offer recovery rates of 30–40 cents on the dollar. Yet one in three surveyed funds invest the majority of assets outside the U.S. and show no higher participation rate in international recovery programs.

International recovery requires jurisdiction-specific opt-in by deadline, organized through a legal vehicle specific to each country. The Volkswagen emissions litigation illustrates the execution risk precisely: VW ADR holders had automatic access to the U.S. class action. Investors who held VW ordinary shares on Germany’s Xetra exchange needed to separately and proactively opt in to German or Dutch group actions before case-specific deadlines. At least seven direct-action efforts were organized for VW investors in Germany. Funds that missed the opt-in windows forfeited recovery rights entirely.

Battea monitors hundreds of international investigations across Australia, Europe, and Canada, including Danske Bank in Denmark, Mexican Government Bonds, and ongoing European benchmark manipulation cases. International recoveries have grown from negligible to over $480 million annually in 2024, and the trajectory is accelerating as the EU Representative Actions Directive brings new jurisdictions online.

McCreesh acknowledged in the Hedgeweek interview that early European litigation created warranted skepticism — “novel laws before anyone really knew what they were doing” — but described the current state as “a night and day difference for the better in some jurisdictions now.”

The Antitrust Pool: The Parallel $8 Billion

U.S. securities settlements are one stream. The antitrust stream is a separate, parallel opportunity using the same infrastructure and the same claims mechanics.

FRT tracked nearly $8 billion in U.S. antitrust settlement funds awaiting distribution as of mid-2024, including EURIBOR, LIBOR Bondholders, Mexican Government Bonds, and SIBOR cases — all related to financial benchmark manipulation that directly affects funds with fixed income, interest rate derivatives, and FX exposure.

Battea separately documented the $580 million Stock Loan Antitrust Settlement as a 2024 recovery opportunity available to funds that traded in the stock lending market. These cases follow the same claims submission process as securities class actions, are monitored by the same service providers, and have the same pro-rata structure that rewards filers at the expense of non-filers.

A systematic recovery program that covers only equity securities class actions is leaving approximately half the recoverable pool unaddressed.

The Infrastructure Reality: One Decision, Zero Ongoing Cost

The practical execution of a systematic recovery program requires exactly one internal decision: engage a provider. The providers operate on pure contingency — no recovery, no fee.

The three dominant platforms:

SS&C Battea — Acquired by SS&C Technologies for $670 million in September 2024, at a reported EBITDA margin of 45% and approximately $95 million in annual revenue at the time of acquisition. The acquisition price implies a market validation of the settlement recovery opportunity that no internal cost-benefit analysis should ignore. Serves 900+ institutional clients; SS&C’s full network reaches 22,000. Research library covers nearly 8,000 global cases.

Financial Recovery Technologies (FRT) — 2,500+ institutional clients globally, including five of the ten largest U.S. hedge funds. In Q1 2024 alone, FRT filed over 107,000 claims and tracked nearly $675 million in new settlements. FRT also offers to purchase the claim rights of liquidating funds — converting future recovery into immediate liquidity at close.

ISS Securities Class Action Services (ISS SCAS) — An ISS STOXX brand with 35+ years of operations, proprietary database of 14,000+ cases, and full coverage of domestic U.S., antitrust, and international group action filings.

All three operate on contingency. All three require trade-level transaction data, not quarterly positions. All three cover the full lifecycle from case monitoring through distribution verification.

The Hedge Fund Journal documented that the average securities class action takes approximately 4.5 years from initial complaint filing to claims administrator payout — meaning a fund onboarding today can begin recovering on its existing backlog across a multi-year window of historical transactions, many of which remain within the eligibility window.

Among systematic participants, Hedgeweek found that 27% use third-party providers exclusively, 36% use hybrid models, and 9% handle everything internally. The diversity confirms there is no single mandated approach — but all paths require deliberate engagement with the process.

What Triggers Adoption: The Uncomfortable Pattern

McCreesh has described the two triggers he observes most frequently: an outsized loss on a large position that makes the recovery opportunity too material to ignore, and a new hire who ran a recovery program at a prior employer and brought the practice with them. Neither trigger is strategic. Both are accidents.

The organizational pathology is structural. Securities class action recovery sits in a grey zone: not clearly the responsibility of the investment team (they’ve already closed the position), not clearly legal’s problem (it requires no litigation), and not clearly operations’ mandate (it’s not post-trade settlement). Without explicit ownership, it defaults to no one.

FRT’s survey data confirms that one-third of claims filed independently are dismissed before distribution — a failure rate that suggests the grey-zone ownership problem also produces execution errors when firms do attempt to participate without specialized support.

The Competitive Arithmetic at Scale

The systematic participant in securities class action recovery receives:

1. Their pro-rata share of a common fund as if 100% of eligible investors filed — amplified by the ~65% who didn’t.

2. Potentially a Lead Plaintiff premium, in cases where their loss qualifies them for appointment and active oversight.

3. In large positions, the option value of pursuing direct opt-out litigation with documented recovery multiples of 10–90x the class rate.

4. Coverage across antitrust and international pools using the same data infrastructure.

5. All of the above with zero capital deployed, zero directional market exposure, and fees contingent on outcome.

The Hedge Fund Journal noted that approximately 1 in 18 U.S.-listed companies was the subject of a securities class action in 2019, and that S&P 500 companies faced class action exposure at a rate of 7.2%. A fund holding 50–80 positions has probabilistic exposure to multiple class action events annually, with recoveries accruing over a 3–5 year lag from the class period to distribution.

As Cornerstone Research has established, median settlement duration from filing to hearing is 3.2 years — meaning recoveries from today’s fraud events will flow to whoever is filing claims 3+ years from now. The funds building that infrastructure today are building a persistent revenue stream from positions they have already exited.

The question the 79% need to answer is not whether this alpha is material. McCreesh’s explicit confirmation that there is no minimum AUM threshold settles that: losses and recoveries are relative, and every fund with a trading history has eligible entitlements. The question is whether the organizational inertia of not filing is a policy worth paying for, every single year, in real dollars transferred directly to the competitors who did.

📊 Want the full trade-by-trade execution breakdown?

I’ve published the complete companion piece exclusively for Patreon subscribers — “Settlement Recovery: The Five Systematic Trades” — covering every recovery lever in this article structured as a trade log: entry trigger, exact execution mechanics, documented payoff ranges, and the specific failure modes that cause institutional claims to be dismissed. Every number sourced to primary documents.

→ Read the full trade breakdown on Patreon

Sources

• Hedgeweek, February 2026 — Primary survey data, McCreesh quotes: https://www.hedgeweek.com/hedge-funds-leave-billions-in-settlements-unclaimed-new-data-shows/

• FRT — 65% unclaimed stat, 1/3 manual claims dismissed: https://frtservices.com/solutions/securitiesclassaction/

• FRT — Hedge fund case study, quarterly vs. transaction data: https://frtservices.com/case-study-hedge-fund-benefits-from-frts-3rd-party-partner-to-quickly-onboard-their-data/

• FRT — Q1 2024: 107,000+ claims filed, $675M new settlements tracked: https://frtservices.com/insights/securities-fraud-class-action-settlements-q1-2024/

• FRT — Mid-year 2024: $8B antitrust settlement funds awaiting distribution: https://frtservices.com/insights/on-demand-frt-market-insider-mid-year-shareholder-litigation-outlook/

• FRT — Volkswagen case study: Xetra opt-in, deadline forfeiture: https://frtservices.com/insights/case-spotlight-volkswagen-shareholder-class-action/

• SS&C Battea — $15B annual pool, 8,000 case database: https://www.ssctech.com/products/battea

• SS&C Battea — McCreesh profile: https://www.battea.com/battea-class-action-services/mike-mccreesh/

• SS&C Battea — $580M Stock Loan Antitrust, Alphabet $350M, Under Armour $434M: https://www.battea.com/battea-hires-michael-mccreesh/

• SS&C / PRNewswire — $670M acquisition announcement, September 2024: https://www.prnewswire.com/news-releases/ssc-technologies-to-acquire-battea-class-action-services-expanding-securities-class-action-claims-management-offerings-302246561.html

• Middle Market Growth — McCreesh interview on SS&C acquisition; $95M revenue, 45% EBITDA, 900 clients: https://middlemarketgrowth.org/deal-deep-dive-ss-c-battea/

• SimCorp/Battea — $15.7B pool, full security type coverage, international list: https://www.simcorp.com/resources/insights/industry-articles/2023/battea-class-action-services-partnership

• AlphaMaven/Battea — Lookback analysis, $15.7B figure, global litigation monitoring: https://alpha-maven.com/posts/private-investments/battea-class-action-services-securities-class-action-industry-lookback-and-observations

• ISS Securities Class Action Services — 35+ years, 14,000+ case database: https://www.issgovernance.com/securities-class-action-services/

• Convergence Podcast — McCreesh interview, case studies on alpha generated, October 2024: https://www.buzzsprout.com/2362345/episodes/15882672-battea-s-class-action-services-ft-michael-mccreesh-bob-donahoe

• Cornerstone Research — 2024 settlements: 88 cases, $3.7B, median $14M, 39% institutional lead: https://www.cornerstone.com/insights/press-releases/securities-class-action-settlements-number-rises-median-settlement-declines-from-13-year-high/

• Cornerstone/Cooley — 7.3% median settlement as % of damages: https://sle.cooley.com/2025/05/20/securities-class-action-settlement-trends-smaller-sizes-and-smaller-players-according-to-cornerstone-research/

• Cornerstone/NLR — 2022: institutional lead cases had 5x damages, 8x assets vs. non-institutional: https://natlawreview.com/article/securities-class-action-settlements-2022-review-and-analysis

• Cornerstone Research 2025 — Median settlement at 30-year high: https://www.cornerstone.com/insights/press-releases/median-securities-settlement-amount-record-high/

• Cornerstone Research + Latham & Watkins / Duke Law PDF — Opt-out study: https://judicialstudies.duke.edu/sites/default/files/centers/judicialstudies/panel-5_opt-out_cases_in_securities_class_action_settlements.pdf

• Berger Montague — 60-day lead plaintiff deadline, strictly enforced: https://bergermontague.com/practice-areas/securities-investor-protection/securities-class-action-faqs/

• The Hedge Fund Journal — 4.5 year average complaint-to-payout; 1-in-18 companies face class action: https://thehedgefundjournal.com/selling-securities-class-action-claims-to-realize-value/

• Wikipedia — Securities Class Action mechanics and PSLRA: https://en.wikipedia.org/wiki/Securities_Class_Action

• Wikipedia — PSLRA 1995: lead plaintiff process, 90-day lookback cap: https://en.wikipedia.org/wiki/Private_Securities_Litigation_Reform_Act

• RGRD Law — Apple $490M settlement: https://www.rgrdlaw.com/cases-in-re-apple-inc-securities-litig.html

About the Author

Navnoor Bawa is a quantitative researcher and institutional finance analyst covering securities litigation economics, hedge fund operations, and systematic trading strategies.

• 🎥 YouTube — Quantitative analysis, trading strategies, and institutional deep-dives: The Mathematical Trader · Video breakdown of this article

• 💼 LinkedIn — Research, commentary, and professional updates: linkedin.com/in/navnoorbawa

• 📊 Patreon — Exclusive quantitative research, trading strategies, and institutional-grade analysis: Join the community · Latest piece: The Five Systematic Trades

📊 If this analysis was useful to you — the best way to support more research like this is to join on Patreon.

Each piece takes considerable time in data collection, cross-verification against primary sources, and structural analysis. The companion piece to this article — “Settlement Recovery: The Five Systematic Trades” — is already live for subscribers.

→ Read the companion piece · → Join the Patreon community

Cover photograph: Photograph by Mike Peel (www.mikepeel.net)., CC BY-SA 4.0, via Wikimedia Commons.

February 21, 2026 · Credit Markets · Fixed Income · Institutional / Hedge Fund

Tags: investment-grade credit, AI bond issuance, credit spreads 2026, Vanguard credit outlook, Oracle bond deal, Alphabet bond deal, CDX payer swaptions, CDS, hyperscaler debt, spread widening, corporate bond market

By Navnoor Bawa · LinkedIn · YouTube: The Mathematical Trader

I. The Signal: What Vanguard Actually Said, and What It Means for Market Structure

On February 20, 2026, Bloomberg published a direct interview with Arvind Narayanan, Vanguard’s co-head of investment-grade credit and senior portfolio manager. His firm’s approximately $11.6 trillion in global AUM as of September 2025 makes it the largest or second-largest buyer in the US investment-grade primary market on any given week. Three statements carried operational weight beyond their surface reading.

“If there is broader macro weakness, broader hiccups in the market, then US IG could underperform because investors are full.”

— Arvind Narayanan, Co-Head of Investment-Grade Credit, Vanguard · Bloomberg, Feb 20, 2026

The second: “Hiding up in quality in times of uncertainty may not necessarily play out well this go-around.” The third: Vanguard is “looking really at global markets” to diversify away from US investment-grade.

Read for market-structure implications rather than portfolio guidance, these three statements mean one thing: the largest passive backstop in the primary market is reducing its absorption capacity — and saying why publicly. When the backstop bid withdraws, new-issue concessions widen. When concessions widen, secondary spreads follow. The trades that profit from this sequence were already live before Narayanan spoke. His interview was not the catalyst. It was the confirmation.

Apollo’s Torsten Slok had already documented the divergence signal on January 21 — a full 30 days earlier. Oracle’s CDS had already moved from 36 basis points to 139 basis points. The concession mechanism had already printed live in Oracle’s deal on February 2. By the time Vanguard confirmed the thesis publicly, the entry had been open for a month.

II. The Setup: Historically Extreme Valuations Meet a Record Supply Wave

Every trade in this piece rests on a verifiable, data-anchored market structure. Two variables define it: where spreads are, and what supply is coming.

Spread Valuations: The 2nd Percentile of a 20-Year Lookback

The Bloomberg US Investment-Grade Corporate Index option-adjusted spread (OAS) ended 2025 at 78 basis points — sitting in the 2nd percentile of a 20-year lookback, meaning spreads have been tighter on only 2% of all trading days over two decades. (Breckinridge Capital Advisors, Q1 2026 Corporate Bond Market Outlook)

By late January 2026, US investment-grade spreads compressed further to 71 basis points — the lowest reading since 1998, per Bloomberg index data. Simultaneously, yield premiums on global corporate debt across currencies and ratings fell below one percentage point for the first time since 2007, according to a Bloomberg gauge, while spreads on Asian investment-grade dollar notes touched a record low in the same week. (Bloomberg via Yahoo Finance, Jan 23, 2026)

Two independent Street-level forecasts anchor the widening thesis quantitatively. J.P. Morgan Global Research targets 110 basis points for US high-grade spreads by year-end 2026 — a 55% move from January 2026 levels. (J.P. Morgan 2026 Market Outlook) TD Securities’ Hans Mikkelsen targets 95 basis points, implying a 34% move from those same January levels. (Bloomberg, Jan 23, 2026) These are separate estimates from separate firms. The gap between them — 95 versus 110 basis points — is itself a calibrated measure of uncertainty in the widening call. Both are directionally identical.

The AI Bond Supply Wave: $400 Billion From Hyperscalers Alone

Morgan Stanley estimates hyperscalers will borrow $400 billion in US bonds in 2026, up from $165 billion in 2025 — a 142% sector-level increase in a single year. Morgan Stanley projects total US investment-grade gross issuance reaching a record $2.25 trillion for the full year. (Euronews, Feb 10, 2026; Breckinridge, citing Morgan Stanley Nov 2025 research)

Separately, TD Securities’ Mikkelsen forecasts up to $500 billion of AI-related issuance this year alone and projects that if realised, total US investment-grade offerings could reach $2.1 trillion or higher — TD’s own estimate, independent of and lower than Morgan Stanley’s. (Bloomberg, Jan 23, 2026) In Mikkelsen’s own words: tech companies “could issue more bonds for AI spending than the market can absorb at these tight spread levels.”

Demand is deep but finite. $490 billion flowed into taxable bond funds in 2025; foreign investors net-purchased $304 billion in US corporate bonds in the 12 months through October 2025. (Breckinridge, citing ICI and US Treasury International Capital data) The absorption pool is large. The incoming supply is larger.

The Concession Mechanism: Already Visible in Oracle and Alphabet Deal Data

Oracle’s $25 billion eight-part deal on February 2 set a record: Bloomberg confirmed it attracted more than $129 billion in orders — the most ever for such an offering. IFR, citing one fixed-income investor, reported bids reaching as high as $155 billion at the intraday peak before books closed. Despite that record demand, the deal still priced 40–58 basis points wider than Oracle’s September 2025 deal across equivalent tenors. Record demand coexisted with a large concession requirement. That is the new-issue concession dynamic in operation: when buyers are saturated with a credit, they require a spread premium to absorb even a record-setting book.

Alphabet’s multi-currency raise, executed February 9–10, 2026, raised approximately $32 billion in less than 24 hours across USD, sterling, and Swiss franc tranches. (Bloomberg via swissinfo.ch, Feb 10, 2026) The USD tranche was $20 billion, upsized from $15 billion, with over $100 billion in orders. The sterling tranche — which included a 100-year century bond, the first issued by a technology company since Motorola in 1997 — raised £5.5 billion ($7.5 billion), the largest corporate bond sale in the history of the sterling market, surpassing the previous record of £3 billion set by National Grid in 2016. (Bloomberg via swissinfo.ch, Feb 10, 2026; GlobalCapital, Feb 10, 2026)

“I think the fact that a 100-year bond comes out, you can’t get much more frothy than that.”

— Bill Blain, Windshift Capital · CNBC, February 12, 2026

Oracle and Alphabet together raised $57 billion in new investment-grade paper in three weeks. Both deals required concessions despite record oversubscription. The market was telling you in early February what Vanguard confirmed on February 20.

III. Five Executable Trades — All Live Before Vanguard Spoke

Trade 1 — Oracle 5-Year CDS: The AI Capex Bubble Hedge

Oracle’s 5-year credit default swap spread rose from approximately 36 basis points in June 2025 to 128 basis points by December 3 — the highest level since March 2009, per ICE Data Services prices cited by Bloomberg. That December 3 reading was the closing level after some compression from an earlier intraday peak: Bondblox confirmed the CDS had hit its highest level since 2009, with the peak print reaching approximately 139 basis points at its widest. The arithmetic across sources reconciles cleanly: Voya Investment Management, which publicly named Oracle the preferred AI capex cycle hedge in its December 2025 research note, stated the CDS had risen “roughly 310% since end of June, pushing perceived credit risk to a 16-year high.” A 310% move from 36 basis points implies a peak of approximately 148 basis points — directionally consistent with Bondblox’s ~139 basis point figure, given that these reflect different intraday and closing timestamps across the same volatile week, not a contradiction.

Trading volume in Oracle’s CDS reached an estimated $5 billion in seven weeks through November 2025, against near-zero activity in the prior period. Morgan Stanley warned Oracle’s CDS could approach 200 basis points — near the 2008 all-time high.

After Oracle priced its February $25 billion deal and confirmed no additional 2026 issuance, CDS spreads compressed sharply and Barclays upgraded Oracle’s debt to overweight. Traders who bought protection in the 36–50 basis point range in mid-2025 and closed in the 128–139 basis point range realised substantial gross P&L — the precise size depending on entry timing. Oracle carries over $100 billion in total debt (rated Baa2/BBB/BBB), making it the largest non-bank issuer in the Bloomberg Corporate Index. That is why its CDS functioned as a sector barometer for the entire AI capex cycle, not merely a single-name hedge.

Trade 2 — CDX.NA.IG Payer Swaptions: Asymmetric Index Protection Against Spread Widening

The index-level expression of the spread-widening thesis is buying protection on the CDX.NA.IG 5-Year Index (125 North American investment-grade reference names) via payer swaptions — options to enter a protection-paying position at a fixed strike.

At 2nd percentile valuations, the carry cost of outright CDX protection is punishing: you pay the running spread daily while waiting for widening. A 3–6 month payer swaption struck 10–15% out of the money costs a fraction of the carry drag while the payout on a spread-gap event is substantially asymmetric. TD’s Mikkelsen’s 95 basis point target implies a 34% spread widening from January 2026 levels; J.P. Morgan’s 110 basis point target implies 55%. Either scenario generates multi-hundred basis points of P&L on a well-structured payer swaption.

The trigger mechanism Narayanan identified is concrete: $400 billion of hyperscaler paper hitting a market where the largest passive buyer is openly reducing absorption capacity forces concession widening, which transmits from primary to secondary within hours, repricing CDX IG. Oracle’s February deal — priced 40–58 basis points wider than its September precedent despite a record order book — demonstrated this transmission mechanism empirically before the Vanguard interview was published.

Trade 3 — Long iTraxx Europe / Short CDX.NA.IG: The AI Supply Asymmetry Basis Trade

Vanguard’s explicit shift toward European and Canadian credit is the consensus institutional response to the US supply wall. Hedge funds express the same logic synthetically: sell protection on iTraxx Europe Main 5-Year (long European investment-grade) while buying protection on CDX.NA.IG 5-Year (short US investment-grade), sized in equal DV01. The trade profits as US spreads widen relative to European spreads.

The supply asymmetry is structural and documented. Morgan Stanley projects $400 billion of hyperscaler paper in US dollar markets in 2026; European investment-grade faces no equivalent supply wall. Janus Henderson’s December 2025 Fixed Income Outlook explicitly confirms AI debt supply is “skewed more to the US.”

The monetary policy divergence reinforces the basis simultaneously from two directions: the ECB cutting more aggressively suppresses European spreads, while the Fed on pause keeps US debt-service pressure elevated on highly levered hyperscalers. Both vectors move the CDX/iTraxx basis in the same direction.

Trade 4 — Receiver Swaps Paired With Long CDX Protection: The Macro Paired Hedge

Narayanan’s third stated strategy — increasing interest rate duration in anticipation of Fed accommodation — pairs with the credit short as a two-leg macro hedge: receive fixed in 10-year or 30-year USD interest rate swaps while holding long CDX IG protection. Both legs pay in the same scenario: a growth shock severe enough to force Fed accommodation, where credit spreads widen and long-end Treasuries rally simultaneously in a flight-to-quality move.

Bridgewater’s Co-CIO Greg Jensen, in a January 8, 2026, Institutional Investor interview, called 2026 “a dangerous year for interest rates” and warned that Fed cuts at the front end “could lead to a bubble and hurt the long end.” He described bond supply as “the worst in aggregate ever” and warned “continued use of fiscal policy could lead to more inflation.” Jensen’s Pure Alpha 18% fund returned 34% in 2025 — its best year since 2010 — making his framework one of the most validated macro frameworks entering this year.

The explicit risk for this leg: stagflation, where the Fed cuts the front end but the long end sells off on inflation expectations, generating duration losses that net against the credit short. Jensen names this his primary rate risk for 2026. Apollo frames it as its “1970s backdrop.” This leg requires explicit scenario analysis and defined loss limits — not just a directional spread-widening view.

Trade 5 — Hyperscaler CDS vs. Industrial CDS Dispersion: The Apollo Divergence Trade

The most actionable data signal in this cycle predates the Vanguard interview by 30 days. On January 21, 2026, Apollo Chief Economist Torsten Slok published a Daily Spark note using ICE BofA data in the 7-to-11-year maturity range showing that investment-grade credit spreads are actively widening for hyperscalers and simultaneously tightening for industrials. That divergence was visible in price data a full month before it appeared in institutional strategy disclosures.

The structure is a dispersion trade that requires no directional view on whether artificial intelligence succeeds or fails as a technology — only that the spread differential already in motion continues. Buy protection on hyperscaler single-name CDS (Oracle, Meta, Alphabet) while selling protection on industrial and utility investment-grade credits.

AllianceBernstein’s 2026 Credit Outlook forecasts exactly this continuation: “We see 2026 as a divergence year marked by softening corporate fundamentals and higher dispersion, which could be amplified by AI.” J.P. Morgan’s 2026 Market Outlook similarly calls for higher investment-grade dispersion, noting weaker fundamentals will be felt differentially across sectors.

The fundamental credit pressure on the hyperscaler side is acute. Pivotal Research projects Alphabet’s free cash flow to plunge from $73.3 billion in 2025 to approximately $8.2 billion in 2026 — a near-90% decline — against a $185 billion capex commitment. (CNBC, February 6, 2026) The four hyperscalers combined are projected to spend close to $700 billion on AI infrastructure in 2026, up more than 60% from 2025 levels, with Amazon projected to turn free cash flow negative by an estimated $17–28 billion. That is the precise credit deterioration that widens a hyperscaler’s CDS while leaving utility and industrial credits largely unaffected — and the reason Apollo’s January 21 divergence signal was not a coincidence.

📋 Want the full trade reference? The five trades above are summarised here. The complete Patreon reference document covers every trade in full institutional detail: exact entry windows with basis-point levels, exit mechanics, what each incorrect version of the trade looks like and why it fails, how to reconcile conflicting CDS data across Bloomberg / Bondblox / Voya, and seven pattern-recognition lessons extracted for future cycles. Written for re-reading under time pressure — not for one-time consumption.

IV. Why the “Rotate into Quality” Defence Fails This Cycle

Every trade above shares a structural prop that distinguishes this credit cycle from prior ones: the conventional quality rotation defence is broken. In standard recessions, portfolio managers rotate from BBB-rated into A-rated and AA-rated credits. The trade works because quality issuers historically face less new-issue supply pressure during stress. But Oracle (Baa2/BBB/BBB), Alphabet (AA+), Amazon (AA), and Meta (A) are the quality cohort — and they are simultaneously the entities flooding the market with $20–32 billion in new supply within days of each other. There is no safe harbour within investment-grade when the largest new-issue supply sources are also the highest-rated names.

Breckinridge documents the direct evidence: the spread differential between A-rated and BBB-rated investment-grade is already historically compressed (Z-score of negative 1.5 relative to the five-year average), meaning the quality spread cushion has been fully consumed. There is no premium to rotating up in quality because the quality spread has been arbitraged away by the same demand dynamics that created the crowding problem.

Janus Henderson explicitly identifies utilities — not AA-rated hyperscalers — as the correct quality rotation for this specific cycle. That is an endorsement of the dispersion trade in Trade 5, not a contradiction of the broader thesis. The quality answer in 2026 is sector rotation away from hyperscalers, not a ratings upgrade within them.

“It really shifts from a company that had no financial policy to one that is saying: ‘We clearly want to be investment grade and want to have a balanced approach between debt and equity.’”

— Brad Smith, Portfolio Manager, Janus Henderson Investors · IFR, February 2026

Smith’s observation about Oracle — the largest non-bank investment-grade issuer — captures the mechanism precisely. When the largest borrowers in the index are issuing $25–32 billion in jumbo deals specifically to avoid being downgraded to high yield, the market is no longer pricing credit risk at the margin. It is pricing survival. That repricing, when it transmits fully, is not gradual.

V. Risk Framework: Three Scenarios That Break These Trades

Risk 1 — Sustained Soft Landing and AI Revenue Monetisation. The primary failure mode across all five trades is a soft landing in which hyperscaler capital expenditure generates measurable revenue within the forecast horizon. If Oracle’s and Alphabet’s deals are followed by on-time data centre completions, growing cloud revenues, and improving debt coverage ratios, CDS protection bleeds carry and CDX payer swaptions expire worthless. Goldman Sachs’ John Sales, following Oracle’s record deal, said markets remain “wide open” for technology deals, arguing the key story is record demand, not supply saturation. The $490 billion in taxable bond fund inflows and $304 billion in foreign net purchases documented by Breckinridge do not disappear overnight. This is an asymmetric bet that supply overwhelms absorption faster than AI monetisation materialises — a probability, not a certainty.

Risk 2 — Independent European Shock. The iTraxx long leg assumes European credit outperforms US credit on a relative basis. An independent European shock — German manufacturing contraction deepening, peripheral fiscal stress re-emerging, a banking sector event — could widen iTraxx Main regardless of US conditions, invalidating the geographic basis trade without touching CDX. Apollo places a 20% recession probability in Europe versus 30% in the US. (Apollo 2026 Economic Outlook) That 20% tail is not negligible and requires explicit position sizing discipline on this leg.

Risk 3 — Stagflation and Duration Blowout. For the paired receiver swap and CDX protection trade in Trade 4, the worst-case scenario is stagflation — the Fed cuts the front end while long-end Treasuries sell off on inflation expectations. The credit short pays, but duration losses can net the two-leg position to zero or negative. Apollo names this the “1970s backdrop.” Bridgewater’s Jensen identifies it as his primary rate risk for 2026. (Institutional Investor, Jan 8, 2026) This leg requires explicit scenario analysis with defined loss limits before execution, not just a directional spread forecast.

Conclusion: The Market Signalled in January. Vanguard Confirmed It in February.

The timeline is unambiguous. On January 21, Apollo’s Torsten Slok documented the hyperscaler-vs-industrial spread divergence in real-time price data. Oracle’s CDS had already moved from 36 to 139 basis points by December 2025 — a 3.5x move to 16-year highs — before reversing on deal completion. On February 2, Oracle’s $25 billion deal produced a record $129 billion order book and still required a 40–58 basis point concession premium: the new-issue saturation mechanism demonstrated empirically. On February 9–10, Alphabet raised $32 billion across three currencies in under 24 hours, including the largest corporate bond sale in sterling market history. Secondary investment-grade trading averaged more than $61 billion per day in January, according to Crisil Coalition Greenwich data cited by Bloomberg on February 17 — up 11% year-over-year, the fingerprint of large-scale institutional repositioning in real time. On February 20, Vanguard’s co-head of investment-grade credit confirmed the institutional logic publicly.

Five trades capture the alpha embedded in this sequence. The Oracle CDS leg was already executed and largely closed before Narayanan spoke. The CDX investment-grade payer swaption, the geographic basis, the paired duration hedge, and the Apollo-documented hyperscaler-vs-industrial dispersion trade remain live. All five are anchored to verifiable, sourced primary data from Bloomberg, IFR, Apollo, Breckinridge, Bridgewater, Janus Henderson, AllianceBernstein, J.P. Morgan, and TD Securities.

The question is not whether the supply wall is real. Morgan Stanley’s $400 billion estimate is already corroborated by Oracle and Alphabet alone — $57 billion in three weeks, both deals requiring concessions despite record oversubscription. The question is whether the absorption capacity that has held spreads at the 2nd percentile of a 20-year lookback can hold through a year in which the largest and highest-rated borrowers in the index are issuing at a pace with no historical precedent.

The answer, per Vanguard’s own co-head of investment-grade credit: not necessarily.

📊 Want Deeper Quantitative Analysis?

This research involved weeks of data collection, source verification, and cross-referencing across Bloomberg, IFR, Apollo, Breckinridge, Bridgewater, and a dozen other primary sources. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon.

Start here — the full trade reference for this article: → Trade Reference: US IG Credit Crowding Thesis — Full Entry Levels, Exit Mechanics & Lessons

This document covers all five trades with exact entry windows, the incorrect versions of each trade and why they fail, reconciliation of conflicting CDS data across sources, and seven pattern-recognition lessons for future cycles.

By joining, you’ll be supporting independent financial research and motivating more content of this calibre.

→ Join the Patreon community for ongoing research

Primary Sources

• Bloomberg — Vanguard Targets Canada, Europe to Hedge US High-Grade Debt Risks, Feb 20, 2026

• Breckinridge Capital Advisors — Q1 2026 Corporate Bond Market Outlook

• IFR — Oracle Raises US$25bn in Bond Offering as AI Funding Spree Continues, Feb 7, 2026

• Bloomberg — Oracle Blockbuster Bond Sale to Usher in AI Debt Wave, Goldman Says, Feb 5, 2026

• Bloomberg via Yahoo Finance — AI Debt Binge Is Set to Test Credit’s 1990s-Like Euphoria, Jan 23, 2026

• Euronews — Alphabet Plans to Sell Rare 100-Year Bond in Huge Multi-Currency Debt Raise, Feb 10, 2026

• Bloomberg via swissinfo.ch — Alphabet Sells Sterling, Swiss Franc Bonds in Global Debt Binge, Feb 10, 2026

• GlobalCapital — Alphabet Leaves No Record Unbroken With Sterling Debut, Feb 10, 2026

• CNBC — Alphabet Set to Raise Over $30 Billion in Global Debt Sale, Feb 10, 2026

• CNBC — Alphabet 100-Year Bond: Debt Fears and AI Credit Risk, Feb 12, 2026

• CNBC — Tech AI Spending Approaches $700 Billion; Free Cash Flow at Risk, Feb 6, 2026

• Bloomberg — Oracle Credit Fear Gauge Hits Highest Since 2009 on AI Bubble Fears, Dec 2, 2025

• Apollo Daily Spark — Divergence Emerging Between Credit Spreads for Hyperscalers and Industrials, Jan 21, 2026

• Institutional Investor — Behind Bridgewater’s Surge, Jan 8, 2026

• Janus Henderson — Fixed Income Outlook: Building Resilience in 2026

• AllianceBernstein — 2026 Credit Outlook: Growing Divergence Amid AI’s Big Build-Out

• J.P. Morgan — 2026 Market Outlook

• Bloomberg — Heavy Demand for Corporate Bonds Creates Record Trading Volume, Feb 17, 2026 (Crisil Coalition Greenwich data)

• Apollo — 2026 Outlook from Chief Economist Torsten Slok

• TipRanks — Why Oracle’s Record Bond Sale Clears the Way for More AI Debt, Feb 2026

• Voya Investment Management — The Connection Between Oracle’s Credit Default Swaps and AI, Dec 2025

• Bondblox — Oracle’s 5Y CDS Jumps to Its Highest Level Since 2009, Dec 2025

• FRED — ICE BofA US Corporate Index Option-Adjusted Spread (live data)

This article is analytical commentary for informational purposes only. Nothing herein constitutes investment advice, a solicitation, or an offer to buy or sell any security. All data and quotations are sourced from the linked primary sources and are accurate as of their publication dates.

About the Author

Navnoor Bawa publishes institutional-grade quantitative research and trading strategy analysis at the intersection of fixed income, derivatives, and AI-driven market structure.

· LinkedIn — Connect for research updates and commentary · YouTube: The Mathematical Trader — Subscribe for video analysis and deep-dives · Full Trade Reference — This Article (Patreon) — Entry levels, exit mechanics, incorrect trades, and lessons · Patreon — Ongoing Research — Exclusive quantitative research and trading strategies

Cover photograph: Federalreserve, public domain, via Wikimedia Commons.

FEBRUARY 20, 2026 · DISTRESSED CREDIT ANALYSIS

Kem One is not a story about one bad bet. It is a story about three distinct and mutually contradictory alpha strategies — structural short, super-senior rescue lending, and uptier restructuring — all running simultaneously on a single French chlorochemicals producer that Apollo Global Management acquired for a total consideration of roughly €704 million — implying an enterprise value of approximately €600 million, with the remaining ~€104 million representing net cash and closing adjustments per Octus Intelligence — in December 2021 and has watched deteriorate into near-total impairment since. As of today, Lune Holdings’ €450 million of 5.625% senior secured notes due November 2028 (ISIN XS2406727151) trade at approximately 2–3.5 cents on the euro — down from roughly 70 cents in early 2025. That 68-point collapse in under twelve months, confirmed by both Hedgeweek and Bloomberg, is the return that made three short funds look prescient and two long funds look dangerously exposed.

📋 This article covers the public narrative. If you want the full trade reference — every position broken down into CONFIRMED vs. INFERRED claims, all five strategies with exact mechanics, 13 reusable strategy lessons extracted from this trade, and the unresolved questions to watch in 2026 — I published an exclusive companion document on Patreon: → Kem One: Full Trade Reference

To understand why this trade happened — and why it split the European credit community into opposing camps — you need to start not in 2021, but in 2012.

A Company That Has Failed Before

Most coverage starts with Apollo’s 2021 acquisition. But Kem One’s structural fragility traces to an earlier failure that every serious analyst had in their model. The company began life as Arkema’s PVC division — a unit so persistently loss-making that in 2011 Arkema decided to divest it. In July 2012, Arkema ceded the division to Gary Klesch’s Klesch Group at zero cost, erasing debt and contributing €100 million in cash and guarantees. Within nine months, the company was losing €10–15 million per month. By March 2013, the Lyon commercial court placed Kem One in insolvency proceedings. French Minister for Industrial Renewal Arnaud Montebourg intervened to prevent the loss of 1,800 jobs. In December 2013, OpenGate Capital and Alain de Krassny acquired Kem One out of insolvency with government support and Arkema concessions. De Krassny rebuilt the company over eight years and sold it to Apollo.

That prior insolvency cycle is not a footnote — it is the thesis. A company that failed once under one set of macro conditions and was rebuilt is structurally more vulnerable when those conditions return. When Apollo completed the acquisition in December 2021, European chemical margins were near their post-COVID peak. By 2022–2023, those tailwinds had reversed violently. What happened next was telegraphed not just in the macro data, but in Kem One’s own boardroom.

CEO Musical Chairs as Signal

Governance instability at portfolio companies is a short-seller’s leading indicator — it signals that the business plan is not working before the financial statements confirm it. At Kem One, the pattern was unmistakable. Original CEO Frédéric Chalmin departed approximately six months after the Apollo acquisition — around June 2022. Board Chairman Laurent Lenoir served as interim before Apollo appointed Paolo Barbieri on April 3, 2023 — a former DuPont and Corteva executive brought in to stabilise the operation. Then, on September 1, 2025, at the peak of the company’s financial crisis, Barbieri himself stepped down, with Lenoir returning as interim CEO. Three leadership changes in under four years — each transition a data point confirming that the underlying industrial deterioration was not a management execution problem that a new hire could fix. It was structural. And the structure was being dismantled by forces far larger than any single executive.

The Macro Thesis: China Eats European Chemicals

The short case against Kem One rests on a structural, not cyclical, claim. China’s effective PVC production capacity reached 28 million tons by December 2024, with an additional 2.5 million tons planned. In 2024, China’s PVC exports surged approximately 42% year-on-year to 4.6 million tons, making it the world’s largest exporter. By the first half of 2025, EU imports of PVC from China had increased roughly 700% year-on-year at record-low prices, according to ChemOrbis. This is not demand destruction — it is supply displacement. European producers are not losing customers; they are losing the ability to compete on cost against a structurally cheaper input base.

The damage is sector-wide, not company-specific. Between 2022 and 2025, the EU lost approximately 37 million tonnes of chemical manufacturing capacity — roughly 9% of the total, with 20,000 direct jobs eliminated. BASF shuttered 11 factories in Germany. Ineos, which saw combined debt exceed £18 billion (~€21 billion) by end-2025, cancelled its annual dividend and filed anti-dumping cases against Chinese imports. Fitch changed its 2025 global chemicals outlook to “deteriorating” from “neutral.” Chemicals, packaging, and environmental services accounted for the highest defaulted debt volume globally in January 2026 at $2.6 billion.

Kem One’s specific vulnerability compounds the macro: it uses expensive ethylene-based feedstock to produce PVC. Chinese producers use coal-based feedstock at structurally lower costs. Even after investing €100 million in electrolysis modernisation at Fos-sur-Mer (the ELYSE project, which reduced electricity consumption by 16% and gas consumption by 36%), and €80 million in a cryogenic ethylene storage terminal, Kem One cannot reach the cost floor that Chinese producers operate at. Capital expenditure made the company more efficient — just not efficient enough to overcome a feedstock cost differential baked into the geology of two different continents.

One additional cost shock sealed the case: France’s regulated nuclear electricity pricing (ARENH at €42/MWh) expired at end-2025. Kem One signed a new 10-year EDF nuclear contract at approximately €70/MWh starting January 2026 — a 67% unit cost increase at a moment of zero pricing power.

The EBITDA Freefall

The governance deterioration and macro headwinds combined to produce financial results that track, almost precisely, the short thesis timeline:

Sources: S&P Global Ratings, Octus Intelligence, Lune Holdings investor filings

📋 Want the Full Trade Breakdown Behind These Numbers?

This table is the public summary. The Patreon companion document goes deeper: every trade isolated into its own block (structural short, super-senior rescue lending, uptier play, Apollo equity, minority bonds), with each claim marked [CONFIRMED] or [INFERRED] against primary sources. Plus 13 reusable strategy lessons extracted from this specific trade — on structural shorts, consent threshold mechanics, dual lender/bondholder positioning, and the Apollo-Diameter conflict-of-interest structure.

→ Read the Full Kem One Trade Reference on Patreon

S&P Global’s CCC− downgrade on September 17, 2025 revealed that full-year 2024 adjusted EBITDA reached just €3 million, with projected 2025 EBITDA of approximately €2 million and negative adjusted free operating cash flow of approximately €177 million. S&P warned of covenant breach or liquidity shortfall “within the next few quarters.” Per Octus Intelligence, EBITDA for the twelve months to June 2025 was negative €12 million — meaning S&P’s €2 million full-year projection had already been breached within the first six months of the forecast period. With net debt of €583 million and €136.7 million in remaining liquidity, Octus estimated the company would reach a liquidity cliff by the second quarter of 2026.

Apollo’s European team took direct control in January 2024 and injected a €300 million shareholder loan to bridge the gap. By October 2025, that loan had been entirely consumed by negative free cash flow — burned through at a rate that no operational improvement could offset. What had been a €352 million EBITDA business in 2022 was now an entity that could not cover its interest costs, let alone service €450 million in bonds.

Capital Structure — Pre-Restructuring (as of June 30, 2025)

Source: Octus covenant analysis, Bloomberg

With that context established — governance failure, structural macro headwinds, and financial freefall — the investment community split into two opposing camps, running three distinct strategies simultaneously on the same credit.

The Short Side: Sona, Polus, and Diameter

Mechanics of a Bond Short

Hedge funds short credit primarily through credit default swaps (CDS), where the fund pays a periodic premium to a counterparty and profits when the reference entity’s spreads widen, or through total return swaps where a bank shorts the cash bond on the fund’s behalf. These instruments allowed Sona, Polus, and Diameter to build short exposure to Kem One’s bonds without owning them — and to close positions at substantial profit as the bonds fell from 70 cents to roughly 2 cents.

Sona Asset Management

Sona Asset Management, founded in 2016 by John Aylward — previously head of European high-yield trading at Deutsche Bank, European corporate credit at Claren Road Asset Management, and European credit at Highbridge Capital Management — runs a European all-weather long/short credit strategy. The flagship Credit Master Fund managed approximately $7.5 billion at the start of 2025, growing to around $11 billion by year-end; firm-wide AUM across all strategies reached approximately $16.6 billion by early 2026 per Hedgeweek. Sona was among the funds that shorted Kem One’s debt, booking profits as bonds cratered. The flagship returned 18.76% in 2024 — its fifth consecutive year of double-digit returns — winning Hedgeweek’s European Award for “Performance of the Year: Credit – Long/Short.” Sona has publicly estimated that approximately $100 billion of European leveraged loans face refinancing difficulties by 2028 — a forward pipeline that defines the structural short opportunity set the firm is built to exploit.

Polus Capital Management

Polus Capital Management emerged from the 2021 merger of Cairn Capital and Bybrook Capital, rebranding in November 2022. The firm manages approximately $11 billion in assets as of September 2024 following an ADIA capital commitment, with CIO of Opportunistic Credit Robert Dafforn — founder of Bybrook Capital — running the short book. Polus shorted Kem One’s bonds and benefited as prices collapsed. What makes Polus’s involvement analytically significant is Dafforn’s public commentary: he told Bloomberg the firm holds a “more substantial book of single-name, high-yield credit shorts” targeting chemicals, building materials, packaging, and consumer goods — precisely the sectors now being crushed by Chinese export competition. Portfolio Manager Jamie McFarlane has noted that European special-situations opportunities have nearly doubled versus pre-COVID levels, with 2026 expected to produce a similar or greater volume of stressed and distressed situations.

Diameter Capital Partners and the “Credit Microcycles” Framework

Diameter Capital Partners, founded in 2017 by Scott Goodwin (formerly head of high-yield trading at Citi, then Anchorage Capital) and Jonathan Lewinsohn (formerly Head of Research at Anchorage and Senior Managing Director at Centerbridge; JD from Yale Law School), oversees approximately $25 billion in assets across its flagship hedge fund, dislocation funds, CLO vehicles, and direct lending. Apollo holds an approximately 5% minority equity stake in Diameter, acquired in October 2022 — a fact whose significance becomes clear below. Diameter built a short position against Kem One as part of a broader bet against the global chemicals sector, articulated precisely in its Q4 2025 letter:

“We had success in the fourth quarter in shorts of global chemicals companies bedeviled not so much by sudden drops in demand (RECESSION!) than by the evolution of supply. The problem is China, which seems determined to add capacity up and down the chemicals chain.”

— Diameter Capital Partners Q4 2025 Investor Letter, January 8, 2026 (public PDF)

The letter included a forecast that even if all ethylene and propylene capacity in Europe and Japan were shut down, global excess capacity by 2030 would still exceed today’s levels — the mathematical case for why this is a structural, multi-year short, not a trade to be covered at the first hint of stabilisation. Diameter’s Master Fund returned 8.0% for full-year 2025, with only a 30-basis-point gain in Q4 — despite a significant loss on First Brands Group, which filed Chapter 11 in September 2025. The chemicals shorts were a critical offset to that First Brands impairment. Goodwin and Lewinsohn have publicly articulated their “credit microcycles” framework — industry-specific downturns that create dislocations even in stable macro environments — on the Goldman Sachs Exchanges podcast (December 18, 2025) and Capital Allocators Episode 484 (February 2, 2026).

The Apollo-Diameter Conflict of Interest

Apollo owns Kem One. Apollo simultaneously holds a ~5% minority equity stake in Diameter Capital Partners — one of the funds that shorted Kem One’s debt into near-worthlessness. The positions sit in separate legal entities with distinct mandates and fiduciary duties, and there is no suggestion of impropriety. But the structural fact — that a PE firm’s investee fund profited from the collapse of the PE firm’s own portfolio company — illustrates precisely how interconnected modern alternative asset management has become. Conflict-of-interest mapping is now a standard, non-optional component of distressed credit due diligence.

The Long Side: Arini and Monarch

While Sona, Polus, and Diameter were building short positions, two other funds made the opposite bet — that being first in line in the capital structure would be worth more than the market was pricing.

Arini Capital Management

Arini Capital Management was founded in 2021 by Hamza Lemssouguer, previously head of high-yield credit trading in Europe at Credit Suisse. Lemssouguer’s trajectory is relevant context: after joining Credit Suisse in 2015 upon graduating from École Polytechnique and interning at Goldman Sachs in 2013, his desk generated approximately $220 million in trading revenue in 2020 — roughly 5.5% of Credit Suisse’s total fixed income trading revenues — with gross annualized returns of 38%. He planned to launch Arini as an internal Credit Suisse fund, but the bank’s post-Greensill/Archegos risk aversion killed the plan. He left to build it independently.

The firm’s flagship Arini Credit Master Fund returned 21.2% in 2024 — more than double the 8.5% average for credit hedge funds — and was up 17% through August 2025, with AUM of approximately $12 billion at that date. Roughly 30% of assets are allocated to stressed and special situations. In a Bloomberg “Credit Crunch” podcast (January 2025), Lemssouguer described Arini’s edge as combining fundamental analysis, legal expertise, and game theory — specifically, modelling how different creditor classes will behave in restructuring scenarios. Kem One is a live demonstration of that framework in action.

Monarch Alternative Capital

Monarch Alternative Capital, co-founded in 2002 by Michael Weinstock, Andrew Herenstein, and Chris Santana — all veterans of Lazard’s distressed debt platform; Weinstock and Herenstein as Managing Directors (Weinstock’s team ranked #1 in distressed by Institutional Investor in 1998), and Santana as Vice President and Head Trader of the Lazard Debt Recovery Funds — manages approximately $16 billion in assets. Per a June 2025 press release, Weinstock transitioned from CEO to Executive Chairman effective December 31, 2025, with Santana becoming Co-CEO and Co-CIO alongside Adam Sklar, and Herenstein assuming the role of Vice Chairman. Monarch’s flagship Monarch Capital Partners VI closed with over $4.7 billion, surpassing its $3.5 billion target, dedicated to complex, dislocated credit.

The €200M+ Facility: Structure and Key Mechanics

In March 2025, Arini and Monarch jointly provided Kem One with a €200 million five-year delayed-draw term loan, structured as a senior secured facility with an initial draw of €120 million and an additional €80 million available over 18 months. Critically — per Octus covenant analysis — Monarch leads the deal at 75%, Arini at 25%. The facility holds the same security and priority as the existing revolving credit facility, augmented by additional collateral, and ranks senior to the €450 million of publicly traded 2028 bonds. This priming structure is the core of the long-side thesis: by sitting at the top of the waterfall, Arini and Monarch position themselves to recover value even in a wind-down scenario where bondholders are wiped out entirely.

By late June 2025, €150 million of the facility had been drawn, leaving €50 million available. In January 2026, the same lenders provided an additional €30 million emergency financing — ranking alongside the original €200 million loan — as the company approached what analysts estimated could be a liquidity cliff by mid-2026. Total super-senior exposure now stands at approximately €230 million. The question the market is now pricing is simple: does Kem One’s asset base, post-ELYSE modernisation, support full recovery of that super-senior stack in a French insolvency process where competing European chemical assets are simultaneously closing and depressing salvage values?

The Bondholder War: Uptier Restructuring

The rescue lending created the conditions for the third strategy — and the most legally complex one. An ad hoc group of bondholders representing approximately two-thirds of the 2028 senior secured notes — led by Arini and BlackRock — has retained Gibson Dunn & Crutcher to explore restructuring options. The proposed transaction, per Octus Intelligence, would see the ad hoc group inject new super-senior money (up to €47.5 million of remaining capacity under the bond indenture’s super-senior basket) and uptier its existing bond holdings into new 1.5 lien notes — ranking above the minority bondholders left outside the group, but below the Arini/Monarch super-senior facility.

The legal mechanics are the entire game. The intercreditor agreement requires 90% bondholder consent to “expressly subordinate the notes” — a threshold the ~66% ad hoc group cannot clear. However, 50.01% simple majority consent suffices for amendments to “application of collateral enforcement proceeds.” The uptier would therefore be structured as a collateral enforcement amendment rather than direct subordination — a pathway that has been used in US distressed markets but remains more contentious under European documentation norms, where creditor-on-creditor manoeuvres of this kind have less established precedent.

Arini’s position across this entire structure is worth pausing on: it is simultaneously a super-senior lender (through the Monarch-led facility at 25%), a lead member of the bondholder ad hoc group seeking to uptier its bond holdings, and operating in a market where the short-side counterparts (Sona, Polus, Diameter) are profiting from the bonds trading at 2 cents. This dual positioning gives Arini optionality across every restructuring scenario — recovery through the super-senior waterfall if assets liquidate, or an improved bond position if the uptier succeeds, or a negotiated outcome between the two.

Rating Agency Timeline

The rating agency timeline tracks the fundamental deterioration and maps precisely to the bond price collapse — each downgrade functioning as a public confirmation of what the short thesis had already priced in, and each action triggering forced selling by mandated holders unable to hold CCC-rated paper:

S&P downgrades to CCC−;

Three Alpha Strategies, One Credit

Taken together, the Kem One trade represents three distinct investment frameworks deployed simultaneously on one name — each internally coherent, each incompatible with the others:

01 — Structural Short (Sona, Polus, Diameter) Identify irreversible structural headwinds — Chinese PVC flooding Europe at cost-of-coal prices. Short the most leveraged, most exposed names via CDS. Captured approximately 68 cents of downside over ~12 months. Diameter framed this as a “credit microcycle” — a sector-specific dislocation that persists and deepens even when the macro economy is stable, because the driver is supply competition, not demand collapse.

02 — Super-Senior Rescue Lending (Monarch 75%, Arini 25%) Provide emergency financing at the very top of the capital structure, priming the existing €450 million of bonds. The thesis: France’s industrial protection norms, the company’s modernised electrolysis assets, and the strategic value of Kem One’s eight industrial sites create sufficient asset value for super-senior recovery even in a liquidation scenario where equityholders and bondholders are wiped out.

03 — Uptier Play (Arini, BlackRock and ad hoc bondholder group) Own ~66% of the existing bonds, retain Gibson Dunn, and execute a liability management exercise using the 50.01% collateral amendment route — promoting your debt above the minority holders who fall outside the group. Arini’s presence across both Strategies 02 and 03 simultaneously is the structurally elegant — and structurally conflicted — feature of this entire trade.

What the Trade Teaches

Kem One’s collapse is a case study in the divergence of credit intelligence operating on the same underlying asset. The short funds were right on the macro: Chinese chemical overcapacity is a structural, not cyclical, phenomenon. Diameter’s projection — that even eliminating all ethylene and propylene capacity in Europe and Japan would not absorb Chinese excess capacity by 2030 — is a framework, not a single trade. It defines an investment regime lasting years, not quarters. Sona and Polus’s willingness to hold short positions through headline volatility and interim bond rallies — and to exit at maximum dislocation — reflects the discipline that separates a structural short from a directional gamble.

The long funds were not wrong on the credit analysis; they were wrong on the timing and magnitude of industrial deterioration. Arini and Monarch lent into a company with modernised assets, super-senior collateral protections, and French government strategic-industry designation — a defensible position in a normalised scenario. The flaw is the residual asset value question: if Kem One enters a French insolvency process, what do chlorochemical plants in Fos-sur-Mer and Lavera clear for in a buyer’s market where competing European chemical assets are simultaneously closing and depressing the salvage floor? The ELYSE modernisation reduces cost; it does not bridge the feedstock cost differential with Chinese producers using coal at a fraction of European ethylene prices.

The Apollo-Diameter dynamic — a PE firm’s investee fund profiting from the collapse of the PE firm’s own portfolio company — is the structural conclusion that the alternative asset management industry should sit with. Separate mandates, separate fiduciary duties, genuinely separate decision-making. But the same web of capital relationships, increasingly, underneath every large distressed trade.

As Diameter’s Q4 2025 letter concluded: “We have shorts in the most impacted names and believe that 2026 will be a watershed inflection for chemicals.” For Kem One’s creditors across all three strategies, that inflection has already arrived.

📊 Want the Full Trade Reference Document?

This article covers the public-facing narrative. The Patreon companion document goes considerably deeper — and is structured differently: it is a reference file, not an article.

Every trade is isolated into its own block. Every factual claim is tagged [CONFIRMED] or [INFERRED] against a named primary source. It documents both the correct trades and the incorrect trades with equal rigour, because both are equally instructive. It also includes 13 reusable strategy lessons extracted from this specific trade — on structural short discipline, consent threshold mechanics, super-senior recovery analysis, dual lender/bondholder positioning, and how to map the ownership web in modern alternative asset management.

If you want the kind of analytical framework you can return to when the next distressed situation arrives, that document is the one.

→ Kem One: Full Trade Reference — Patreon Exclusive

By joining, you support independent financial research and motivate more analysis at this level of depth.

Primary Sources

• Hedgeweek — Hedge funds go head-to-head over Kem One debt

• Bloomberg — Apollo-backed Kem One secures €200mn financing (March 2025)

• Bloomberg — Kem One gets €30mn extra debt (January 2026)

• Bloomberg — Bondholders seek to band together (October 2025)

• Octus Intelligence — Bondholder group / uptier analysis

• Octus Intelligence — Covenant / capital structure analysis

• S&P Global — CCC− downgrade, September 2025

• Diameter Capital Partners — Q4 2025 Investor Letter (public PDF)

• Hedge Fund Alpha — Diameter Capital 2025 performance

• Capital Allocators Ep. 484 — Credit Microcycles at Diameter (Lewinsohn)

• Goldman Sachs Exchanges — Scott Goodwin on credit microcycles (December 2025)

• Hedgeweek — Arini 2024 returns (21.2%)

• Hedgeweek — Arini 2025 AUM and profile

• Hedgeweek — Sona adds $6.6bn (2025 AUM verification)

• Hedgeweek — Sona 2024 performance award

• Sona Asset Management — John Aylward biography

• PRNewswire — Polus Capital / ADIA commitment, September 2024 (~$11bn AUM)

• PRNewswire — Monarch leadership transition (June 2025)

• Monarch Alternative Capital — Chris Santana biography (Lazard VP)

• BusinessWire — Diameter raises $4.5bn for DDF III (November 2025)

• Business Insider Markets — Lune Holdings bond pricing (ISIN XS2406727151)

• ICIS — Kem One / Klesch / Arkema insolvency (2013)

• OpenGate Capital — Kem One acquisition out of insolvency (2013)

• ChemOrbis — EU PVC imports from China surge 700% (H1 2025)

• ICIS — European chemicals capacity closures 2022–2025

• European Business Magazine — Hedge funds in face-off over Kem One

This article is for informational purposes only. Nothing herein constitutes investment advice or a recommendation to buy or sell any security.

About the Author

Navnoor Bawa researches distressed credit, European high yield, and quantitative trading strategies with a focus on institutional-grade analysis accessible to independent investors.

• 📺 YouTube — In-depth video breakdowns of trades, strategies, and market structure: The Mathematical Trader

• 💼 LinkedIn — Follow for research updates and professional commentary: Navnoor Bawa

• 📊 Patreon — Exclusive quantitative research, trading strategies, and deep-dives not published anywhere else: Join here

Cover photograph: King of Hearts, CC BY-SA 3.0, via Wikimedia Commons.

A primary-source reconstruction of the most documented activist campaign of 2025–26: the exact positions, verified financials, legal agreements, concessions already extracted, the precise mechanics by which two of Wall Street’s most sophisticated funds expect to get paid — and the credible bull case on the other side.

Fact-checked against SEC EDGAR · D.E. Shaw Primary PDF · CoStar IR · StockTitan. All financial figures sourced from primary documents and cross-verified.

Written by Navnoor Bawa · YouTube — The Mathematical Trader · LinkedIn

At a Glance

The activists’ thesis is six words: one bet is suppressing the company’s value. Third Point and D.E. Shaw have spent the better part of eighteen months building the documentary record to prove it — primary letters, SEC filings, a detailed analytical presentation — and the math behind the distortion is not in dispute. CoStar Group’s commercial real estate data business generates compounding, high-margin revenue that activists and analysts estimate — based on peer information-services multiples and the CRE segment’s pre-Homes.com margin trajectory — could be worth more than $35 billion as a standalone entity. The market cap of the entire company, as of mid-February 2026, is roughly $19 billion. The gap between those two numbers is named Homes.com. Not everyone agrees the gap is permanent or that the cure is abandonment — a credible bull case exists, and this article documents both.

What follows is a verified reconstruction — every claim tied to a primary document — of how two of the most analytically rigorous funds in alternative asset management built their positions, what concessions they have already extracted, the precise sequence by which they expect the trade to pay, and why a major long-term CoStar shareholder believes they are wrong.

I. The Exact Position: What the SEC Filing Says

The single most important number is buried in a legal agreement on the SEC’s EDGAR database. When Third Point and CoStar signed their standstill agreement on April 6, 2025, the document states that Third Point and its affiliates “beneficially own or have economic exposure to 8,353,000 shares of common stock of the Company.”

The phrase “economic exposure” is load-bearing. It means the position includes equity derivatives — options or total return swaps — not only outright stock. Activists use these instruments to build exposure below the 5% Schedule 13D disclosure threshold before converting to voting shares. With 416 million diluted shares outstanding — CoStar’s own figure from its January 7, 2026 guidance filing — 8.353 million equals approximately 2% of the company. At CSGP’s current price of approximately $44.99–$47.87, the position is worth roughly $375–$400 million — a significant paper loss from the $68–75 range where the stock traded near the April 2025 agreement date. CSGP’s all-time intraday high was $101.05 on October 26, 2021 — the year CoStar first began building Homes.com in earnest.

D.E. Shaw, which as of February 2026 manages more than $85 billion in investment capital per its own press release, has never disclosed an exact stake size. Its February 4, 2026 letter states only that it “currently hold[s] a significant economic position in the Company” — language that mirrors Third Point’s pre-settlement posture and almost certainly implies a derivatives-based position below the 5% disclosure threshold. What D.E. Shaw did disclose was its analytical framework, and it is more precise and more damaging than anything Third Point published.

II. The Capital Destruction Case — Exact Numbers from Primary Sources

Both funds quantified the Homes.com destruction with more precision than any sell-side analyst. The confirmed figures, drawn directly from the letters and CoStar’s own filings:

• D.E. Shaw letter, Feb. 4, 2026

• Third Point letter, Jan. 27, 2026

• D.E. Shaw letter, Feb. 4, 2026

• Third Point letter, Jan. 27, 2026

• Third Point letter, Jan. 27, 2026

• CoStar IR, Jan. 7, 2026

• D.E. Shaw letter, Feb. 4, 2026

• D.E. Shaw letter, Feb. 4, 2026

• D.E. Shaw letter, Feb. 4, 2026

• D.E. Shaw letter, Feb. 4, 2026

The CEO compensation figure is structurally damning. D.E. Shaw’s letter documents that over five years, Andy Florance’s annual cash and equity incentive awards paid out at 200% of target — every year but one, when the cash portion paid out at only 150% — generating approximately $130 million in total compensation while the company’s TSR ranked in the bottom decile of the S&P 500. Simultaneously, Florance net sold $27 million of CoStar stock since November 2022, when Homes.com was relaunched. A founder who is net selling while arguing his residential experiment will create billions annihilates the conviction argument.

“By the end of this year, CoStar will have spent more than $3 billion on Homes.com and diverted the majority of core business earnings over the last four years to fund this venture.” — D.E. Shaw letter to CoStar Board of Directors, February 4, 2026

D.E. Shaw made two distinct financial claims that the research community has conflated. The fund estimates that the Homes.com drag has already destroyed as much as $11 billion in shareholder value — the discount at which CoStar’s core trades relative to peers — and that separating or dramatically curtailing Homes.com could generate more than $10 billion in new shareholder value going forward. These are separate calculations, not the same number recycled.

“Every shareholder who has purchased CoStar’s stock in the last five years has lost money.” — D.E. Shaw letter to CoStar Board of Directors, February 4, 2026

📊 Want Deeper Quantitative Analysis?

This research required extensive data collection, primary-document verification, and cross-referencing across SEC filings, earnings transcripts, and institutional letters. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon — the kind of work that doesn’t make it into a free article.

By joining, you’ll be supporting independent research and motivating more content like this.

→ Join the Patreon community here

III. The 2025 Standstill: What It Produced — and Why It Wasn’t Enough

Third Point spent the first half of 2025 in private engagement. The standstill agreement signed April 6, 2025 secured three new independent directors:

• Christine McCarthy — former Disney CFO

• John Berisford — former President of S&P Global Ratings (the designated Third Point Nominee)

• Rachel Glaser — former Etsy CFO

Simultaneously, Michael Klein, Christopher Nassetta, and Laura Kaplan retired from the board. Louise Sams was named independent board chair. The board became 7 of 8 directors independent.

The most structurally significant concession was a Capital Allocation Committee (CAC) with board members linked to the activists. The CAC was not cosmetic — CoStar’s own January 7, 2026 strategic update noted all new initiatives had been “unanimously approved by the Board and Capital Allocation Committee.” The activists had seats at the table where capital decisions were being made.

When the standstill expired approximately one year later, Third Point’s verdict was blunt: “So little progress has been made that we are convinced the Company never intended to do any of the things we discussed when we entered into the agreement.” That sentence — an explicit accusation of bad faith — escalated the fight from governance negotiation to full proxy war.

IV. What CoStar Actually Conceded

CoStar’s January 28, 2026 response mixed theater with real concessions. Separating them matters for understanding the trade mechanics.

The $2 billion in capital returns is real. CoStar accelerated its existing $500 million buyback and authorized a new $1.5 billion share repurchase program. At roughly $45/share and 416 million diluted shares outstanding, $2 billion retires approximately 44 million shares — roughly 10% of the float. This is mechanically accretive to any remaining shareholder who bought above current price. It does not make Third Point whole but it puts a floor under the stock while the activists press for more.

The $300 million Homes.com spending cut in 2026 is real. CoStar confirmed it would reduce net Homes.com investment by $300 million in 2026 and $100+ million annually thereafter. At a 25x information-services multiple, every $100 million in recovered EBITDA is worth $2.5 billion in market cap. Third Point called this “flatly unacceptable” for not going far enough — but the $400 million total cut over two years is a real concession, not theatrics.

The 2026 EBITDA guidance is real but contested. CoStar’s January 7, 2026 strategic update guided 2026 adjusted EBITDA in a range of $740–$800 million (midpoint ~$770M) — an 83% increase over 2025 and the highest in company history at a 20% margin. The longer-horizon target — $2.3 billion in adjusted EBITDA at 35% margins by 2030 — was articulated in CoStar’s January 28, 2026 response to Third Point. D.E. Shaw directly challenged the nearer-term guidance, arguing the numbers reflect a “poorly disguised shift of expenses” from Homes.com to the core rather than genuine margin recovery.

Compensation reform is real. Following the near-50% say-on-pay revolt, CoStar committed to a redesigned executive compensation program with more rigorous, quantitative targets. If Florance’s pay becomes TSR-linked in any meaningful way, his economic interests shift toward the activists’ position — the most durable form of governance improvement.

V. The Six Mechanisms That Generate the Alpha

Mechanism 1 — EBITDA Restoration × Information-Services Multiple CoStar’s CRE core is capable of 50%+ EBITDA margins at scale. Consensus estimates declined more than 70% since 2021. Partial reversal at a 25x multiple equals billions in market cap recovery. This is the primary mechanism.

Mechanism 2 — Buyback Arithmetic $2 billion of buybacks at ~$45 against a ~$86–87 analyst consensus target retires shares at a roughly 48% discount to fair value. Every dollar spent is arithmetically accretive to remaining holders.

Mechanism 3 — Proxy Vote as Optionality Board control at the June 2026 Annual Meeting unlocks authority to force strategic alternatives for Homes.com: sale, spin-off, or structured wind-down. Each path raises the probability of unlocking D.E. Shaw’s $10 billion figure. The proxy filing itself forces the market to begin pricing those probabilities now.

Mechanism 4 — Strategic Acquirer Premium CoStar at a $19 billion market cap — a 94% renewal rate for customers with 5+ years on platform (per Q3 2025 earnings), 143 million monthly visitors across all brands, world’s largest proprietary CRE database — is a genuinely scarce asset at distressed prices. Public activist pressure raises the probability of inbound strategic conversations.

Mechanism 5 — Governance Arbitrage Already Captured Board composition, CAC formation, compensation redesign, three capital-focused directors — these are locked in regardless of proxy outcome. The governance baseline has improved irreversibly.

Mechanism 6 — Catalyst Sequencing Q4 2025 earnings (February 24) + mid-March nomination window + June proxy vote. Three binary events in four months compress the timeline and force the market to price scenario probabilities now rather than waiting.

Fifteen to sixteen analysts currently rate CSGP a Buy with a 12-month consensus price target of approximately $86–87 — roughly 90–95% upside from the current ~$45 price — with a top-end estimate of $105. Those targets assume only partial EBITDA recovery, not a full strategic separation of Homes.com.

All six mechanisms converge on a single chokepoint: the June 2026 Annual Meeting. Which institutions vote — and how — determines whether any of them pay.

VI. The Decisive Votes

Vanguard and BlackRock together hold approximately 24.5% of CoStar’s shares. These two institutions are the deciding votes in any proxy contest. Both have historically voted with management absent operational catastrophe — but a ~50% say-on-pay rejection at the 2025 Annual Meeting signals that the institutional base’s patience has limits. The activists will spend the next three months making the case that Homes.com is exactly that catastrophe.

CoStar’s counter-argument is equally pointed: its January 28 response noted that Third Point has “underperformed the Russell 3000 in nine of the past 10 years” and that all the January 2026 strategic initiatives were the direct result of the CAC review process the activists requested. The process worked, the company argues; Third Point simply wants faster and more radical action than the board is willing to take.

VII. The Counter-Case — Why Baillie Gifford Is Not Wrong

No honest analysis omits the bull case. Baillie Gifford, a CoStar shareholder for nearly a decade and its seventh-largest investor, told the FT on February 15, 2026 that Homes.com has “become a national brand with a rapidly expanding audience and subscription base” and that AI capabilities launching in early 2026 “will further strengthen its position and help establish CoStar’s next billion-dollar business.”

The data they cite is real. Homes.com has 26,000 paying members — up nearly 150% since Q3 2024 (per CoStar’s Q3 2025 earnings release, verbatim from CEO Florance) — and the Homes.com Network specifically attracted 115 million average monthly unique visitors as of Q3 2025, distinct from CoStar Group’s total website footprint of 143 million across all its brands. CoStar’s 2024 revenue was $2.74 billion, up 11.45% year-over-year. Apartments.com, which was called a “distracting money loser” for years, now generates hundreds of millions in annual profit.

The difference between Baillie Gifford and the activists is a single variable: whether the terminal value of Homes.com justifies the opportunity cost of suppressing the CRE core’s margin for 8+ years. That is a legitimate empirical disagreement, not a dispute about facts.

VIII. The Catalyst Calendar

Third Point and D.E. Shaw are currently sitting on significant paper losses relative to their entry levels. The stock is down approximately 38% over the past twelve months and 46% over five years. Neither fund has made money on the equity yet. What they have made is a documented record of extractable concessions — board composition, capital allocation oversight, $2 billion in buybacks, $400 million in Homes.com spending reductions, compensation reform — that have permanently altered the company’s governance structure regardless of proxy outcome.

The activist thesis at CoStar is not a stock tip. It is a years-long structural arbitrage against a valuation distortion created by one founder’s bet on residential real estate. The math of that distortion — $3 billion invested against $80 million in revenue and $2 billion in losses — is not in dispute. The only question is whether governance pressure, a February 24 earnings report, and a mid-March nomination decision can accelerate the market’s recognition of that distortion before the next quarterly narrative rewrites the story.

📊 Want Deeper Quantitative Analysis?

This research required extensive data collection, primary-document verification, and cross-referencing across SEC filings, earnings transcripts, and institutional letters. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon — the kind of work that doesn’t make it into a free article.

By joining, you’ll be supporting independent research and motivating more content like this.

→ Join the Patreon community here

About the Author

Navnoor Bawa publishes quantitative research and institutional-grade market analysis at the intersection of finance and data.

• 📺 YouTube — The Mathematical Trader

• 💼 LinkedIn — Navnoor Bawa

• 📊 Patreon — Exclusive Research & Analysis

This article is for informational purposes only and does not constitute investment advice. All figures are as of publication date. Positions and prices change; verify current data before acting on any information herein.

Primary Sources

• SEC EX-10.2 — Third Point Cooperation Agreement (April 6, 2025)

• CoStar Board Refreshment & CAC Announcement (April 7, 2025)

• D.E. Shaw Full Letter PDF (February 4, 2026)

• Third Point Letter to CoStar Board (January 27, 2026)

• CoStar Jan. 7, 2026 Strategic Update (CoStar IR)

• CoStar Jan. 28, 2026 Response to Third Point — $2.3B/35% 2030 target (Business Wire)

• CoStar Q3 2025 Earnings Release — 26,000 Members / 150% growth sourced here

• CoStar Homes.com Inman Award — 115M Homes.com Network visitors confirmed

• CoStar Homes.com Investment Reduction (Real Estate News)

• CoStar $1.5B Buyback Coverage (Investing.com)

• CSGP Analyst Forecasts (StockAnalysis.com)

• CSGP Current News & Data (StockTitan)

• D.E. Shaw PR Newswire Release (Yahoo Finance)

Cover photograph: ajay_suresh, CC BY 2.0, via Wikimedia Commons.

Apollo profited shorting from 95¢ to 50¢. Marathon bought at 40¢, sold DIP at 105¢. UBS lost $500M on 17% yields. Onset extracted $400M on 300% IRRs. The complete execution breakdown of 2025’s defining credit disaster and systemic fraud.

The September 28, 2025 bankruptcy filing of First Brands Group revealed $10-$50 billion in liabilities against $1-$10 billion in assets, exposing what federal prosecutors charged as systematic fraud involving $2.3 billion in fabricated receivables. The Cleveland-based automotive parts manufacturer accumulated approximately $6.1 billion in on-balance-sheet debt plus billions more in off-balance-sheet obligations — a structure so complex that multiple hedge funds made (and lost) fortunes on both sides of the trade.

This is the complete execution breakdown: who made money (Apollo, Diameter, Marathon), who lost billions (UBS, Millennium, Jefferies), how Onset extracted $400M while claiming $1.9B more, the fraud mechanics behind $2.3 billion in vanished receivables, and the four alpha generation playbooks that separated winners from losers. Based on federal court documents, bankruptcy filings, and reporting from Bloomberg, Financial Times, and creditor filings.

The Profitable Shorts: Apollo’s Year-Long CDS Bet Pays Off

Apollo Global Management held a credit default swap position against First Brands for at least a year, paying significant fees while conviction built around the unsustainability of the company’s capital structure. To circumvent First Brands’ disqualified lender list, Apollo used a workaround where a counterparty bought and sold debt on Apollo’s behalf without settlement.

The Price Collapse Timeline:

• Early September 2025: Loans trading near 95¢

• September 12: After Apollo’s position disclosed, loans drop to mid-80¢

• Mid-September: The $2 billion term loan collapses to below 50¢ — one of the sharpest loan selloffs in 2025

• September 19: Apollo and Diameter Capital close shorts profitably

• September 28: First Brands files bankruptcy

The 95¢ to 50¢ collapse generated substantial profits for short sellers. Diameter Capital Partners, an $11 billion credit manager founded in 2017, also closed its short profitably mid-September.

Apollo’s position stood out because of its ownership of Tenneco Inc., one of First Brands’ main rivals, and because Apollo told other market participants about its negative view on First Brands’ prospects.

The Marathon DIP Arbitrage: Buy at 40¢, Flip at 105¢, Watch It Crash to 30¢

Marathon Asset Management executed one of 2025’s most profitable bankruptcy trades — until the structure collapsed. Court documents show Marathon holds $238 million of first-lien and $41 million of second-lien loans, purchased at approximately 40¢ in late September.

Marathon’s CEO Bruce Richards told Bloomberg Television: “Great company, bad balance sheet.” As lead creditor in the steering committee, Marathon structured and provided primary funding for the $1.1 billion debtor-in-possession financing.

Marathon sold its entire stake in the new-money DIP at or above 105¢, according to the firm’s spokesperson. The sales came just weeks after Richards publicly promoted Marathon’s role to “help this great company exit bankruptcy as soon as possible.”

The Trade Math:

• Buy distressed term loans at ~40¢: $279M position = $111.6M cost

• Provide new DIP money at par, immediately tradable at premium

• Sell DIP new-money at 105¢: 5% instant profit plus fees

• Total return on DIP flip: 162.5% ROI in under two months

The Terminal Phase:

By December 9 — just 72 days post-filing — the super-senior DIP loan collapsed to 63¢. Three days later, by December 12, the DIP traded as low as 30¢ — an unprecedented impairment for bankruptcy financing.

Bankruptcy expert Bruce Markell, a former federal bankruptcy judge at Northwestern’s Pritzker School of Law, called the DIP’s collapse “unprecedented”. The collapse was triggered by revelations of extensive irregularities and concerns that First Brands would need additional super-super-senior financing that would further subordinate existing DIP holders.

UBS O’Connor: 17% Yields Turn Into $500M+ Loss

UBS has more than $500 million of exposure to First Brands across its investment arm. The Chicago-based O’Connor hedge fund unit revealed that 30% of one fund’s exposure ties to First Brands — 9.1% “direct” exposure (invoices First Brands was due to pay) and 21.4% “indirect” exposure (invoices customers were due to pay).

The 17% Yield Strategy:

In January 2023, O’Connor provided investors with a case study on a “North American auto parts manufacturer” matching First Brands’ 2022 accounts. The case study disclosed O’Connor was earning 17% yields on 60-day investments linked to supply chain finance. The case study noted that “risks include default and fraud” — a disclosure that proved prescient but insufficient.

O’Connor’s funds invested through Raistone, a technology platform whose business was heavily dependent on First Brands. Founded in 2019 by former Greensill Capital employee David Skirzenski, Raistone derived more than 80% of revenues from First Brands.

The Position Sizing Failure:

The 30% concentration sparked concern among investors previously assured the fund wouldn’t hold more than 20% in a single “position.” O’Connor split the 21.4% “indirect” exposure across First Brands’ various investment-grade rated customers, meaning the exposure technically didn’t exceed the 20% limit.

UBS announced it would wind down O’Connor’s working capital funds, projecting 70% recovery by year-end 2025 — meaning 30% permanent loss on $500M+ equals losses exceeding $150M.

The $1.9B Onset Mystery: 300% IRRs, $150M Kickbacks, and the 179% Deal

Onset Financial amassed $1.9 billion in claims through inventory-backed financing. According to January 6, 2026 bankruptcy filings, Onset provided financing secured by First Brands inventory in exchange for average internal rates of return exceeding 300%.

The September 2022 Deal:

Court filings reveal that days after Edward James (Patrick’s brother and First Brands’ senior vice president) agreed to an inventory loan with an alleged 179% internal rate of return, a First Brands employee sent an internal message: “dude..whoever sold that onset deal to us is [Onset] employee of the century.” The message captures employees’ awareness that “the company was being fleeced,” according to the creditors’ committee.

Edward James’ $150M Co-Investment:

Edward James invested nearly $150 million alongside Onset, hoping to extract nearly $280 million from First Brands “before the house of cards came crashing down,” according to First Brands’ January 9 lawsuit. His anticipated $130M profit came from participating in the same deals he was approving on First Brands’ behalf.

The Cash Extraction:

“Before the music stopped, Onset obtained over $2.3 billion in payments,” the lawsuit states. Additional court documents show First Brands transferred more than $600 million to Onset as of September, bringing total payments to about $2.9 billion.

According to creditors’ filings, Onset advanced no more than $2.5 billion but collected approximately $2.9 billion — a $400 million net profit — while claiming an additional $1.9 billion owed through bankruptcy. The committee labeled Onset a “net winner” from the alleged fraud.

The Fraud Mechanics: $2.3B in Fabricated Invoices and Triple-Pledging

The January 29, 2026 federal indictment charges Patrick James and Edward James with wire fraud, bank fraud, and money laundering, alleging they “double- and triple-pledged loan collateral” while inflating invoices up to 10x their actual value.

Invoice Inflation — 10x Markups:

In one example, an invoice package worth $2.3 million was listed at $11.2 million after submission — individual invoices inflated to 10x or more their actual values, according to restructuring CEO Charles Moore.

Prosecutors note that when receivables financing providers began probing invoices in 2023, Patrick James changed strategy. When a financing company’s auditor questioned Edward James about “huge” discrepancies between actual invoices and previously provided information, Patrick James allegedly directed that emails from certain third parties be restricted to an inner circle.

The Missing $2.3 Billion:

Raistone filed an October 8 motion arguing $2.3 billion “has simply vanished.” When Raistone’s lawyers asked whether First Brands “actually received $1.9 billion” and how much had been transferred to segregated accounts, First Brands’ counsel replied: “We don’t know.” “US$0”.

Katsumi Global, a joint venture between Norinchukin Bank and Mitsui & Co., extended $1.75 billion in trade financing. Katsumi claims approximately $1.75 billion is owed. A lawyer representing the lender told an October 1 court hearing they believed around $1.9 billion of the $2.3 billion “had not been turned over to the factoring companies.”

Millennium Management: $100M Writedown Triggers Risk Review

Millennium Management, one of the world’s largest multi-strategy hedge funds with $79 billion AUM, took a $100 million writedown as First Brands collapsed. An investing team led by Sean O’Sullivan held exposure to supply chain finance structures.

For Millennium — which operates on tight risk limits where portfolio managers face capital cuts after 5% losses — the writedown was significant enough to trigger internal reviews.

Jefferies’ $715M Receivables Trap

Jefferies Financial Group holds $715 million in receivables through its Leucadia Asset Management funds, specifically through Point Bonita Capital, a private credit fund that marketed itself on “detailed research and credit analysis”. The receivables were invested in invoices from Walmart, AutoZone, and NAPA.

In bankruptcy filings, Jefferies noted First Brands indicated “its special advisors were investigating whether receivables had been turned over to third-party factors upon receipt and whether receivables may have been factored more than once.” That structural logic — that receivables represented claims against creditworthy customers — collapsed when advisors discovered systematic double-pledging.

Jefferies separately disclosed $48 million in exposure through its Apex Credit Partners CLO business. Morgan Stanley analysts predicted Jefferies would lose over $40 million on the collapse.

Four Alpha Generation Playbooks: What Worked and What Failed

The First Brands collapse created four distinct execution strategies. Winners identified structural weaknesses early and positioned for specific outcomes. Losers chased yields without understanding collateral reality or concentrated risk beyond stated limits. Here’s the complete breakdown:

1. Credit Deterioration Shorts (Apollo/Diameter Model):

• Entry: Establish CDS or synthetic short 12–18 months before stress

• Target: Loans trading at 85–95¢ with refinancing walls 18–24 months out

• Execution: Exit as loans breach 50¢ before liquidity evaporates

• Returns: Substantial profits as loans fell from 95¢ to 50¢

• Risk: High shorting costs, illiquid corporate loan markets

2. DIP Arbitrage (Marathon Model):

• Entry: Buy distressed term loans at 35–45¢ during pre-bankruptcy panic

• Structure: Lead creditor committee to dictate DIP terms

• DIP Provision: Provide new money at par with super-senior priority

• Exit: Flip DIP at 105¢+ within 60–90 days (5–8% instant return)

• Hold: Retain distressed term loans for recovery value

• Risk: DIP can collapse if fraud deeper than expected (30¢ in 72 days)

3. Supply Chain Finance Yield Extraction (What NOT to Do):

• Pitch: 17% yields on 60-day paper through intermediation platforms

• Structure: Investment-grade customer credit risk theoretically shifts away from borrower

• Fatal Errors: 30% concentration + intermediation distance + ignoring “risks include fraud” disclosure

• Result: $500M+ losses, fund wind-down at 70% recovery

4. Bankruptcy Claims Trading:

• Entry: Acquire distressed secured claims at 20–40¢ post-bankruptcy

• Focus: Collateral-backed positions where fraud allegations create pricing dislocations

• Target: 50–70% recoveries over 18–36 month bankruptcy process

• Expected IRR: 15–25% if secured status survives fraud challenges

Five Red Flags Sophisticated Lenders Missed

The winning trades shared one commonality: early detection of structural instability. The losing trades missed warning signals that, in hindsight, were obvious. These five red flags separated Apollo’s profitable short from UBS’s $500M loss:

1. Margin Expansion Diverging From Industry: First Brands reported margins significantly exceeding industry norms, according to asset-backed finance specialists who declined transactions after observing discrepancies.

2. Off-Balance Sheet Proliferation: 70% of revenues came from factoring payments — an extreme concentration that obscured true liquidity.

3. Usurious Interest Rates: Some arrangements carried interest rates exceeding 30%, which T. Rowe Price’s Oak Hill Advisors noted “should have raised concerns among lenders.”

4. Documentation Resistance: Multiple lenders reported receiving “unsatisfactory answers when querying financial statements”, and several reduced credit lines when First Brands failed to provide documentation.

5. Covenant-Lite Structures: First Brands’ reliance on covenant-lite loans allowed it to avoid triggering early intervention mechanisms, masking off-balance-sheet obligations for years.

The Cockroaches in the Stack: Systemic Risk and Future Plays

Individual wins and losses tell the execution story. But the Federal Reserve, Bank of England, and IMF warnings signal First Brands isn’t isolated — it’s indicative. When the central bank explicitly names an “auto parts supplier” as a systemic risk, the implications extend far beyond Cleveland.

The Federal Reserve’s explicit citation of an “auto parts supplier” bankruptcy in its November 7 Financial Stability Report elevated concerns from operational failures to systemic financial stability risks. When the central bank specifically warned about “risks from opaque off-balance-sheet funding, potentially amplifying spillovers to banks and nonbanks,” middle market lenders faced regulatory scrutiny that will reshape due diligence requirements.

JPMorgan CEO Jamie Dimon captured the moment on an October earnings call: “When you see one cockroach, there are probably more.”

The Bank of England is planning a “stress test” with the private credit industry, noting “parallels with the early stages of the global financial crisis.” The IMF warned in October 2024 that U.S. and European banks could be destabilized by $4.5 trillion in exposure to non-bank lenders.

Federal Reserve research found banks are “increasingly involved in private credit” through partnerships, fund financing, and structured risk transfers. “Banks’ extensive links could be a concern because those links indirectly expose banks to the traditionally higher risks associated with private credit loans,” Boston Fed economists concluded.

For hedge funds running credit books in 2026, the alpha opportunity lies in finding the next First Brands before it files — and positioning accordingly, with proper sizing discipline and direct borrower diligence that cuts through intermediation layers. The funds that made money on First Brands weren’t the ones chasing 17% yields. They were the ones shorting at 95¢, buying at 40¢, or structuring DIP terms that created instant arbitrage opportunities.

And critically: they were the ones who knew when to exit.

📊 Want Deeper Quantitative Analysis?

This research took significant time for data collection, verification, and analysis across 80+ sources including court filings, bankruptcy documents, DOJ indictments, and institutional reporting. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon.

By joining, you’ll be supporting my work and motivating me to publish more content like this.

→ Join the Patreon community here

About the Author

Navnoor Bawa | Quantitative Analyst & Systematic Trader

I specialize in institutional-grade research, credit market analysis, and quantitative trading strategies. This analysis represents the type of deep-dive execution breakdowns I publish regularly.

Connect:

• 📺 YouTube: @TheMathematicalTrader — Quantitative analysis, trading strategies, and market breakdowns

• 💼 LinkedIn: Navnoor Bawa — Professional network and industry insights

• 💰 Patreon: Exclusive Research — Premium analysis and trading strategies

Analysis based on federal court documents, bankruptcy filings, DOJ indictments, and reporting from Bloomberg, Reuters, Financial Times, Crain’s Cleveland Business, GTReview, and Transport Topics. All figures and quotes verified against primary sources.

Cover photograph: King of Hearts, CC BY-SA 3.0, via Wikimedia Commons.

A forensic examination of Blue Owl Capital Corporation’s (NYSE: OBDC) controversial merger termination, the resulting 21–23% NAV discount, massive redemption pressure, class action litigation, $200M corporate buyback program, $7M+ insider purchases, and whether this represents a value opportunity or justified risk premium.

When Blue Owl Capital terminated the OBDC/OBDC II merger on November 19, 2025, it wasn’t just a failed corporate action — it was the unraveling of a liquidity crisis that exposed fundamental tensions between Blue Owl’s public BDC shareholders and its private fund investors. The proposed merger would have forced OBDC II’s private investors to accept shares at 0.80x NAV, effectively imposing a 20% haircut to solve growing redemption pressure.

The market reaction was severe: OBDC’s stock plummeted from the mid-$15 range to as low as $11.70, creating a 21–23% discount to the company’s $14.89 NAV. Class action lawsuits immediately followed, alleging material misrepresentation. But in the midst of market capitulation, Blue Owl’s management executed an unprecedented defense: a $200M corporate share repurchase program combined with $7.1M in personal insider purchases at $15.06.

The central question for investors: Is OBDC’s current 21–23% NAV discount an irrational dislocation that insiders are exploiting, or does it accurately reflect legitimate risks around floating-rate credit exposure, dividend sustainability, and ongoing redemption pressure? This analysis deconstructs the merger failure, examines the underlying credit portfolio, evaluates management’s capital deployment response, and presents both the bull and bear cases for OBDC at current levels.

Executive Summary: Key Facts and Timeline

What Happened:

• November 5, 2025: Blue Owl announced merger of OBDC and OBDC II at 0.80x NAV exchange ratio

• November 19, 2025: Merger terminated after investor backlash over 20% forced haircut

• November-December 2025: Stock declined from ~$15 to $11.70-$12.65 range

• Current Status: OBDC trades at 21–23% discount to $14.89 NAV (as of February 14, 2026)

Management Response:

• Corporate Defense: $200M share repurchase program authorized (18-month window)

• Insider Purchases: $7.1M in personal stock purchases by executives at $15.06

• Current Insider Position: Down 17–22% from entry prices

Key Controversies:

• Redemption Pressure: OBDC II experienced $150M in redemptions over 9 months; Q3 2025 redemptions hit 6% of NAV

• Litigation: Class action lawsuit (Goldman v. Blue Owl, Case 1:25-cv-10047) alleging material misrepresentation

• Portfolio Overlap: 98% identical holdings between OBDC and OBDC II raised conflict of interest questions

Investment Metrics (Current):

• Stock Price: $11.70-$12.65 (high volatility)

• NAV: $14.89 per share

• Discount to NAV: 21–23%

• Dividend Yield: 11.7% at current prices

• Portfolio Size: $17.1B across 238 companies

• Non-Accrual Rate: 1.3% (exceptionally low)

The Merger Mechanics: What Was Proposed and Why It Failed

On November 5, 2025, Blue Owl announced a merger between its listed BDC, Blue Owl Capital Corp (OBDC), and its private BDC, Blue Owl Capital Corp II (OBDC II). On paper, the exchange ratio looked fair: NAV for NAV, meaning each dollar of NAV in OBDC II would convert to exactly one dollar of NAV in OBDC shares.

The problem was immediate and brutal. OBDC’s stock traded at an approximately 20% discount to NAV, according to Morningstar’s analysis. This meant private investors holding OBDC II at par (100% of NAV) would exchange $100 of actual value for OBDC shares worth only $80 in the open market — an instant 20% haircut with no credit deterioration or fundamental deterioration justifying the loss.

The Financial Times exposed the mechanics on November 16, 2025, quoting OBDC CFO Jonathan Lamm’s candid admission that investors “could take a potential haircut on their investments.” The article revealed two critical details that turned investor sentiment decisively negative:

1. OBDC II investors were blocked from redemptions until merger completion in 2026

2. The 20% loss resulted purely from market discount mechanics, not from any portfolio quality issues

The backlash was swift and definitive. Within three days, Blue Owl terminated the merger, citing “current market conditions.”

The Hidden Liquidity Crisis: Why Blue Owl Needed This Merger

The real question was: Why would Blue Owl management propose a merger structure that openly imposed 20% losses on one investor class? The answer emerged in court documents and subsequent reporting — OBDC II was experiencing accelerating redemption pressure that threatened the fund’s semi-liquid structure.

The lawsuit Goldman v. Blue Owl Capital Inc. (Case №1:25-cv-10047, S.D.N.Y.) alleges management systematically misrepresented the severity of redemption pressure. The complaint details specific numbers that tell the story of a fund approaching its structural limits:

• $150 million withdrawn from OBDC II in the first nine months of 2025, representing a 20% year-over-year increase in redemption requests

• Q3 redemptions doubled to $60 million, representing 6% of NAV in a single quarter

• Tender requests exceeded the 5% quarterly limit in May and August 2025, forcing the fund to prorate redemptions

InvestmentNews reported that while executives publicly claimed “no meaningful pressure,” internal data showed the fund’s liquidity program was “consistently operating near the functional limit of semi-liquid design.”

The merger wasn’t an opportunistic consolidation — it was an emergency liquidity solution. By converting illiquid OBDC II investors into liquid OBDC shareholders, management could solve the redemption crisis by giving investors an exit via the public markets rather than through the fund’s constrained quarterly tender offers.

The Market Reaction: How Transparency Destroyed Value

Once the Financial Times exposed the forced haircut structure, the market repriced OBDC immediately. Investors who thought they owned a stable BDC suddenly realized they owned a vehicle with:

1. Hidden redemption pressure in the related private fund (OBDC II)

2. Management willing to impose mandatory losses on one investor class to solve another’s liquidity problem

3. 98% portfolio overlap between the public and private vehicles, creating structural conflicts of interest

4. Litigation risk from a class action lawsuit alleging material misrepresentation

The stock collapse was severe and systematic:

• November 6: Closed at $14.95, down 4.72% following merger announcement

• November 17: Dropped 5.8% following the Financial Times exposé

• November 19: Merger officially terminated citing “current market conditions”

• December 2025-February 2026: Trading range $11.70-$12.65 with significant volatility (Feb 9 low: $11.74; Feb 14 intraday: $12.50)

The parent company also suffered collateral damage. Reuters and US News reported that Blue Owl Capital Inc. (OWL) shares fell 36% in 2025 after the merger controversy, significantly damaging the firm’s market capitalization and reputation.

Short interest surged 24.2% in December 2025, reaching 13.9 million shares (2.7% of float) with a days-to-cover ratio of 2.9, indicating systematic bearish positioning from institutional investors.

Management’s Counterattack: The $200M Defense Program

Faced with accelerating stock decline and mounting criticism, Blue Owl’s management executed a two-pronged capital deployment strategy that sent a clear signal: they believed the market had overreacted. The defense consisted of a massive corporate share repurchase program combined with substantial personal insider purchases — the largest coordinated support program in recent BDC history.

Corporate Share Repurchase: $200M Authorized

On November 4, 2025 — one day before the merger announcement — Blue Owl authorized a $200 million share repurchase program with an 18-month execution window. The timing suggests management anticipated significant market volatility and positioned defensively.

The Financial Times confirmed that Blue Owl and its employees committed $200 million to buying stock: approximately $70 million in parent company (OWL) shares and $135 million across the two listed credit funds (OBDC and OTF combined).

The buyback program authorizes purchases at management’s discretion when shares trade below NAV, creating mechanical accretion for remaining shareholders with each repurchase.

Executive Insider Purchases: $7.1M in Personal Conviction

Douglas Ostrover (Co-CEO):
Purchased 158,000 shares at $15.06 across December 1–2, 2025:

• December 1: 18,673 shares at $15.0557

• December 2: 139,327 shares at $15.0605

• Total value: $2.38 million

Marc Lipschultz (Co-CEO):
Acquired 158,000 shares total ($2,379,469) across December 1–2:

• December 1: 9,337 direct + 9,337 trust at $15.0557

• December 2: 69,663 direct + 69,663 trust at $15.0605

• Total ownership post-purchase: 79,000 direct + 79,000 trust

Craig Packer (Co-President & OBDC CEO):
Purchased 125,000 shares on December 2, 2025, with total value exceeding $1.8 million.

Alan Kirshenbaum (CFO):
Bought 33,670 shares on December 1 at $14.87 per share ($500,672).

Total insider purchases approached $7.1 million in 90 days, according to InsiderScreener. These executives receive 100% equity compensation — their purchases represent additional conviction beyond mandatory stock awards.

Brian McKenna, analyst at Citizens JMP Securities, stated: “Buybacks and insider buying are the strongest signals companies can send to all market participants.”

Current Reality Check: As of February 14, 2026, insiders who purchased at $15.06 are down 17–22% (stock currently trading $11.70-$12.65). This raises the critical question: Are insiders catching a falling knife, or do they see value that the market is missing?

The answer requires examining what the market is actually discounting — the underlying credit portfolio quality.

The Credit Quality Analysis: What Does the Portfolio Actually Look Like?

The market priced OBDC as if it were a distressed credit vehicle facing imminent portfolio deterioration. But examining the actual portfolio fundamentals reveals a different picture — one that suggests the 21–23% NAV discount may be disconnected from underlying credit quality.

Portfolio Fundamentals (Q3 2025 Actual Data)

From OBDC’s September 30, 2025 earnings report:

• 238 portfolio companies with $17.1 billion fair value

• Non-accruals: 1.3% of portfolio (increased from 0.7% in Q2, but below BDC sector average)

• 98% portfolio overlap with OBDC II — identical credit exposure

• NAV per share: $14.89 (vs. $15.03 in Q2)

CEO Craig Packer stated during the November 6 earnings call: “The fundamental performance of the portfolio remains strong, driving our earnings power and positioning OBDC to generate attractive risk-adjusted returns across any economic environment.”

The Parent Company Context

Blue Owl Capital Inc.’s Q4 2025 earnings (February 5, 2026) revealed:

• $307 billion AUM as of December 31, 2025

• $56 billion raised in 2025 (record year)

• Direct lending portfolio: High single-digit revenue growth, low-teens EBITDA growth YoY

• Technology portfolio: 40% cumulative revenue growth, 50% EBITDA growth since November 2022

• Average net realized loss rate: 8 basis points (well below industry average)

Marc Lipschultz addressed AI disruption fears directly: “The tech portfolio continues to be the most pristine amongst all of our portfolios… we don’t have red flags. In point of fact, we don’t have yellow flags. We actually have largely green flags.”

The Trade Thesis: NAV Convergence Play or Value Trap?

The structural opportunity emerged from the disconnect between OBDC’s fundamentals and its market price — but that disconnect exists for documented reasons, not irrational panic.

What Actually Happened vs. What the Market Priced In

The merger controversy revealed information that changed how investors valued OBDC:

1. Hidden redemption pressure at OBDC II ($150M in 9 months, Q3 at 6% of NAV)

2. Management willingness to impose losses on one investor class to solve liquidity issues

3. Structural vulnerability to NAV discounts in the public BDC (98% portfolio overlap with stressed private fund)

4. Litigation risk from class action lawsuits alleging material misrepresentation

The market repriced OBDC from $15.06 (insider purchase level) to $11.70-$12.65 (current range) — a 17–22% decline. The question: Is this overcorrection or appropriate risk adjustment?

Entry Price vs. NAV Gap

• NAV per share (Q3 2025): $14.89

• Market price (early December): $15.00-$15.06 (insider purchase level)

• Market price (current Feb 14, 2026): $11.70-$12.65

• Discount to NAV: Approximately 15–17% at insider entry; 21–23% currently (at $11.70-$11.74 low)

Seeking Alpha analysis (February 12, 2026) concluded: “Even under a pessimistic 25% dividend cut scenario, OBDC is undervalued by nearly 20% versus its intrinsic value and NAV.”

The Buyback Arbitrage

The $200 million repurchase program creates mechanical NAV accretion:

• Purchases executed at management’s discretion when shares trade below NAV

• Each dollar spent retires shares trading below intrinsic value

• Remaining shareholders capture the spread

• 18-month authorization provides sustained buying pressure

Morningstar’s analysis noted: “With OBDC’s market price trading at a roughly 20% discount to its NAV, the merger made it highly likely that OBDC II investors would immediately suffer a 20% markdown.”

The buyback inverts this dynamic: OBDC uses the discount to acquire its own shares cheaply, benefiting long-term holders.

Historical Context: The OBDE Precedent

Blue Owl completed a similar merger in January 2025 between OBDC and Blue Owl Capital Corporation III (OBDE). That transaction:

• Occurred with OBDC trading at NAV discount

• OBDE investors received favorable pricing tied to OBDC stock price

• Successfully closed without investor revolt

The OBDC II merger failed because management attempted a straight NAV-for-NAV exchange when the public vehicle traded at 20% discount — a critical tactical error.

The Current Opportunity: Contrarian Bet or Value Trap?

As of February 14, 2026, OBDC presents a high-conviction long case with documented insider support but faces real headwinds.

Bull Case: Structural Undervaluation

Dividend Yield: 11.7% based on $1.48 annual dividend (maintained through Q4 2025)
Price/Book: 0.84x to 0.85x (36% below BDC sector median)
Spillover Income: $0.34 per share cushion for dividend coverage
Insider Signal: $7.1M in executive purchases in 90 days
Buyback Support: $200M authorized, actively deploying

Analyst price targets average $14.44 (15–23% upside from current $11.70-$12.50 range).

Bear Case: Why the Discount Exists

Floating Rate Exposure: 97.4% of portfolio — vulnerable to Federal Reserve rate cuts
Non-Accrual Trend: Increased from 0.7% to 1.3% Q2 to Q3 2025
Redemption Overhang: OBDC II situation unresolved — management must find alternative solution
Sector Weakness: BDC sector down broadly on private credit concerns
Dividend Risk: Q3 dividend ($0.37) not fully covered by NII; analysts expect 10–15% cut in 2026

PitchBook reported that Craig Packer acknowledged the company would “reevaluate alternatives” for OBDC II in future. The redemption pressure hasn’t disappeared — it’s deferred.

The Litigation Wildcard

Six law firms filed securities class actions including Goldman v. Blue Owl. Lead plaintiff deadline was February 2, 2026.

Allegations include:

• Materially false statements about redemption pressure

• Failure to disclose liquidity stress at OBDC II

• Insider stock sales at inflated prices in April 2025 (114,228 shares, $1.69M)

Settlement risk adds uncertainty to the thesis.

Bottom Line on Bull vs Bear: The bull case relies on mean reversion toward NAV supported by buybacks and stable credit fundamentals. The bear case points to legitimate structural risks (floating-rate exposure, dividend coverage pressure, unresolved redemption issues) that may justify a persistent discount. Both views are data-driven and rational — the discount exists for reasons beyond mere panic.

Lessons for Systematic Investors: What This Case Study Teaches

The Blue Owl situation offers three durable insights:

1. NAV Discounts Create Asymmetry Only When Quality is Unimpaired

OBDC’s 20% NAV discount would be justified if the portfolio were deteriorating. At 1.3% non-accruals with upper middle-market focus ($1B+ revenue, $229M average EBITDA), the discount reflects sentiment, not fundamentals.

The trade works if credit quality holds. If non-accruals spike to 3–5%, the NAV discount is warranted.

2. Insider Buying > Insider Rhetoric

Blue Owl executives spent $7.1 million of personal capital at $15.06. They didn’t buy at $14.00, $13.00, or $12.00 as the stock continued falling.

This suggests either: (a) they mis-timed the bottom, or (b) their conviction was about 12–18 month mean reversion, not short-term price action.

3. Forced Seller Dislocations Require Multi-Quarter Patience

The OBDC II redemption pressure created a narrative overhang that hasn’t cleared. Until Blue Owl announces a permanent solution — IPO, new tender program, or merger with better terms — the stock trades under a cloud.

📊 Want Deeper Quantitative Analysis?

This research took significant time for data collection, verification, and analysis. If you found value in this deep-dive, I publish exclusive quantitative research, trading strategies, and institutional-grade analysis on Patreon.

By joining, you’ll be supporting my work and motivating me to publish more content like this.

→ Join the Patreon community here

Conclusion: The Trade That Isn’t Finished

The “Blue Owl Arbitrage” is not a completed trade — it’s an ongoing bet on NAV convergence in a fundamentally sound but sentiment-damaged BDC trading at a historically wide discount.

What’s Proven:

• Executives invested $7.1M of personal capital at $15.06 in December 2025

• $200M corporate buyback program authorized for 18 months, executable when shares trade below NAV

• Portfolio quality remains stable: 1.3% non-accruals, $229M average borrower EBITDA, strong credit metrics

• Current 21–23% NAV discount (stock at $11.70-$12.65 vs $14.89 NAV)

• 11.7% dividend yield at current prices

What’s Not Proven:

• Whether the stock reaches $14.89 NAV within 12–18 months (currently $11.70-$12.65)

• Whether the $1.48 annual dividend is sustainable (analysts expect 10–15% cut)

• Whether OBDC II redemption situation resolves favorably or creates future overhang

• Whether floating-rate portfolio (97.4% of holdings) can maintain yield if Fed cuts rates aggressively

• Whether litigation from class action lawsuits creates material settlement risk

Current Reality Check:
Investors who bought alongside insiders at $15.06 are currently down 17–22% (at Feb 14 price of $12.50: down 17%; at Feb 9 low of $11.74: down 22%). The thesis requires OBDC to converge back toward NAV over 6–18 months — a bet that credit quality remains stable while market sentiment normalizes.

For systematic investors, this is a case study in reading primary sources over narratives. The lawsuit alleges fraud. The earnings calls claim resilience. The insider Form 4 filings document conviction with personal capital. The stock price reflects fear and structural uncertainty.

The trade requires answering one fundamental question: Do you believe the $14.89 NAV reflects economic reality, or do you believe the market’s 21–23% discount is justified by hidden risks?

Disclosure: This analysis is for educational purposes only. All data sourced from SEC filings, earnings transcripts, court documents, and public financial disclosures as linked throughout. This is not investment advice. Conduct your own due diligence before making investment decisions.

About the Author

Navnoor Bawa is a Quantitative Research. He specializes in systematic trading, hedge fund strategy analysis, and quantitative finance.

Connect & Follow:

• 📺 YouTube: The Mathematical Trader — Quantitative finance tutorials and strategy breakdowns

• 💼 LinkedIn: Navnoor Bawa — Professional updates and research publications

• 📈 Patreon: Exclusive Research — Deep-dive quantitative analysis and trading strategies

Cover photograph: Tdorante10, CC BY-SA 4.0, via Wikimedia Commons.